image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
9722bcc8fa60e40e09b985bb7174652931bd78de061db8c6edab563ba26d149c.png | complex | <table><tr><td> </td><td colspan="3">Intracerebral hemorrhage</td><td colspan="3">Ischemic stroke</td></tr><tr><td> </td><td>mRS ≤2* (n = 23)</td><td>mRS > 2 (n = 20)</td><td><i>P</i></td><td>mRS ≤2* (n = 82)</td><td>mRS > 2 (n = 81)</td><td><i>P</i></td></tr><tr><td>Age (years)</td><td>54.2 ± 12.9</td><td>66.8 ± 13.9</td><td>0.004</td><td>62.6 ± 14.0</td><td>68.3 ± 12.4</td><td>0.007</td></tr><tr><td>Male</td><td>15 (65.2)</td><td>13 (65)</td><td>1.000</td><td>64 (78.0)</td><td>47 (58.0)</td><td>0.007</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>25.1 ± 3.1</td><td>22.6 ± 3.8</td><td>0.023</td><td>25.9 ± 3.8</td><td>25.5 ± 3.7</td><td>0.528</td></tr><tr><td>Diabetes mellitus</td><td>8 (34.7)</td><td>2 (10.0)</td><td>0.076</td><td>30 (36.6)</td><td>37 (45.7)</td><td>0.267</td></tr><tr><td>Hypertension</td><td>21 (91.3)</td><td>18 (90.0)</td><td>1.000</td><td>53 (64.6)</td><td>66 (81.5)</td><td>0.021</td></tr><tr><td>Hyperlipidemia</td><td>3 (13.0)</td><td>6 (30.0)</td><td>0.263</td><td>25 (30.5)</td><td>28 (34.6)</td><td>0.618</td></tr><tr><td>Atril fibrillation</td><td>1 (4.3)</td><td>1 (5.0)</td><td>1.000</td><td>17 (20.7)</td><td>25 (30.9)</td><td>0.155</td></tr><tr><td>History of stroke</td><td>3 (13.0)</td><td>4 (20.0)</td><td>0.687</td><td>10 (12.2)</td><td>26 (32.1)</td><td>0.002</td></tr><tr><td>WBC (10<sup>3</sup>/μl)</td><td>10.2 ± 4.4</td><td>10.3 ± 2.8</td><td>0.860</td><td>8.3 ± 2.8</td><td>9.3 ± 4.0</td><td>0.050</td></tr><tr><td>Hemoglobin</td><td>14.9 ± 1.3</td><td>13.0 ± 4.4</td><td>0.057</td><td>14.6 ± 3.7</td><td>13.9 ± 1.9</td><td>0.173</td></tr><tr><td>Glucose (mg/dl)</td><td>137.3 ± 59.2</td><td>113.5 ± 32.3</td><td>0.117</td><td>145.5 ± 61.9</td><td>148.8 ± 55.8</td><td>0.723</td></tr><tr><td>Creatinine (mg/dl)</td><td>1.2 ± 0.7</td><td>1.1 ± 0.4</td><td>0.492</td><td>1.2 ± 1.0</td><td>1.3 ± 0.9</td><td>0.356</td></tr><tr><td>NIHSS</td><td>9.7 ± 5.5</td><td>17.6 ± 7.6</td><td><0.001</td><td>5.1 ± 5.8</td><td>13.1 ± 7.4</td><td><0.001</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>184.1 ± 44.5</td><td>190.1 ± 38.2</td><td>0.640</td><td>157.9 ± 31.8</td><td>160.8 ± 32.7</td><td>0.565</td></tr><tr><td>HA < 48 hours (ng/ml)</td><td>202.7 ± 134.1</td><td>310.1 ± 225.9</td><td>0.061</td><td>195.9 ± 164.0</td><td>226.0 ± 242.6</td><td>0.356</td></tr><tr><td>HA 48 to 72 hours (ng/ml)</td><td>271.1 ± 226.8</td><td>879.6 ± 1594.7</td><td>0.077</td><td>206.1 ± 304.2</td><td>379.2 ± 698.0</td><td>0.053</td></tr></table> |
f1a414cfb21bcb80ca0ca418afe7435b13966e6a0efb14c0458214372796b883.png | complex | <table><tr><td></td><td colspan="3">Level of BCPO<sup>d</sup> (%)</td><td></td><td colspan="3"><i>P</i> value</td></tr><tr><td>Parameter</td><td>0</td><td>4</td><td>8</td><td>SEM</td><td>Overall</td><td>Linear</td><td>Quadratic</td></tr><tr><td>C14:0, myristic</td><td>6.67<sup>a</sup></td><td>5.70<sup>b</sup></td><td>5.04<sup>c</sup></td><td>0.53</td><td>0.048</td><td>0.049</td><td>0.395</td></tr><tr><td>C16:0, palmitic</td><td>27.06</td><td>27.05</td><td>24.22</td><td>1.18</td><td>0.170</td><td>0.334</td><td>0.104</td></tr><tr><td>C16:1n-7, palmitoleic</td><td>3.49</td><td>3.44</td><td>2.74</td><td>0.44</td><td>0.409</td><td>0.461</td><td>0.266</td></tr><tr><td>C18:0, stearic</td><td>26.10</td><td>25.28</td><td>24.42</td><td>2.56</td><td>0.898</td><td>0.814</td><td>0.693</td></tr><tr><td>C18:1n-9, oleic</td><td>19.97<sup>b</sup></td><td>18.98<sup>b</sup></td><td>26.30<sup>a</sup></td><td>2.42</td><td>0.050</td><td>0.044</td><td>0.377</td></tr><tr><td>C18:1 <i>trans</i>-11 Vaccenic</td><td>3.48</td><td>4.27</td><td>4.87</td><td>0.73</td><td>0.422</td><td>0.569</td><td>0.239</td></tr><tr><td>CLA <i>cis</i>-9 <i>trans</i>-11</td><td>1.30</td><td>1.51</td><td>1.20</td><td>0.22</td><td>0.612</td><td>0.337</td><td>0.841</td></tr><tr><td>CLA<i> trans</i>-10<i> cis</i>-12</td><td>1.54</td><td>2.08</td><td>1.72</td><td>0.39</td><td>0.618</td><td>0.521</td><td>0.463</td></tr><tr><td>C18:2n-6, linoleic</td><td>3.63</td><td>3.65</td><td>3.53</td><td>0.53</td><td>0.986</td><td>0.878</td><td>0.953</td></tr><tr><td>C18:3n-3, linolenic</td><td>1.56</td><td>1.44</td><td>1.71</td><td>0.23</td><td>0.712</td><td>0.417</td><td>0.952</td></tr><tr><td>C20:4n-6, arachidonic</td><td>1.89</td><td>1.62</td><td>2.13</td><td>0.52</td><td>0.784</td><td>0.491</td><td>0.980</td></tr><tr><td>C20:5n-3, eicosapentaenoic</td><td>1.87<sup>c</sup></td><td>2.78<sup>b</sup></td><td>2.91<sup>c</sup></td><td>0.39</td><td>0.043</td><td>0.011</td><td>0.051</td></tr><tr><td>C22:5n-3, eicosapentaenoic</td><td>1.42</td><td>1.67</td><td>2.11</td><td>0.42</td><td>0.501</td><td>0.458</td><td>0.365</td></tr><tr><td>C22:6n-3, docosahexanoic</td><td>1.92</td><td>1.87</td><td>2.29</td><td>0.52</td><td>0.824</td><td>0.574</td><td>0.804</td></tr><tr><td>Total FA (mg/g of fat)</td><td>842.23</td><td>925.87</td><td>982.87</td><td>160.09</td><td>0.827</td><td>0.804</td><td>0.577</td></tr><tr><td colspan="8">FA sums and ratios</td></tr><tr><td>∑SFA</td><td>59.83</td><td>58.03</td><td>54.09</td><td>3.24</td><td>0.402</td><td>0.353</td><td>0.328</td></tr><tr><td>∑MUFA</td><td>26.95</td><td>26.69</td><td>33.90</td><td>6.62</td><td>0.169</td><td>0.113</td><td>0.299</td></tr><tr><td>∑PUFA</td><td>15.12</td><td>16.61</td><td>17.60</td><td>1.61</td><td>0.437</td><td>0.563</td><td>0.606</td></tr><tr><td>∑n-3</td><td>7.013</td><td>7.76</td><td>9.028</td><td>0.86</td><td>0.268</td><td>0.307</td><td>0.205</td></tr><tr><td>∑n-6</td><td>6.22</td><td>5.27</td><td>5.653</td><td>0.76</td><td>0.696</td><td>0.730</td><td>0.442</td></tr><tr><td>n-6:n-3</td><td>0.89</td><td>0.68</td><td>0.69</td><td>0.09</td><td>0.195</td><td>0.921</td><td>0.074</td></tr><tr><td>UFA:SFA</td><td>0.70</td><td>0.91</td><td>0.77</td><td>0.11</td><td>0.411</td><td>0.317</td><td>0.317</td></tr><tr><td>PUFA:SFA</td><td>0.23</td><td>0.25</td><td>0.26</td><td>0.03</td><td>0.790</td><td>0.782</td><td>0.535</td></tr><tr><td colspan="8">Desaturase and elongase indices</td></tr><tr><td>ID16</td><td>11.42</td><td>11.28</td><td>10.12</td><td>0.87</td><td>0.711</td><td>0.418</td><td>0.111</td></tr><tr><td>ID18</td><td>43.35</td><td>42.88</td><td>51.85</td><td>2.99</td><td>0.612</td><td>0.234</td><td>0.516</td></tr><tr><td>Elongation Index (EI)</td><td>60.13</td><td>59.74</td><td>65.29</td><td>3.03</td><td>0.875</td><td>0.324</td><td>0.198</td></tr></table> |
6068031b53b8d4da48253ae184228a6d325426177cffe51c881e86246b665bd5.png | complex | <table><tr><td>Items</td><td>MS1 T1</td><td>M2 T1</td><td><i>p</i></td><td>Ms1 T2</td><td>MS2 T2</td><td><i>p</i></td><td>MS3 T3</td><td>MS4 T3</td><td><i>p</i></td></tr><tr><td colspan="10">How important are the following factors in considering your career in medicine?</td></tr><tr><td>Opportunities to make a difference in people’s lives</td><td>4.89</td><td>4.83</td><td>NS</td><td>4.88</td><td>4.83</td><td>NS</td><td>4.71</td><td>4.66</td><td>NS</td></tr><tr><td>Intellectual climate</td><td>4.41</td><td>4.52</td><td>NS</td><td>4.41</td><td>4.47</td><td>NS</td><td>4.23</td><td>4.13</td><td>NS</td></tr><tr><td>Desire to do primary care</td><td>3.04</td><td>2.74</td><td>.062</td><td>3.03</td><td>2.75</td><td>.074</td><td>3.04</td><td>2.88</td><td>NS</td></tr><tr><td>Availability of jobs</td><td>3.55</td><td>3.86</td><td>.032*</td><td>3.54</td><td>3.84</td><td>.44*</td><td>4.26</td><td>3.90</td><td>.025*</td></tr><tr><td>Job security</td><td>3.80</td><td>4.03</td><td>.099</td><td>3.80</td><td>4.00</td><td>NS</td><td>4.40</td><td>4.30</td><td>NS</td></tr><tr><td>Opportunity to help patients who are socially disadvantaged</td><td>4.71</td><td>3.89</td><td>.034*</td><td>4.15</td><td>3.90</td><td>.051*</td><td>3.84</td><td>3.51</td><td>.060</td></tr><tr><td>Desire to serve my community</td><td>4.42</td><td>4.32</td><td>NS</td><td>4.39</td><td>4.33</td><td>NS</td><td>4.23</td><td>3.66</td><td><.001*</td></tr><tr><td>High income potential</td><td>2.82</td><td>3.36</td><td><.001**</td><td>2.82</td><td>3.32</td><td><.001**</td><td>3.45</td><td>3.25</td><td>NS</td></tr><tr><td>Job satisfaction</td><td>4.76</td><td>4.75</td><td>NS</td><td>4.77</td><td>4.77</td><td>NS</td><td>4.84</td><td>4.78</td><td>NS</td></tr><tr><td>Status of physicians</td><td>2.69</td><td>2.97</td><td>.088</td><td>2.65</td><td>2.86</td><td>NS</td><td>2.84</td><td>2.80</td><td>NS</td></tr><tr><td colspan="10">How important are the following factors in considering your choice for a specialty?</td></tr><tr><td>Income expectations for the specialty</td><td>2.81</td><td>3.27</td><td>.002**</td><td>2.76</td><td>3.23</td><td>.001**</td><td>3.43</td><td>3.15</td><td>NS</td></tr><tr><td>Amount of education debt I have</td><td>2.81</td><td>3.04</td><td>NS</td><td>2.83</td><td>2.99</td><td>NS</td><td>3.30</td><td>3.09</td><td>NS</td></tr><tr><td>Ability to balance my work life with my family responsibilities</td><td>4.37</td><td>4.62</td><td>.013*</td><td>4.38</td><td>4.60</td><td>.026*</td><td>4.53</td><td>4.44</td><td>NS</td></tr><tr><td>Content of the specialty</td><td>4.69</td><td>4.70</td><td>NS</td><td>4.71</td><td>4.69</td><td>NS</td><td>4.59</td><td>4.70</td><td>NS</td></tr><tr><td>Competitiveness of the specialty</td><td>3.13</td><td>3.07</td><td>NS</td><td>3.11</td><td>3.06</td><td>NS</td><td>2.91</td><td>2.74</td><td>NS</td></tr><tr><td>Options for fellowship training associated with the specialty</td><td>3.25</td><td>3.47</td><td>NS</td><td>3.24</td><td>3.40</td><td>NS</td><td>3.51</td><td>3.58</td><td>NS</td></tr><tr><td>Length of residency training associated with the specialty</td><td>3.18</td><td>3.44</td><td>.080</td><td>3.17</td><td>3.48</td><td>.040*</td><td>3.48</td><td>2.98</td><td>.008**</td></tr><tr><td>The lifestyle of the specialty I am considering</td><td>4.20</td><td>4.42</td><td>.066</td><td>4.20</td><td>4.38</td><td>NS</td><td>4.36</td><td>4.16</td><td>NS</td></tr><tr><td>Prestige of the specialty I am considering</td><td>2.20</td><td>2.49</td><td>.042*</td><td>2.17</td><td>2.42</td><td>.072</td><td>2.41</td><td>2.59</td><td>NS</td></tr><tr><td>Career workshops and courses</td><td>2.66</td><td>2.53</td><td>NS</td><td>2.63</td><td>5.47</td><td>NS</td><td>2.71</td><td>2.36</td><td>.054*</td></tr><tr><td>Opportunities to do research in this specialty</td><td>2.58</td><td>2.42</td><td>NS</td><td>2.57</td><td>2.38</td><td>NS</td><td>3.37</td><td>3.10</td><td>NS</td></tr><tr><td>Opportunities to provide care to underserved populations</td><td>3.43</td><td>3.28</td><td>NS</td><td>3.41</td><td>3.28</td><td>NS</td><td>3.37</td><td>3.10</td><td>NS</td></tr><tr><td colspan="10">Attitudes toward primary care</td></tr><tr><td>I would like to become a primary care doctor in the future.</td><td>3.12</td><td>2.97</td><td>NS</td><td>3.11</td><td>3.13</td><td>NS</td><td>3.13</td><td>2.62</td><td>.024*</td></tr><tr><td>I am more interested in learning the skills required for my chosen specialty rather than a general set</td><td>2.79</td><td>2.82</td><td>NS</td><td>2.75</td><td>2.69</td><td>NS</td><td>2.69</td><td>3.45</td><td><.001*</td></tr><tr><td>Primary care knowledge is useful for all medical students.</td><td>4.75</td><td>4.68</td><td>NS</td><td>4.75</td><td>4.70</td><td>NS</td><td>4.70</td><td>4.75</td><td>NS</td></tr><tr><td>Primary care should be a patient’s first contact with the health care system.</td><td>4.39</td><td>4.36</td><td>NS</td><td>4.38</td><td>4.68</td><td>NS</td><td>4.68</td><td>4.47</td><td>.060</td></tr><tr><td>Medical interviewing is a fundamental tool for all medical students to learn.</td><td>4.89</td><td>4.83</td><td>NS</td><td>4.92</td><td>4.87</td><td>.062</td><td>4.87</td><td>4.88</td><td>NS</td></tr><tr><td>Preventative care knowledge is essential for all medical students to learn.</td><td>4.83</td><td>4.53</td><td><.000**</td><td>4.85</td><td>4.70</td><td><.001**</td><td>4.70</td><td>4.67</td><td>NS</td></tr><tr><td>It is essential that medical students learn how to best communicate with patients</td><td>4.89</td><td>4.86</td><td>NS</td><td>4.91</td><td>4.89</td><td>NS</td><td>4.89</td><td>4.87</td><td>NS</td></tr><tr><td>Primary care doctors mostly manage chronic health problems.</td><td>3.26</td><td>3.79</td><td><.001**</td><td>3.25</td><td>3.89</td><td><.001**</td><td>3.89</td><td>3.81</td><td>NS</td></tr><tr><td>It is impossible to be an expert in such a wide field as primary care</td><td>2.69</td><td>3.0</td><td>.035*</td><td>2.69</td><td>2.97</td><td>.016*</td><td>2.97</td><td>3.31</td><td>0.76</td></tr><tr><td>Primary care is not very intellectually stimulating</td><td>1.90</td><td>2.22</td><td>.010*</td><td>1.91</td><td>2.47</td><td>.014*</td><td>2.47</td><td>2.58</td><td>NS</td></tr><tr><td>Primary care doctors have a large work overload.</td><td>3.63</td><td>3.95</td><td>.006**</td><td>3.63</td><td>4.15</td><td>.005**</td><td>4.15</td><td>4.05</td><td>NS</td></tr><tr><td>Primary care doctors are poorly valued by the rest of the medical profession.</td><td>3.48</td><td>3.76</td><td>0.22*</td><td>3.49</td><td>3.78</td><td>.033*</td><td>3.78</td><td>3.77</td><td>NS</td></tr><tr><td>A primary care doctor is clinically competent to provide most of the health care an individual may</td><td>3.96</td><td>3.99</td><td>NS</td><td>3.94</td><td>4.36</td><td>NS</td><td>4.36</td><td>4.36</td><td>NS</td></tr></table> |
61ddb634f850303156938c68d65a5cd676357a3f1df3c68b1f44b91763fc4c32.png | complex | <table><tr><td>Stigma</td><td colspan="4">Medication adherence</td><td>Total</td><td>Statistics</td></tr><tr><td></td><td colspan="2">Non adherent</td><td colspan="2">Adherent</td><td></td><td></td></tr><tr><td></td><td><i>f</i></td><td>%</td><td><i>f</i></td><td>%</td><td></td><td></td></tr><tr><td>No perceived stigma</td><td>8</td><td>9.2</td><td>79</td><td>90.8</td><td>87</td><td>χ<sup>2</sup> = 0.497</td></tr><tr><td>Experienced stigma</td><td>7</td><td>13.0</td><td>47</td><td>87.0</td><td>54</td><td><i>p</i> = 0.481</td></tr><tr><td>Total</td><td>15</td><td>10.6</td><td>126</td><td>89.4</td><td>141</td><td>-</td></tr></table> |
7f0242ff918556966d026c12303533cca03d61913e2eba5df07f81fa03bdc2bc.png | complex | <table><tr><td>Model</td><td>Parameters</td><td>True value</td><td>Mean estimation</td><td>Estimated error</td></tr><tr><td colspan="5">Three-way model</td></tr><tr><td>Case I</td><td>G-C/M-C/M-G</td><td>0.2</td><td>0.23</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-C/M-G</td><td>0.3</td><td>0.31</td><td>0.05</td></tr><tr><td>Case III</td><td>G-C/M-C/M-G</td><td>0.4</td><td>0.40</td><td>0.05</td></tr><tr><td colspan="5">Independent model</td></tr><tr><td>Case I</td><td>G-C/M-C</td><td>0.2</td><td>0.22</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-C</td><td>0.3</td><td>0.31</td><td>0.05</td></tr><tr><td>Case III</td><td>G-C/M-C</td><td>0.4</td><td>0.43</td><td>0.04</td></tr><tr><td>Causal model</td><td></td><td></td><td></td><td></td></tr><tr><td>Case I</td><td>G-C/M-G</td><td>0.2</td><td>0.23</td><td>0.04</td></tr><tr><td>Case II</td><td>G-C/M-G</td><td>0.3</td><td>0.31</td><td>0.05</td></tr><tr><td>Case III</td><td>G-C/M-G</td><td>0.4</td><td>0.41</td><td>0.04</td></tr><tr><td colspan="5">microRNA model</td></tr><tr><td>Case I</td><td>M-C</td><td>0.2</td><td>0.22</td><td>0.04</td></tr><tr><td>Case II</td><td>M-C</td><td>0.3</td><td>0.30</td><td>0.04</td></tr><tr><td>Case III</td><td>M-C</td><td>0.4</td><td>0.39</td><td>0.05</td></tr></table> |
60f181fc7f61bf64fb9bb25840e94a83f1e30babde182ff110da4db543064cb5.png | complex | <table><tr><td></td><td>Univariate OR (95 % CI)<sup>a</sup></td><td><i>p</i> value<sup>b</sup></td><td>Multivariate aOR (95 % CI)</td><td><i>p</i> value</td></tr><tr><td colspan="5">Sociodemographic</td></tr><tr><td> Intercept</td><td>–</td><td>–</td><td>4.78 (0.98, 23.41)</td><td>0.054</td></tr><tr><td> Age: per 5-year increase</td><td>0.85 (0.77, 0.94)</td><td><0.001</td><td>0.90 (0.81, 1.00)</td><td>0.057</td></tr><tr><td> Male</td><td>1.58 (1.07, 2.31)</td><td>0.020</td><td>1.26 (0.78, 2.04)</td><td>0.343</td></tr><tr><td> Born in Canada</td><td>1.09 (0.62, 1.91)</td><td>0.764</td><td>–</td><td>–</td></tr><tr><td> Province of enrolment</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>British Columbia</td><td>Ref.</td><td>Ref.</td><td>Ref.</td><td>Ref.</td></tr><tr><td>Ontario</td><td>0.50 (0.31, 0.81)</td><td>0.005</td><td>0.74 (0.43, 1.27)</td><td>0.275</td></tr><tr><td>Quebec</td><td>0.45 (0.30, 0.65)</td><td><0.001</td><td>0.42 (0.27, 0.67)</td><td><0.001<sup>*</sup></td></tr><tr><td>Other<sup>c</sup></td><td>0.24 (0.07, 0.84)</td><td>0.025</td><td>0.49 (0.14, 1.73)</td><td>0.265</td></tr><tr><td> Aboriginal</td><td>1.75 (1.08, 2.82)</td><td>0.022</td><td>1.12 (0.58, 2.13)</td><td>0.759</td></tr><tr><td> Heterosexual</td><td>1.52 (1.07, 2.16)</td><td>0.019</td><td>1.12 (0.73, 1.70)</td><td>0.605</td></tr><tr><td> Living alone<sup>d</sup></td><td>1.44 (1.09, 1.89)</td><td>0.010</td><td>1.31 (0.92, 1.87)</td><td>0.128</td></tr><tr><td> Without a fixed address<sup>d</sup></td><td>2.19 (1.16, 4.14)</td><td>0.016</td><td>1.19 (0.50, 2.84)</td><td>0.689</td></tr><tr><td> Recent changes in housing situation<sup>e</sup></td><td>1.44 (1.06, 1.95)</td><td>0.021</td><td>1.11 (0.73, 1.68)</td><td>0.635</td></tr><tr><td> Recent incarceration<sup>e</sup></td><td>1.96 (1.14, 3.36)</td><td>0.015</td><td>1.11 (0.59, 2.08)</td><td>0.749</td></tr><tr><td colspan="5">Socioeconomic</td></tr><tr><td> Employment<sup>d</sup></td><td>0.34 (0.24, 0.49)</td><td><0.001</td><td>0.55 (0.35, 0.87)</td><td>0.010<sup>*</sup></td></tr><tr><td> Average personal monthly income ($ CAD): per $100 increase<sup>e</sup></td><td>0.96 (0.93, 0.99)</td><td>0.012</td><td>0.98 (0.97, 0.99)</td><td>0.001<sup>*</sup></td></tr><tr><td> More than high school education</td><td>0.45 (0.30, 0.66)</td><td><0.001</td><td>0.72 (0.45, 1.13)</td><td>0.155</td></tr><tr><td colspan="5">Behavioral</td></tr><tr><td> Recent injection drug use<sup>e</sup></td><td>2.79 (2.02, 3.85)</td><td><0.001</td><td>1.98 (1.33, 2.96)</td><td><0.001<sup>*</sup></td></tr><tr><td> Marijuana use<sup>d</sup></td><td>1.82 (1.37, 2.42)</td><td><0.001</td><td>1.41 (0.99, 2.01)</td><td>0.060</td></tr><tr><td> Cigarette use<sup>d</sup></td><td>1.67 (1.18, 2.35)</td><td>0.004</td><td>0.98 (0.65, 1.50)</td><td>0.940</td></tr><tr><td> Alcohol use<sup>d</sup></td><td>1.28 (0.97, 1.67)</td><td>0.077</td><td>1.21 (0.84, 1.75)</td><td>0.301</td></tr><tr><td><underline>></underline>5 alcoholic drinks per day<sup>d</sup></td><td>1.55 (1.06, 2.25)</td><td>0.023</td><td>1.21 (0.75, 1.94)</td><td>0.433</td></tr><tr><td> Trading away food<sup>e,f</sup></td><td>5.99 (3.53, 10.16)</td><td><0.001</td><td>5.23 (2.53, 10.81)</td><td><0.001<sup>*</sup></td></tr><tr><td colspan="5">Clinical</td></tr><tr><td> Taking cART<sup>d</sup></td><td>0.52 (0.31, 0.88)</td><td>0.015</td><td>0.68 (0.36, 1.29)</td><td>0.237</td></tr><tr><td> Self-described health state—visual analogue scale (0–100): per 5-point increase<sup>d</sup></td><td>0.93 (0.89, 0.96)</td><td><0.001</td><td>0.98 (0.94, 1.02)</td><td>0.242</td></tr><tr><td> Therapy for drug addiction<sup>e</sup></td><td>1.16 (0.79, 1.71)</td><td>0.452</td><td>–</td><td>–</td></tr><tr><td> Recent depressive symptoms (CES-D-10) (in the past week)</td><td>2.78 (2.06, 3.74)</td><td><0.001</td><td>2.11 (1.48, 3.01)</td><td><0.001<sup>*</sup></td></tr><tr><td> Unmet healthcare needs<sup>e</sup></td><td>2.25 (1.55, 3.26)</td><td><0.001</td><td>1.55 (0.93, 2.57)</td><td>0.091</td></tr></table> |
09d00b5a7cdc1c3a549329771e937315bca57695175a90435d43d5c9875a111f.png | complex | <table><tr><td rowspan="2">Participant</td><td rowspan="2">TTD (Months)</td><td rowspan="2">FIGO stage</td><td colspan="9">First attributions of illness symptoms</td></tr><tr><td>Retained condom</td><td>Intestinal worms</td><td>Genital infections (syphilis, gonorrhoea and Candida)</td><td>Menstrual problems (Menopause and other menstrual abnormalities)</td><td>Uterine swelling</td><td>No clue on cause</td><td>HIV and/or its complications</td><td>Cervical cancer</td><td>Other serious illness</td></tr><tr><td>P10</td><td>2</td><td>3B</td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td></tr><tr><td>P11</td><td>2</td><td>1A</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P7</td><td>3</td><td>1A</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P8</td><td>3</td><td>1B</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P4</td><td>4</td><td>1B</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td></tr><tr><td>P3</td><td>7</td><td>4A</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P15</td><td>10</td><td>3B</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P18</td><td>10</td><td>2A</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td></tr><tr><td>P9</td><td>19</td><td>2A</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P16</td><td>21</td><td>3B</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P13</td><td>24</td><td>3A</td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>P12</td><td>26</td><td>2A</td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td></tr><tr><td>P2</td><td>30</td><td>1B</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P5</td><td>39</td><td>2B</td><td></td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td></tr><tr><td>P6</td><td>72</td><td>3B</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P14</td><td>72</td><td>2B</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P17</td><td>72</td><td>3B</td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td>x</td><td></td></tr><tr><td>P1</td><td>Missing</td><td>140</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table> |
5f99058a5c95d9a99115fa18cbb759703ad3bcc3a1d93e455e19a37402fd4265.png | complex | <table><tr><td rowspan="2"></td><td colspan="5">PI-RADS v2 score</td></tr><tr><td>1<i>n</i> = 22</td><td>2<i>n</i> = 11</td><td>3<i>n</i> = 55</td><td>4<i>n</i> = 97</td><td>5<i>n</i> = 30</td></tr><tr><td>Insignificant PCa, n (%)</td><td>3 (13.6%)</td><td>0 (0%)</td><td>2 (3.6%)</td><td>12 (12.4%)</td><td>1 (3.3%)</td></tr><tr><td>Significant PCa, n (%)</td><td>4 (18.2%)</td><td>1 (9.1%)</td><td>6 (10.9%)</td><td>64 (66.0%)</td><td>24 (80.0%)</td></tr><tr><td>Total PCa, n (%)</td><td>7 (31.8%)</td><td>1 (9.1%)</td><td>8 (14.5%)</td><td>76 (78.3%)</td><td>25 (83.3%)</td></tr></table> |
12d852f872368f6a22550a793d2612a6d92a222735dc6b95b999c65ce5bf05a2.png | simple | <table><tr><td>GeneID</td><td>Product Name</td><td>Locus</td><td>AMX*</td><td>CTC*</td><td>ENR*</td></tr><tr><td>1244239</td><td>ImpA</td><td>impA</td><td>-0.52</td><td>-0.53</td><td>4.55</td></tr><tr><td>1244433</td><td>DNA-binding protein Fis</td><td>fis</td><td>ns</td><td>ns</td><td>1.41</td></tr><tr><td>1244528</td><td>LexA repressor</td><td>lexA</td><td>ns</td><td>1.60</td><td>9.87</td></tr><tr><td>1244611</td><td>Hypothetical protein PM1264</td><td>-</td><td>-0.78</td><td>-0.57</td><td>ns</td></tr><tr><td>1244637</td><td>Transcriptional repressor protein MetJ</td><td>metJ</td><td>-0.53</td><td>-0.74</td><td>-0.80</td></tr><tr><td>1244659</td><td>Hypothetical protein PM1312</td><td>-</td><td>-0.56</td><td>-0.68</td><td>-0.31</td></tr><tr><td>1244737</td><td>DNA-directed RNA polymerase subunit alpha</td><td>rpoA</td><td>ns</td><td>-0.77</td><td>1.27</td></tr><tr><td>1244795</td><td>Hypothetical protein PM1448</td><td>-</td><td>-0.81</td><td>-0.70</td><td>1.29</td></tr><tr><td>1244828</td><td>Hypothetical protein PM1481</td><td>-</td><td>-0.53</td><td>-0.51</td><td>-0.51</td></tr><tr><td>1244993</td><td>Hypothetical protein PM1646</td><td>-</td><td>-0.62</td><td>ns</td><td>-0.70</td></tr><tr><td>1245061</td><td>Hypothetical protein PM1714</td><td>-</td><td>-0.74</td><td>-0.91</td><td>ns</td></tr><tr><td>1245083</td><td>DNA-directed RNA polymerase subunit beta'</td><td>rpoC</td><td>ns</td><td>-0.76</td><td>-0.87</td></tr><tr><td>1245184</td><td>ATP-dependent helicase HepA</td><td>hepA</td><td>-0.77</td><td>-0.77</td><td>1.69</td></tr><tr><td>1245314</td><td>DNA-binding transcriptional activator GutM</td><td>gutM</td><td>-0.55</td><td>-0.69</td><td>-0.62</td></tr><tr><td>1243539</td><td>Hypothetical protein PM0192</td><td>recJ</td><td>-0.77</td><td>-0.79</td><td>1.24</td></tr><tr><td>1243679</td><td>Hypothetical protein PM0332</td><td>recN</td><td>ns</td><td>ns</td><td>11.54</td></tr><tr><td>1243758</td><td>DNA-dependent helicase II</td><td>uvrD</td><td>ns</td><td>ns</td><td>4.26</td></tr><tr><td>1243814</td><td>DNA polymerase IV</td><td>dinP</td><td>-0.76</td><td>-0.83</td><td>1.83</td></tr><tr><td>1244020</td><td>Hypothetical protein PM0673</td><td>-</td><td>-0.63</td><td>-0.81</td><td>-0.47</td></tr><tr><td>1244323</td><td>Holliday junction DNA helicase B</td><td>ruvB</td><td>ns</td><td>-0.78</td><td>2.37</td></tr><tr><td>1244324</td><td>Holliday junction DNA helicase motor protein</td><td>ruvA</td><td>ns</td><td>ns</td><td>3.39</td></tr><tr><td>1244459</td><td>DeaD</td><td>deaD</td><td>-0.78</td><td>-0.72</td><td>-0.67</td></tr><tr><td>1244499</td><td>DNA repair protein RadC</td><td>radC</td><td>-0.52</td><td>-0.60</td><td>-0.65</td></tr><tr><td>1244507</td><td>DNA polymerase III subunit beta</td><td>dnaN</td><td>ns</td><td>ns</td><td>1.41</td></tr><tr><td>1244526</td><td>Primosomal replication protein N</td><td>priB</td><td>ns</td><td>ns</td><td>1.67</td></tr><tr><td>1244563</td><td>DNA polymerase III subunit delta</td><td>holA</td><td>ns</td><td>-0.88</td><td>1.38</td></tr><tr><td>1244666</td><td>MutY</td><td>mutY</td><td>-0.68</td><td>-0.86</td><td>1.17</td></tr><tr><td>1244774</td><td>RecQ</td><td>recQ</td><td>-0.86</td><td>-0.84</td><td>1.11</td></tr><tr><td>1244823</td><td>DNA gyrase subunit B</td><td>gyrB</td><td>ns</td><td>1.36</td><td>1.45</td></tr><tr><td>1245063</td><td>NAD-dependent DNA ligase LigA</td><td>ligA</td><td>-0.84</td><td>1.08</td><td>1.56</td></tr><tr><td>1245164</td><td>Recombinase A</td><td>recA</td><td>ns</td><td>ns</td><td>9.96</td></tr><tr><td>1245177</td><td>DNA mismatch repair protein</td><td>mutS</td><td>-0.87</td><td>-0.78</td><td>1.50</td></tr><tr><td>1245268</td><td>ATP-dependent RNA helicase RhlB</td><td>rhlB</td><td>-0.73</td><td>-0.83</td><td>1.07</td></tr><tr><td>1245298</td><td>Excinuclease ABC subunit A</td><td>uvrA</td><td>-0.78</td><td>ns</td><td>2.57</td></tr><tr><td>1243785</td><td>Hypothetical protein PM0438</td><td>ftsH</td><td>-0.94</td><td>-0.80</td><td>1.13</td></tr><tr><td>1244083</td><td>Hypothetical protein PM0736</td><td>DnaK</td><td>ns</td><td>-0.74</td><td>1.50</td></tr><tr><td>1244087</td><td>Hypothetical protein PM0740</td><td>dnaJ</td><td>-0.74</td><td>-0.79</td><td>1.29</td></tr><tr><td>1245051</td><td>ClpB</td><td>clpB</td><td>-0.66</td><td>ns</td><td>2.14</td></tr><tr><td>1245095</td><td>ATP-dependent protease ATP-binding subunit</td><td>hslU</td><td>-0.70</td><td>ns</td><td>2.58</td></tr><tr><td>1245163</td><td>Recombination regulator RecX</td><td>recX</td><td>-0.54</td><td>-0.78</td><td>6.44</td></tr></table> |
ca8e02af11c49ec6fa1b7f988e725671947b556882217599e3e8c89f9ea63dc8.png | simple | <table><tr><td>Variable</td><td>Average interitem covariance</td><td>Number of items in the scale</td><td>Scale reliability coefficient</td></tr><tr><td>Distance</td><td>0.448</td><td>6</td><td>0.748</td></tr><tr><td>Positive</td><td>0.309</td><td>3</td><td>0.563</td></tr><tr><td>Demands</td><td>1.024</td><td>4</td><td>0.852</td></tr></table> |
ed436587e2b5cbe28eb97709387e8ba8b0e05011c68006fdc24a410493d6144f.png | simple | <table><tr><td>Fragment</td><td>Size (bp)</td><td>Primer sequences (5'-3')</td></tr><tr><td>NC1</td><td>2573</td><td>FP: GATCCTGGGCCCCACATCCATCCTC</td></tr><tr><td></td><td></td><td>RP: GATCGAATTCGCCCGGGAGGCCAGGGTCG</td></tr><tr><td>NC2</td><td>524</td><td>FP: GATCGAATTCGGCGAGAAGGGAGAAGCTGC</td></tr><tr><td></td><td></td><td>RP: GATCAAGCTTTCAGTCCTGGGCAGTACCTGT</td></tr></table> |
c77344b3b4cf4404f6c181a605e73981b0f752fd8faf3ff64971d59e6e9e2c42.png | simple | <table><tr><td>Heavy Metal</td><td>Arsenic (47)</td><td>Cadmium (34)</td><td>Mercury (30)</td><td>Lead (29)</td></tr><tr><td>Year</td><td>2012 (16), 2011 (16)</td><td>2009 (4), 2013 (4), 2014 (4)</td><td>2016 (9), 2013 (5), 2015 (5)</td><td>2016 (5), 2002 (4), 2006 (3), 2013 (3)</td></tr><tr><td>Product category</td><td>feed materials (18), pet food (12)</td><td>feed additives (10), feed materials (9), animal nutrition (obsolete) (7)</td><td>feed materials (13), pet food (9)</td><td>animal nutrition (obsolete) (8), feed materials (7), feed additives (6), feed for food-producing animals (obsolete) (5)</td></tr><tr><td>Notifying country</td><td>Italy (10), Germany (8), Belgium (7), Austria (5), United Kingdom (5)</td><td>Belgium (8), Germany (4), Norway (4)</td><td>Italy (14), Spain (5), Germany (4)</td><td>Netherlands (6), Germany (5), Belgium (4)</td></tr><tr><td>Origin country</td><td>Thailand (11), Poland (5)</td><td>China (8), Spain (4)</td><td>Thailand (10), Russia (5), Spain (4)</td><td>Netherlands (5), Spain (4), Turkey (3)</td></tr><tr><td>Notification basis</td><td>official control on the market (21), border control—consignment detained (12), company’s own check (11)</td><td>company’s own check (14), official control on the market (14)</td><td>official control on the market (14), border control—consignment detained (12)</td><td>company’s own check (12), official control on the market (10)</td></tr><tr><td>Notification type</td><td>alert (13), border rejection (12), information for follow-up (11)</td><td>information (12), information for follow-up (11)</td><td>border rejection (12), information for follow-up (10)</td><td>alert (9), information for follow-up (9), information (8)</td></tr><tr><td>Distribution status</td><td>no distribution (11), distribution restricted to notifying country (8), distribution to other member countries (8), information on distribution not (yet) available (7)</td><td>distribution on the market (possible) (10), distribution to other member countries (10), distribution restricted to notifying country (8)</td><td>product not (yet) placed on the market (11), distribution restricted to notifying country (7), no distribution from notifying country (6)</td><td>(not specified) (7), distribution on the market (possible) (6), distribution to other member countries (6), distribution restricted to notifying country (5)</td></tr><tr><td>Risk decision</td><td>undecided (37)</td><td>undecided (25)</td><td>not serious (18)</td><td>undecided (21)</td></tr><tr><td>Action taken</td><td>re-dispatch (8), withdrawal from the market (7), destruction (4), informing recipients (4), official detention (4)</td><td>withdrawal from the market (7), (not specified) (4), official detention (4), seizure (3)</td><td>re-dispatch (6), import not authorized (5), official detention (5), withdrawal from the market (5)</td><td>(not specified) (7), return to consignor (4), withdrawal from the market (4)</td></tr></table> |
e37d12121abb7744b1945deb9be18afa5cb6ba2689c1c2296910407be48a8670.png | complex | <table><tr><td>Location</td><td></td><td colspan="4">Annual average hourly NO<sub>2 </sub>(μg/m<sup>3</sup>) based on the LUR estimate</td></tr><tr><td></td><td>percent</td><td>min</td><td>max</td><td>mean</td><td>sd</td></tr><tr><td>Residences</td><td>100</td><td>6</td><td>56</td><td>28</td><td>8</td></tr><tr><td> freeway/highway/arterial/ramp</td><td>17</td><td>15</td><td>56</td><td>34</td><td>9</td></tr><tr><td> Collector</td><td>17</td><td>2</td><td>56</td><td>26</td><td>8</td></tr><tr><td> local/strata/lane</td><td>66</td><td>2</td><td>56</td><td>26</td><td>8</td></tr><tr><td> Rural</td><td>0.2</td><td>11</td><td>39</td><td>19</td><td>5</td></tr></table> |
927afc4a00e697099cc4ef7f43147612b6b0056f5f74aa275579a38924566e2e.png | complex | <table><tr><td>Name</td><td>First protein</td><td>Second protein</td><td colspan="3">Sequence of the fusion helix</td></tr><tr><td>3,305</td><td>Protein A</td><td>mbp3–16</td><td>266*</td><td>QCAREAAREAAACD</td><td>13*</td></tr><tr><td>3,306</td><td>mbp3–16</td><td>Protein A</td><td>133</td><td>QCAREAAAREAACN</td><td>217</td></tr><tr><td>3,307</td><td>Protein A</td><td>mbp3–16</td><td>263</td><td>NCAQEAAAREAACD</td><td>13</td></tr><tr><td>3,308</td><td>mbp3–16</td><td>Protein A</td><td>129</td><td>ACILQAAAREAACN</td><td>217</td></tr><tr><td>3,309</td><td>Protein A</td><td>mbp3–16</td><td>266</td><td>QCAREAAARDLGCK</td><td>17</td></tr><tr><td>3,310</td><td>mbp3–16</td><td>Protein A</td><td>133</td><td>QCAREAAAREANCE</td><td>219</td></tr><tr><td>3,311</td><td>mbp3–16</td><td>Protein A</td><td>132</td><td>LCKNKAQQAAFYCI</td><td>227</td></tr><tr><td>3,312</td><td>mbp3–16</td><td>Protein A</td><td>125</td><td>NCRLAAILAKNKCQ</td><td>220</td></tr><tr><td>3,313</td><td>Protein A</td><td>mbp3–16</td><td>259</td><td>ACKLNAAQALGRCL</td><td>18</td></tr><tr><td>3,315</td><td>Protein A</td><td>mbp3–16</td><td>260</td><td>ACLNAAQAALGRCL</td><td>18</td></tr><tr><td>4,254</td><td>Protein A</td><td>mbp3–16</td><td>260</td><td>KCLNDALGAKLLCA</td><td>21</td></tr><tr><td>4,256</td><td>Protein A</td><td>mbp3–16</td><td>260</td><td>KCLNDAQAAKLLCA</td><td>21</td></tr><tr><td>4,257</td><td>Protein A</td><td>mbp3–16</td><td>259</td><td>ACKLNAAQALGRCL</td><td>18</td></tr><tr><td>4,258</td><td>Protein A</td><td>mbp3–16</td><td>259</td><td>ACKLNAAQAAGRCL</td><td>18</td></tr><tr><td>4,260</td><td>Protein A</td><td>mbp3–16</td><td>261</td><td>KCNDAAARALLECA</td><td>22</td></tr><tr><td>4,261</td><td>Protein A</td><td>mbp3–16</td><td>261</td><td>KCNDAALGAKLLCA</td><td>21</td></tr><tr><td>4,262</td><td>Protein A</td><td>mbp3–16</td><td>261</td><td>KCNDAAAGAKLLCA</td><td>21</td></tr><tr><td>6,758</td><td>Protein A</td><td>Calmodulin</td><td>260</td><td>KCLNDAEQIAEFCE</td><td>15</td></tr><tr><td>6,759</td><td>Protein A</td><td>Calmodulin</td><td>260</td><td>KCLNDEQIAEFKCA</td><td>16</td></tr><tr><td>6,760</td><td>Protein A</td><td>Calmodulin</td><td>259</td><td>ACKLNAQIAEFKCA</td><td>16</td></tr><tr><td>6,761</td><td>Protein A</td><td>Calmodulin</td><td>260</td><td>KCLNDAQAAAEECI</td><td>10</td></tr></table> |
a9c0d3b016e9ea0c408eeb190b5ca5c6e254283014ff2fcade21354a1bd59422.png | complex | <table><tr><td></td><td colspan="3">Number of filled prescriptions</td><td colspan="6">Switching between different statins</td></tr><tr><td></td><td colspan="3"><i>≥ 2 filled statin prescriptions</i></td><td colspan="3"><i>No switches</i></td><td colspan="3"><i>1-3 switches</i></td></tr><tr><td></td><td>N</td><td>Mean (%)</td><td>95% CI</td><td>N</td><td>Mean (%)</td><td>95% CI</td><td>N</td><td>Mean (%)</td><td>95% CI</td></tr><tr><td><i>Entire study population</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Simvastatin users with generic substitution</td><td>94525</td><td>90.1</td><td>89.9-90.3</td><td>93572</td><td>86.9</td><td>86.0-87.8</td><td>7423</td><td>83.1</td><td>82.0-84.1</td></tr><tr><td>Simvastatin users with active decline of generic substitution</td><td>697</td><td>79.8</td><td>84.7-86.8</td><td>533</td><td>68.1</td><td>56.4-79.9</td><td>268</td><td>80.2</td><td>74.6-85.7</td></tr><tr><td>Simvastatin users not exposed to generic substitution</td><td>2911</td><td>52.5</td><td>76.6-83.0</td><td>5651</td><td>49.3</td><td>45.7-52.9</td><td>1292</td><td>75.9</td><td>73.4-78.5</td></tr><tr><td>Atorvastatin users</td><td>6616</td><td>85.8</td><td>50.9-54.0</td><td>6172</td><td>79.6</td><td>76.2-83.1</td><td>1359</td><td>67.0</td><td>64.6-69.5</td></tr><tr><td><i>Those with generic substitution</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Generic substitution at first purchase</td><td>57844</td><td>88.7</td><td>88.4-89.1</td><td>59175</td><td>83.7</td><td>83.0-84.4</td><td>5139</td><td>80.7</td><td>79.6-81.8</td></tr><tr><td>Generic substitution later on</td><td>36681</td><td>92.2</td><td>91.8-92.5</td><td>34297</td><td>92.4</td><td>91.4-93.4</td><td>2284</td><td>88.4</td><td>86.8-90.1</td></tr></table> |
a79b4b846bf20389144f463aadda3e274ad03ea5287a50ef01a88d73dc3390a3.png | simple | <table><tr><td>Methylation probe</td><td>Distance from <i>MEG3</i> TSS</td><td>Correlation with 14q32 prognostic miRNAs</td><td>Number of miRNAs</td><td>Overlap with CTCF binding site</td></tr><tr><td>cg1656</td><td>1326</td><td>None</td><td>None</td><td>Near site (in promoter)</td></tr><tr><td>cg0928</td><td>775</td><td>0.466 (0.596 to 0.404)</td><td>7</td><td>In site (in promoter)</td></tr><tr><td>cg2583</td><td>156</td><td>0.459 (0.528 to 0.396)</td><td>3</td><td>Near site (in promoter)</td></tr><tr><td>cg05711</td><td>−218</td><td>−0.561</td><td>1</td><td>Near site (within gene body)</td></tr><tr><td>cg1537</td><td>−628</td><td>−0.443 (−0.408 to −0.631)</td><td>13</td><td>Near site (within gene body)</td></tr><tr><td>cg1510</td><td>−1264</td><td>0.546 (0.621 to 0.428)</td><td>2</td><td>Near site (within gene body)</td></tr><tr><td>cg0429</td><td>−1968</td><td>−0.283 (−0.554 to −0.552)</td><td>10</td><td>Not in site (within gene body)</td></tr></table> |
d961a82d35e77ad98acbf39025cdbb7a0ab75b97b5ba4fd479da7f4cf9ce9a2b.png | complex | <table><tr><td rowspan="2">tRF5</td><td rowspan="2">Anticodon</td><td colspan="2">ELISA status</td><td rowspan="2">SE</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td>Negative (RPM)<sup>a</sup></td><td>Positive (RPM)<sup>a</sup></td></tr><tr><td>tRF5-Ala</td><td>CGC</td><td>616</td><td>494</td><td>31</td><td>0.0081</td></tr><tr><td>tRF5-Glu</td><td>CTC</td><td>2584</td><td>1492</td><td>306</td><td>0.0155</td></tr><tr><td>tRF5-Gly</td><td>TCC</td><td>65</td><td>148</td><td>21</td><td>0.0082</td></tr><tr><td>tRF5-Lys</td><td>CTT</td><td>3800</td><td>6933</td><td>534</td><td>0.0002</td></tr><tr><td>tRF5-Lys</td><td>TTT</td><td>728</td><td>1193</td><td>113</td><td>0.0057</td></tr><tr><td>tRF5-Pro</td><td>TGG</td><td>78</td><td>118</td><td>10</td><td>0.0093</td></tr><tr><td>tRF5-SelCys</td><td>UGA</td><td>4.9</td><td>13.7</td><td>1.9</td><td>0.0020</td></tr><tr><td>tRF5-Thr</td><td>TGT</td><td>6.4</td><td>8.2</td><td>0.6</td><td>0.0499</td></tr><tr><td>tRF5-Val</td><td>CAC</td><td>11,409</td><td>15,104</td><td>1275</td><td>0.0468</td></tr></table> |
d57c0be74e03f3c0fd578058963cc498cf7c917e511abd543a9f0431433ac0c6.png | complex | <table><tr><td>Variable</td><td>non-MetS</td><td>MetS</td><td>Entire sample</td><td>p value*</td></tr><tr><td colspan="5"><i>Demographical information</i></td></tr><tr><td>N</td><td>1194</td><td>783</td><td>1977</td><td></td></tr><tr><td>Age years</td><td>59.8 ± 8.85</td><td>61.56 ± 8.37</td><td>60.5 ± 8.71</td><td><0.001</td></tr><tr><td>Gender male, %</td><td>409 (34.25 %)</td><td>258 (32.95 %)</td><td>667 (33.74 %)</td><td>0.396</td></tr><tr><td>Height cm</td><td>161.5 ± 7.89</td><td>161.48 ± 7.79</td><td>161.49 ± 7.85</td><td>0.942</td></tr><tr><td>Weight kg</td><td>60.41 ± 9.78</td><td>67.69 ± 10.5</td><td>63.3 ± 10.68</td><td><0.001</td></tr><tr><td>SBP mmHg</td><td>122.61 ± 17.33</td><td>135.52 ± 18.34</td><td>127.71 ± 18.82</td><td><0.001</td></tr><tr><td>DBP mmHg</td><td>77.82 ± 9.38</td><td>82.8 ± 9.38</td><td>79.79 ± 9.69</td><td><0.001</td></tr><tr><td colspan="5"><i>Medical history</i>, %</td></tr><tr><td>Smoking yes</td><td>182 (15.24 %)</td><td>122 (15.58 %)</td><td>304 (15.38 %)</td><td>0.773</td></tr><tr><td>HTN yes</td><td>371 (31.07 %)</td><td>557 (71.14 %)</td><td>928 (46.94 %)</td><td><0.001</td></tr><tr><td>DM yes</td><td>112 (9.39 %)</td><td>307 (39.21 %)</td><td>419 (21.2 %)</td><td><0.001</td></tr><tr><td>CAN yes</td><td>173 (14.49 %)</td><td>190 (24.27 %)</td><td>363 (18.36 %)</td><td><0.001</td></tr><tr><td colspan="5"><i>Laboratory assays</i> </td></tr><tr><td>FPG mmol/L</td><td>5.01 ± 1.27</td><td>6.19 ± 2.16</td><td>5.48 ± 1.78</td><td><0.001</td></tr><tr><td>PBG mmol/L</td><td>6.63 ± 2.87</td><td>9.08 ± 4.02</td><td>7.6 ± 3.58</td><td><0.001</td></tr><tr><td>FINS uml/L</td><td>6.07 ± 10.53</td><td>9.07 ± 14.08</td><td>7.26 ± 12.16</td><td><0.001</td></tr><tr><td>TC mmol/L</td><td>5.31 ± 0.96</td><td>5.33 ± 1.07</td><td>5.32 ± 1</td><td>0.603</td></tr><tr><td>TG mmol/L</td><td>1.35 ± 0.66</td><td>2.26 ± 1.14</td><td>1.71 ± 0.99</td><td><0.001</td></tr><tr><td>HDL mmol/L</td><td>1.46 ± 0.32</td><td>1.2 ± 0.26</td><td>1.36 ± 0.33</td><td><0.001</td></tr><tr><td>LDL mmol/L</td><td>3.18 ± 0.76</td><td>3.21 ± 0.8</td><td>3.19 ± 0.78</td><td>0.212</td></tr><tr><td>SCr μmol/L</td><td>76.56 ± 28.72</td><td>79.14 ± 22.9</td><td>77.58 ± 26.59</td><td>0.003</td></tr><tr><td>UA μmol/L</td><td>265.96 ± 78.37</td><td>302.66 ± 87.82</td><td>280.51 ± 84.17</td><td><0.001</td></tr><tr><td colspan="5"><i>HRV indices</i></td></tr><tr><td>HR bpm</td><td>71.57 ± 9.92</td><td>73.96 ± 10.34</td><td>72.52 ± 10.16</td><td><0.001</td></tr><tr><td>TP ms<sup>2</sup></td><td>938.73 ± 728.92</td><td>788.78 ± 668.07</td><td>879.34 ± 709.16</td><td><0.001</td></tr><tr><td>LF ms<sup>2</sup></td><td>210.37 ± 219.54</td><td>164.72 ± 189.4</td><td>192.29 ± 209.3</td><td><0.001</td></tr><tr><td>HF ms<sup>2</sup></td><td>203.82 ± 241.68</td><td>155.52 ± 183.24</td><td>184.69 ± 221.63</td><td><0.001</td></tr><tr><td>LF/HF</td><td>1.67 ± 2.05</td><td>1.74 ± 1.87</td><td>1.7 ± 1.98</td><td>0.307</td></tr><tr><td colspan="5"><i>SNP</i></td></tr><tr><td>rs9340799</td><td>237 (19.97 %)</td><td>147 (19.08 %)</td><td>384 (19.62 %)</td><td>0.495</td></tr></table> |
75d4c9794a55e3bc3f1f940b144934300158645eb8689767594bb084bfe333db.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Multivariate analysis (DFS)</td><td colspan="2">Multivariate analysis (OS)</td></tr><tr><td><i>P</i>-value</td><td>HR (95%CI)</td><td><i>P</i>-value</td><td>HR (95%CI)</td></tr><tr><td>AJCC stage (I/II vs. III/IV)</td><td>0.037*</td><td>2.621 (1.011–6.668)</td><td>0.029*</td><td>2.915 (1.113–7.634)</td></tr><tr><td>N stage (N0 vs. N1 + N2)</td><td>0.043*</td><td>2.354 (1.027–5.395)</td><td>0.033*</td><td>2.785 (1.086–7.141)</td></tr><tr><td>M stage (M0 vs. M1)</td><td>0.049*</td><td>3.649 (1.008–13.214)</td><td>0.035*</td><td>2.465 (1.067–5.696)</td></tr><tr><td>Vascular invasion (Yes vs. No)</td><td>0.038*</td><td>2.488 (1.051–5.891)</td><td>0.024*</td><td>2.945 (1.151–7.535)</td></tr><tr><td>TIMP1 expression (Negative vs. Positive)</td><td>0.027*</td><td>2.603 (1.115–6.077)</td><td>0.013*</td><td>2.907 (1.254–6.737)</td></tr></table> |
ebde2c998d2b109b052c444bf1c4ed63f5923f839073d747a7285ca8919edc47.png | simple | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td><td>Patient 4</td></tr><tr><td>First time TB diagnosis</td><td>1995</td><td>1992</td><td>1985</td><td>2001</td></tr><tr><td>Immigration Date</td><td>August-97</td><td>July-97</td><td>March-92</td><td>March-03</td></tr><tr><td>Duration between TB and MDR TB diagnosis</td><td>2 years</td><td>5 years</td><td>12 years</td><td>2 years</td></tr><tr><td>Duration between MDR TB and XDR TB diagnosis</td><td>2 years</td><td>5 years</td><td>1.3 years</td><td>concurrent</td></tr><tr><td>Duration between XDR TB diagnosis and end of antituberculous drug therapy in Germany</td><td>2.4 years</td><td>1.9 years</td><td>2 years</td><td>2.5 years</td></tr><tr><td>Overall length of inhospital treatment in Germany</td><td>4.5 years</td><td>6 years</td><td>6 years</td><td>11 months</td></tr><tr><td>Outcome</td><td>treatment failure</td><td>cure</td><td>death</td><td>cure</td></tr><tr><td>Last sputum cultures</td><td>positive</td><td>negative</td><td>positive</td><td>negative</td></tr><tr><td>Radiologic signs of activity</td><td>present</td><td>not present</td><td>present</td><td>not present</td></tr><tr><td>Known transmission of XDR strain to contacts</td><td>no</td><td>no</td><td>no</td><td>no</td></tr></table> |
c3f3037d5eb812cb70de4c21f3b5123aa14641517f1142a5c43a091096ad2845.png | simple | <table><tr><td></td><td>p-value</td></tr><tr><td>MicroRNA</td><td>(Hypoxia vs Normoxia)</td></tr><tr><td>ambi_miR_8488</td><td>0.00038</td></tr><tr><td>hsa_miR_152</td><td>0.00064</td></tr><tr><td>ambi_miR_13232</td><td>0.00137</td></tr><tr><td>hsa_miR_193b</td><td>0.00161</td></tr><tr><td>hsa_miR_26a</td><td>0.00204</td></tr><tr><td>ambi_miR_2537</td><td>0.00460</td></tr><tr><td>hsa_miR_512_5p</td><td>0.01019</td></tr><tr><td>mmu_miR_431</td><td>0.01033</td></tr><tr><td>hsa_miR_23a</td><td>0.01074</td></tr><tr><td>ambi_miR_7036</td><td>0.01075</td></tr><tr><td>hsa_miR_210</td><td>0.01103</td></tr><tr><td>hsa_miR_125a</td><td>0.01483</td></tr><tr><td>ambi_miR_10594</td><td>0.01708</td></tr><tr><td>hsa_miR_188</td><td>0.01969</td></tr><tr><td>hsa_miR_27b</td><td>0.02119</td></tr><tr><td>hsa_miR_191</td><td>0.02243</td></tr><tr><td>hsa_miR_30d</td><td>0.02262</td></tr><tr><td>hsa_miR_339</td><td>0.02339</td></tr><tr><td>hsa_miR_200b</td><td>0.02427</td></tr><tr><td>hsa_miR_23b</td><td>0.02885</td></tr><tr><td>hsa_miR_452_AS</td><td>0.03012</td></tr><tr><td>hsa_miR_491</td><td>0.03651</td></tr><tr><td>hsa_miR_30a_5p</td><td>0.03778</td></tr><tr><td>hsa_miR_30c</td><td>0.04013</td></tr><tr><td>rno_miR_333</td><td>0.04207</td></tr><tr><td>ambi_miR_562</td><td>0.04695</td></tr><tr><td>hsa_miR_213</td><td>0.04702</td></tr><tr><td>hsa_miR_206</td><td>0.04786</td></tr></table> |
07042467c60a195c6869a677371bd6d024c682bf79ecb22adcac2a88971f1b04.png | simple | <table><tr><td>DHA source</td><td>Frequency, n</td></tr><tr><td>Salmon</td><td>6</td></tr><tr><td>Herring</td><td>5</td></tr><tr><td>Tuna</td><td>4</td></tr><tr><td>Cod</td><td>3</td></tr><tr><td>Brook trout</td><td>3</td></tr><tr><td>Trout</td><td>2</td></tr><tr><td>Carp</td><td>1</td></tr><tr><td>Sardines</td><td>1</td></tr><tr><td>Haddock</td><td>1</td></tr><tr><td>Grouper</td><td>1</td></tr><tr><td>Pike</td><td>1</td></tr><tr><td>White fish</td><td>1</td></tr><tr><td>Fish sticks (contains minced pollock)</td><td>3</td></tr><tr><td>Crustaceans</td><td>3</td></tr><tr><td>Caviar</td><td>1</td></tr></table> |
8c7a165ecb7c7ad95aa6860e25844e8e456fd274b8c57f9c295484f48f312d14.png | simple | <table><tr><td>Site</td><td>MPM</td><td>AF</td><td>BU</td><td>HE</td><td>HY</td><td>LE</td><td>RA</td><td>XE</td><td>Unk</td></tr><tr><td>Djorse</td><td>Pos</td><td>12</td><td>10</td><td></td><td></td><td></td><td>4</td><td></td><td></td></tr><tr><td>Otuaplem</td><td>Pos</td><td>4</td><td></td><td>10</td><td></td><td>1</td><td>2</td><td>12</td><td></td></tr><tr><td>Sarpeiman</td><td>Pos</td><td>1</td><td>13</td><td></td><td>8</td><td></td><td></td><td></td><td></td></tr><tr><td>Seduase</td><td>Pos</td><td>9</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Achiaman</td><td>Pos</td><td></td><td></td><td></td><td>18</td><td></td><td>1</td><td></td><td></td></tr><tr><td>Kwashikuma</td><td>Pos</td><td>16</td><td></td><td></td><td>48</td><td></td><td>3</td><td></td><td>1</td></tr><tr><td>Weija</td><td>Pos</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table> |
e7bc9588165c9745e0e744c596f5e4759d482ccc867bf182aa14d99fbe767527.png | simple | <table><tr><td>Cigarette</td><td>Erg %</td><td>LPS %</td></tr><tr><td>Newport Menthol</td><td>4.45</td><td>3.36</td></tr><tr><td>Camel Turkish Royal</td><td>9.90</td><td>6.18</td></tr><tr><td>Pall Mall</td><td>13.3</td><td>6.01</td></tr><tr><td>Kool</td><td>9.30</td><td>4.26</td></tr><tr><td>Parliament Lights</td><td>10.00</td><td>3.00</td></tr><tr><td>Liggett Select Full Flavor</td><td>8.57</td><td>3.99</td></tr><tr><td>University of Kentucky</td><td>10.86</td><td>6.30</td></tr></table> |
169cc4ee0226214a346997cd4ef405ac0b79bce6299df79fa9a266a0bc34dddb.png | simple | <table><tr><td>Trait</td><td>Reference</td></tr><tr><td>Agronomic traits</td></tr><tr><td>Yield and yield parameters</td><td>Nath and Alam (2002)</td></tr><tr><td>Pod characters</td><td>Swamy et al. (2006)</td></tr><tr><td>Seed dormancy</td><td>Wang et al. (2012)</td></tr><tr><td>Early maturity</td><td>Upadhyaya et al. (2006)</td></tr><tr><td>Resistance to diseases and insect pests</td></tr><tr><td>Early leaf spot (<i>Cercospora arachidicola</i> Hori)</td><td>Singh et al. (1997), Holbrook and Isleib (2001)</td></tr><tr><td>Late leaf spot [<i>Phaeoisariopsis personata</i> (Berk. & Curt.) Van Arx]</td><td>Singh et al. (1997, 2003), Holbrook and Isleib (2001), Li et al. (2012)</td></tr><tr><td>Leaf rust (<i>Puccinia arachidis</i> Spegazzini)</td><td>Singh et al. (1997, 2003)</td></tr><tr><td>Aflatoxin contamination (<i>Aspergillus </i>spp.)</td><td>Singh et al. (1997), Whitaker et al. (2004)</td></tr><tr><td>Stem and pod rot (<i>Sclerotium rolfsii</i>)</td><td>Singh et al. (1997), Gorbet et al. (2004)</td></tr><tr><td>Bacterial wilt resistance (<i>Ralstonia solanacearum</i>)</td><td>Singh et al. (1997)</td></tr><tr><td>Root-knot nematode (<i>Meloidogyne </i>spp.)</td><td>Holbrook and Isleib (2001)</td></tr><tr><td>Tomato spotted wilt virus (TSWV)</td><td>Li et al. (2012)</td></tr><tr><td>Groundnut rosette disease (GRD)</td><td>Subrahmanyam et al. (1998)</td></tr><tr><td>Kalahasty malady (<i>Tylenchorhynchus brevilineatus</i>)</td><td>Mehan et al. (1993)</td></tr><tr><td>Insect pests</td><td>Amin et al. (1985), Harish et al. (2012)</td></tr><tr><td>Abiotic stress tolerance</td></tr><tr><td>Drought tolerance</td><td>Upadhyaya (2005), Jogloy et al. (2009), Balota et al. (2012)</td></tr><tr><td>Heat</td><td>Ntare et al. (2001)</td></tr><tr><td>Cold</td><td>Upadhyaya et al. (2009)</td></tr><tr><td>Salinity</td><td>Singh et al. (2008)</td></tr><tr><td>Aluminum toxicity</td><td>Boshou et al. (2000)</td></tr><tr><td>Nitrogen fixation tolerant to soil drying</td><td>Devi et al. (2010)</td></tr><tr><td>Quality parameters and others</td></tr><tr><td>Nutritional quality</td><td>Wang et al. (2010), Upadhyaya et al. (2012)</td></tr><tr><td>Traits for confectionary uses</td><td>Dwivedi et al. (1994), Dwivedi and Nigam (2005)</td></tr><tr><td>Root hairs on roots and gynophores that enhance phosphorus uptake</td><td>Wissuwa and Ae (2001)</td></tr><tr><td>Phosphorus (P) uptake</td><td>Wissuwa and Ae (1998)</td></tr></table> |
372340f9773360aff7ef8edfe00ed9d82722a9455d98a23fc48e4c71dadc6e6f.png | complex | <table><tr><td>Clinical data</td><td colspan="2">Dengue</td><td colspan="2">Non-dengue</td><td>OR(95%CI)</td></tr><tr><td> </td><td>N</td><td>%</td><td>N</td><td>%</td><td> </td></tr><tr><td>History:</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Exhaustion</td><td>68</td><td>98.6</td><td>69</td><td>95.8</td><td> </td></tr><tr><td> Myalgia</td><td>64</td><td>92.8</td><td>67</td><td>93.1</td><td> </td></tr><tr><td> Headache</td><td>60</td><td>87.0</td><td>64</td><td>87.7</td><td> </td></tr><tr><td> Lumbar pain</td><td>59</td><td>85.5</td><td>59</td><td>81.9</td><td> </td></tr><tr><td> Anorexia</td><td>55</td><td>79.7</td><td>55</td><td>75.3</td><td> </td></tr><tr><td> Retro-orbital pain</td><td>49</td><td>71.0</td><td>44</td><td>60.3</td><td> </td></tr><tr><td> Taste disorder</td><td>47</td><td>70.1</td><td>36</td><td>52.2</td><td>2.15 (1.06–4.36)</td></tr><tr><td> Nausea</td><td>45</td><td>65.2</td><td>40</td><td>54.8</td><td> </td></tr><tr><td> Arthralgia</td><td>44</td><td>63.8</td><td>43</td><td>58.9</td><td> </td></tr><tr><td> Photophobia</td><td>38</td><td>55.9</td><td>35</td><td>47.9</td><td> </td></tr><tr><td> Chills</td><td>33</td><td>47.8</td><td>42</td><td>57.5</td><td> </td></tr><tr><td> Dizziness</td><td>33</td><td>47.8</td><td>34</td><td>46.6</td><td> </td></tr><tr><td> History of rash</td><td>30</td><td>44.1</td><td>14</td><td>19.2</td><td>3.33 (1.56–7.07)</td></tr><tr><td> Cough</td><td>25</td><td>36.2</td><td>26</td><td>35.6</td><td> </td></tr><tr><td> Diarrhea</td><td>25</td><td>36.2</td><td>18</td><td>24.7</td><td> </td></tr><tr><td> Vomiting</td><td>22</td><td>31.9</td><td>17</td><td>23.6</td><td> </td></tr><tr><td> Itching</td><td>21</td><td>31.3</td><td>13</td><td>18.6</td><td> </td></tr><tr><td> Abdominal pain</td><td>21</td><td>30.4</td><td>31</td><td>42.5</td><td> </td></tr><tr><td> Coryza</td><td>20</td><td>29.0</td><td>21</td><td>28.8</td><td> </td></tr><tr><td> Sore throat</td><td>16</td><td>23.2</td><td>27</td><td>37.0</td><td> </td></tr><tr><td> Nasal congestion</td><td>14</td><td>20.9</td><td>17</td><td>24.6</td><td> </td></tr><tr><td> History of bleeding</td><td>12</td><td>17.4</td><td>6</td><td>8.2</td><td> </td></tr><tr><td> Earache</td><td>11</td><td>16.2</td><td>5</td><td>6.9</td><td> </td></tr><tr><td> Hoarseness</td><td>11</td><td>16.2</td><td>9</td><td>12.5</td><td> </td></tr><tr><td> Dyspnea</td><td>10</td><td>14.5</td><td>7</td><td>9.7</td><td> </td></tr><tr><td>Physical exam:</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Rash</td><td>48</td><td>71.6</td><td>31</td><td>45.6</td><td>3.02 (1.48–6.16)</td></tr><tr><td> Conjunctival redness</td><td>38</td><td>55.9</td><td>20</td><td>29.0</td><td>3.10 (1.53–6.29)</td></tr><tr><td> Lymph node enlargement</td><td>33</td><td>50.8</td><td>14</td><td>20.6</td><td>3.98 (1.86–8.53)</td></tr><tr><td> Dehydration</td><td>24</td><td>35.3</td><td>16</td><td>23.2</td><td> </td></tr><tr><td> Pharyngeal erythema</td><td>15</td><td>22.4</td><td>21</td><td>31.3</td><td> </td></tr><tr><td> Pallor</td><td>11</td><td>16.4</td><td>15</td><td>21.7</td><td> </td></tr><tr><td> Petechiae</td><td>9</td><td>13.4</td><td>4</td><td>5.9</td><td> </td></tr><tr><td> Hepatomegaly</td><td>7</td><td>10.4</td><td>5</td><td>7.4</td><td> </td></tr><tr><td> Splenomegaly</td><td>5</td><td>7.5</td><td>5</td><td>7.2</td><td> </td></tr></table> |
bb5843917e41ab572c53e644028bd131793db90db1f14a940755889f7c4b097c.png | simple | <table><tr><td></td><td>Number</td><td>Age at diagnosis</td><td>Disease duration</td><td>Anti-CCP-positive</td><td>RF-positive</td></tr><tr><td></td><td></td><td>(years)</td><td>(years)</td><td>(%)</td><td>(%)</td></tr><tr><td>RA <1 year</td><td>144</td><td>54</td><td>0.8</td><td>70</td><td>68</td></tr><tr><td>RA >5 years</td><td>59</td><td>48</td><td>11</td><td>87</td><td>75</td></tr><tr><td>AS</td><td>88</td><td>34</td><td>10</td><td>1</td><td>nd</td></tr><tr><td>PsA</td><td>30</td><td>41</td><td>6</td><td>3</td><td>nd</td></tr><tr><td>SLE</td><td>21</td><td>37</td><td>8</td><td>5</td><td>nd</td></tr><tr><td>SSC</td><td>20</td><td>51</td><td>0.5</td><td>5</td><td>nd</td></tr><tr><td>Healthy</td><td>50</td><td>nd</td><td>nd</td><td>0</td><td>nd</td></tr></table> |
1fcd65c82f7c0dbc9827527a1f82d706187bf2e2553f146c837465dc5e836b63.png | simple | <table><tr><td>Pathology</td><td>Human FXTAS</td><td>CGG knock-in mouse</td></tr><tr><td>CGG trinucleotide repeat length</td><td>55 to 199 CGG repeat length, repeat instability</td><td>70 to 300 CGG repeats, modest repeat instability</td></tr><tr><td>Elevated FMR1 mRNA expression</td><td>Increased 2- to 8-fold</td><td>Increased 1.5- to 3-fold</td></tr><tr><td>Fragile X mental retardation protein levels</td><td>Reduced in several brain regions</td><td>Reduced in several brain regions</td></tr><tr><td>Motor impairments</td><td>Tremor/ataxia, postural sway, parkinsonism</td><td>Impaired on rotarod and ladder rung task</td></tr><tr><td>Cognitive Impairments</td><td>Poor working memory, anxiety, depression, social phobia</td><td>Spatial memory deficits, altered anxiety-like behaviors</td></tr><tr><td>Intranuclear inclusions</td><td>Neurons and astrocytes, highly correlated with CGG repeat length, frequency increases with age</td><td>Neurons and astrocytes, related to length of CGG repeat, frequency increases with age</td></tr></table> |
8ad6c83b2bc2d333600198de3ce3dc8e987489e6345c9fb97daf89ba9a795b4d.png | complex | <table><tr><td></td><td colspan="2">Any quantity fills</td><td colspan="2">Single bottle gills of 2.5 mL</td></tr><tr><td>Method of imputing days supply</td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>Medication possession</td><td></td><td></td><td></td><td></td></tr><tr><td>Unadjusted days supply</td><td>56%</td><td>63%</td><td>47%</td><td>79%</td></tr><tr><td>2.0-2.1 Variable Factor*</td><td>60%</td><td>60%</td><td>53%</td><td>77%</td></tr><tr><td>2.0 Constant Factor/45</td><td></td><td></td><td></td><td></td></tr><tr><td> Minimum<sup>†</sup></td><td>61%</td><td>60%</td><td>54%</td><td>77%</td></tr><tr><td>Days covered</td><td></td><td></td><td></td><td></td></tr><tr><td>Unadjusted days supply</td><td>53%</td><td>68%</td><td>43%</td><td>99%</td></tr><tr><td>2.0-2.1 Variable Factor*</td><td>67%</td><td>69%</td><td>61%</td><td>90%</td></tr><tr><td>2.0 Constant Factor/45</td><td></td><td></td><td></td><td></td></tr><tr><td> Minimum<sup>†</sup></td><td>70%</td><td>70%</td><td>65%</td><td>90%</td></tr></table> |
b4268249ddcd4f47f75ee5f089e2f67cceb1fcb150cb9d144c5cddc2153afcf6.png | simple | <table><tr><td>Trial</td><td>Design</td><td>No. of Participants</td><td>Women %</td><td>Mean Age</td><td>Suppl. (Y)</td><td>Follow-up (Y)</td><td>BC, mg</td><td>Vit A μg</td><td>Vit C mg</td><td>Vit E mg</td><td>Selenium μg</td></tr><tr><td>AREDS [62] 2001</td><td>2x2</td><td>4757</td><td>56</td><td>68</td><td>6.3</td><td>6.3</td><td>15</td><td></td><td>500</td><td>400</td><td></td></tr><tr><td>ARMDS [63] 1996</td><td>Parallel</td><td>71</td><td>7</td><td>72</td><td>1.5</td><td>1.5</td><td>72</td><td></td><td>750</td><td>165</td><td>50</td></tr><tr><td>Allsup et al [64], 2004</td><td>Parallel</td><td>164</td><td>63</td><td>83</td><td>0.15</td><td>0.5</td><td></td><td>800</td><td>120</td><td>60</td><td>60</td></tr><tr><td>Avenell et al [65], 2005</td><td>Parallel</td><td>910</td><td>47</td><td>72</td><td>1</td><td>1</td><td></td><td>800</td><td>60</td><td>10</td><td></td></tr><tr><td>Boaz et al [66], 2000</td><td>Parallel</td><td>196</td><td>31</td><td>65</td><td>1.42</td><td>1.42</td><td></td><td></td><td></td><td>537</td><td></td></tr><tr><td>Brown et al [67], 2001</td><td>2x2</td><td>160</td><td>13</td><td>53</td><td>3</td><td>3</td><td>25</td><td></td><td>1000</td><td>537</td><td>100</td></tr><tr><td>Chylack et al [68], 2002</td><td>Parallel</td><td>297</td><td>59</td><td>68</td><td>3</td><td>3</td><td>18</td><td></td><td>750</td><td>600</td><td></td></tr><tr><td>Collins et al [69], 2003</td><td>2x2</td><td>52</td><td>2</td><td>67</td><td>0.5</td><td>2.5</td><td></td><td></td><td></td><td>400</td><td></td></tr><tr><td>Cook et al [70], 2007</td><td>2x2x2</td><td>8171</td><td>100</td><td>61</td><td>9.4</td><td>9.4</td><td>25</td><td></td><td>500</td><td>221</td><td></td></tr><tr><td>Correa et al [71], 2000</td><td>2x2x2</td><td>976</td><td>54</td><td>51</td><td>6</td><td>6</td><td>30</td><td></td><td>2000</td><td></td><td></td></tr><tr><td>Desnuelle et al [72], 2001</td><td>Parallel</td><td>288</td><td>45</td><td>64</td><td>1</td><td>1</td><td></td><td></td><td></td><td>1000</td><td></td></tr><tr><td>Garbagnati et al [73], 2009</td><td>Parallel</td><td>72</td><td>35</td><td>65</td><td>1</td><td>1</td><td>19</td><td></td><td>240</td><td>290</td><td></td></tr><tr><td>Girodon et al [74], 1999</td><td>2x2</td><td>725</td><td>74</td><td>84</td><td>2</td><td>2</td><td>6</td><td></td><td>120</td><td>15</td><td>100</td></tr><tr><td>Goodman et al [75], 2004</td><td>Parallel</td><td>18314</td><td>34</td><td>58</td><td>4</td><td>10</td><td>30</td><td>7500</td><td></td><td></td><td></td></tr><tr><td>Graat et al [76], 2002</td><td>2x2</td><td>652</td><td>50</td><td>N/A</td><td>1</td><td>1</td><td>1.2</td><td>600</td><td>60</td><td>210</td><td>25</td></tr><tr><td>Graf et al [77], 2005</td><td>Parallel</td><td>160</td><td>35</td><td>58</td><td>1.5</td><td>1.5</td><td></td><td></td><td></td><td>5000</td><td></td></tr><tr><td>Green et al [78], 1999</td><td>2x2</td><td>1621</td><td>56</td><td>49</td><td>4.5</td><td>4.5</td><td>30</td><td></td><td></td><td></td><td></td></tr><tr><td>Greenberg et al [79], 1990</td><td>Parallel</td><td>1805</td><td>30</td><td>N/A</td><td>5</td><td>5</td><td>50</td><td></td><td></td><td></td><td></td></tr><tr><td>Greenberg et al [80], 1994</td><td>2x2</td><td>864</td><td>21</td><td>61</td><td>4</td><td>4</td><td>25</td><td></td><td>1000</td><td>400</td><td></td></tr><tr><td>Grieger et al [81], 2009</td><td>Parallel</td><td>115</td><td>65</td><td>NA</td><td>0.5</td><td>0.5</td><td>3</td><td></td><td>75</td><td>12,2</td><td></td></tr><tr><td>Hennekens et al [82], 1996</td><td>2x2</td><td>22071</td><td>0</td><td>53</td><td>12</td><td>12.9</td><td>25</td><td></td><td></td><td></td><td></td></tr><tr><td>Hercberg et al [83], 2010</td><td>Parallel</td><td>13017</td><td>61</td><td>49</td><td>7.54</td><td>7.54</td><td>6</td><td></td><td>120</td><td>30</td><td>100</td></tr><tr><td>Hodis et al [84], 2002</td><td>Parallel</td><td>353</td><td>52</td><td>56</td><td>3</td><td>3</td><td></td><td></td><td></td><td>364</td><td></td></tr><tr><td>Jacobson et al [85], 2000</td><td>Parallel</td><td>112</td><td>42</td><td>42</td><td>0.5</td><td>0.5</td><td>12</td><td></td><td>500</td><td>268</td><td></td></tr><tr><td>Lee et al [86], 2005</td><td>2x2</td><td>39876</td><td>100</td><td>55</td><td>10.1</td><td>10.1</td><td>25</td><td></td><td></td><td>221</td><td></td></tr><tr><td>Li et al [87], 1993</td><td>Parallel</td><td>3318</td><td>56</td><td>54</td><td>6</td><td>6</td><td>15</td><td>3000</td><td>180</td><td>54</td><td>50</td></tr><tr><td>Lippman et al [88], 2008</td><td>2x2</td><td>35533</td><td>0</td><td>62</td><td>5.5</td><td>5.5</td><td></td><td></td><td></td><td>400</td><td>200</td></tr><tr><td>Liu et al [89], 2007</td><td>Parallel</td><td>763</td><td>68</td><td>85</td><td>1.6</td><td>1.6</td><td>16</td><td>400</td><td>80</td><td>44</td><td>20</td></tr><tr><td>Lonn et al [90], 2005</td><td>2x2</td><td>9541</td><td>27</td><td>66</td><td>4.5</td><td>7</td><td></td><td></td><td></td><td>294</td><td></td></tr><tr><td>Magliano et al [91], 2006</td><td>Parallel</td><td>409</td><td>55</td><td>63</td><td>4</td><td>4</td><td></td><td></td><td></td><td>336</td><td></td></tr><tr><td>Manuel-y-Keenoy et al [92], 2004</td><td>Parallel</td><td>24</td><td>14</td><td>51</td><td>0.5</td><td>4.5</td><td></td><td></td><td></td><td>503</td><td></td></tr><tr><td>Marras et al [93], 2005</td><td>2x2</td><td>800</td><td>34</td><td>61</td><td>2.6</td><td>13</td><td></td><td></td><td></td><td>2000</td><td></td></tr><tr><td>McNeil et al [94], 2004</td><td>Parallel</td><td>1193</td><td>56</td><td>66</td><td>4</td><td>4</td><td></td><td></td><td></td><td>500</td><td></td></tr><tr><td>Meydani et al [95], 2004</td><td>Parallel</td><td>617</td><td>73</td><td>84</td><td>1</td><td>1</td><td></td><td></td><td></td><td>182</td><td>100</td></tr><tr><td>Mezey et al [96], 2004</td><td>Parallel</td><td>51</td><td>33</td><td>48</td><td>0.25</td><td>1</td><td></td><td></td><td></td><td>1000</td><td></td></tr><tr><td>Milman et al [97], 2008</td><td>Parallel</td><td>1434</td><td>52</td><td>69</td><td>1.5</td><td>1.5</td><td></td><td></td><td></td><td>268</td><td></td></tr><tr><td>Moon et al [98], 1997</td><td>Parallel</td><td>2297</td><td>30</td><td>63</td><td>3.8</td><td>3.8</td><td></td><td>7500</td><td></td><td></td><td></td></tr><tr><td>Mooney et al [99], 2005</td><td>Parallel</td><td>284</td><td>45</td><td>37</td><td>1.25</td><td>1.25</td><td></td><td></td><td>500</td><td>364</td><td></td></tr><tr><td>HPS [100] 2002</td><td>2x2</td><td>20536</td><td>25</td><td>N/A</td><td>5</td><td>5</td><td>20</td><td></td><td>250</td><td>600</td><td></td></tr><tr><td>Murphy et al [101], 1992</td><td>Parallel</td><td>109</td><td>N/A</td><td>N/A</td><td>0.003</td><td>0.25</td><td></td><td>667</td><td></td><td></td><td></td></tr><tr><td>Pike et al [102], 1995</td><td>Parallel</td><td>47</td><td>72</td><td>69</td><td>1</td><td>1</td><td></td><td>800</td><td>90</td><td>45</td><td></td></tr><tr><td>Plummer et al [103], 2007</td><td>Parallel</td><td>1980</td><td>53</td><td>NA</td><td>3</td><td>3</td><td>18</td><td></td><td>750</td><td>600</td><td></td></tr><tr><td>Prince et al [104], 2003</td><td>Cross-over</td><td>61</td><td>92</td><td>58</td><td>0.25</td><td>0.25</td><td>3</td><td></td><td>150</td><td>50</td><td>75</td></tr><tr><td>Richer et al [105], 2004</td><td>Parallel</td><td>61</td><td>4</td><td>75</td><td>1</td><td>1</td><td>9</td><td>750</td><td>1500</td><td>413</td><td>200</td></tr><tr><td>Salonen et al [106], 2003</td><td>2x2</td><td>520</td><td>51</td><td>N/A</td><td>6</td><td>6</td><td></td><td></td><td>250</td><td>182</td><td></td></tr><tr><td>Sesso et al [107], 2008</td><td>2x2x2</td><td>14641</td><td>0</td><td>64</td><td>8</td><td>8</td><td>25</td><td>1050</td><td>560</td><td>182</td><td>20</td></tr><tr><td>Stephens et al [108], 1996</td><td>Parallel</td><td>2002</td><td>16</td><td>62</td><td>1.4</td><td>1.4</td><td></td><td></td><td></td><td>403</td><td></td></tr><tr><td>Tam et al [109], 2005</td><td>Parallel</td><td>39</td><td>100</td><td>46</td><td>0.23</td><td>2.67</td><td></td><td></td><td>500</td><td>661</td><td></td></tr><tr><td>Virtamo et al [110], 2003</td><td>2x2</td><td>29133</td><td>0</td><td>57</td><td>6.1</td><td>14.1</td><td>20</td><td></td><td></td><td>50</td><td></td></tr><tr><td>Waters et al [111], 2002</td><td>2x2</td><td>423</td><td>100</td><td>65</td><td>3</td><td>3</td><td></td><td></td><td>1000</td><td>800</td><td></td></tr><tr><td>White et al [112], 2002</td><td>Parallel</td><td>100</td><td>42</td><td>63</td><td>0.23</td><td>0.23</td><td></td><td></td><td>1000</td><td>200</td><td></td></tr><tr><td>Witte et al [113], 2005</td><td>Parallel</td><td>32</td><td>N/A</td><td>N/A</td><td>0.75</td><td>0.75</td><td></td><td>800</td><td>500</td><td>400</td><td>50</td></tr><tr><td>Wluka et al [114], 2002</td><td>Parallel</td><td>136</td><td>45</td><td>64</td><td>2</td><td>2</td><td></td><td></td><td></td><td>368</td><td></td></tr></table> |
c2a4786ae85f1bd322d37e6da86a75e276d90473728e5ff5d05187c1516dc36f.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="5">Blood component</td></tr><tr><td>Plasma</td><td>P-PRP+NID</td><td>P-PRG</td><td>PPP+NID</td><td>PPG</td></tr><tr><td> </td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td><td><i>(n=40)</i></td></tr><tr><td>Total protein -TP- (mg/mL)*</td><td>45.9 (4.4)<sup>a</sup></td><td>49.5 (6.2)<sup>b</sup></td><td>46.1 (4.5)</td><td>46.4 (5.0)</td><td>45.5 (5.5)</td></tr><tr><td>TGF-β1 (pg/mL)</td><td>1114.3 (457.7)<sup>c</sup></td><td>3192.7 (1395.3)<sup>d</sup></td><td>2555.5 (1069.4)<sup>d</sup></td><td>1714.3 (496.3)</td><td>1508.0 (445.9)</td></tr><tr><td>TGF-β1 (pg/mg of TP)</td><td>24.4 (11.2)<sup>c</sup></td><td>64.9 (29.5)<sup>d</sup></td><td>56.0 (24.3)<sup>d</sup></td><td>37.2 (11.2)</td><td>33.3 (10.5)</td></tr><tr><td>PDGF-BB (pg/mL)</td><td>158.1 (281.0)<sup>c</sup></td><td>1259.7 (418.6)<sup>d</sup></td><td>1228.8 (418.0)<sup>d</sup></td><td>601.8 (339.3)</td><td>611.7 (295.9)</td></tr><tr><td>PDGF-BB (pg/mg of TP)</td><td>3.5 (6.5)<sup>c</sup></td><td>25.5 (8.7)<sup>d</sup></td><td>27.2 (10.8)<sup>d</sup></td><td>13.2 (7.9)</td><td>13.6 (7.3)</td></tr></table> |
fd56fb8c62a46419cc47becdc99be03e661fbb67f6eec7f2479dfbe2bc4f1c34.png | simple | <table><tr><td>Haplotype</td><td>Case</td><td>Control</td><td>P-value</td></tr><tr><td>2-2-1-2-1-1</td><td>6.115</td><td>6.69</td><td>0.2675</td></tr><tr><td>2-2-1-2-1-2</td><td>0.9372</td><td>0</td><td>0.308</td></tr><tr><td>2-2-1-2-3-1</td><td>0.6905</td><td>0</td><td>0.9992</td></tr><tr><td>2-2-1-4-1-1</td><td>828.9</td><td>834</td><td>0.8783</td></tr><tr><td>2-2-1-4-1-2</td><td>9.433</td><td>10.21</td><td>0.8322</td></tr><tr><td>2-2-1-4-3-1</td><td>57.67</td><td>113</td><td>3.747E-05</td></tr><tr><td>2-2-1-4-3-2</td><td>1.007</td><td>0</td><td>0.3188</td></tr><tr><td>2-2-3-2-1-1</td><td>12.98</td><td>6.27</td><td>0.3267</td></tr><tr><td>2-2-3-2-1-2</td><td>0</td><td>0.6707</td><td>1</td></tr><tr><td>2-2-3-2-3-1</td><td>1.204</td><td>0</td><td>1</td></tr><tr><td>2-2-3-4-1-1</td><td>0.867</td><td>1.918</td><td>0.3793</td></tr><tr><td>2-2-3-4-1-2</td><td>15.44</td><td>19.16</td><td>0.7131</td></tr><tr><td>2-2-3-4-3-1</td><td>30.39</td><td>43.74</td><td>0.2237</td></tr><tr><td>2-2-3-4-3-2</td><td>2.114</td><td>0.9249</td><td>0.609</td></tr><tr><td>2-4-1-4-1-1</td><td>1.627</td><td>3.416</td><td>0.365</td></tr><tr><td>2-4-3-2-1-2</td><td>0.8596</td><td>2.21</td><td>0.6195</td></tr><tr><td>2-4-3-4-1-1</td><td>1.591</td><td>13.85</td><td>0.002506</td></tr><tr><td>2-4-3-4-1-2</td><td>137.2</td><td>122.5</td><td>0.4528</td></tr><tr><td>2-4-3-4-3-1</td><td>0</td><td>2.456</td><td>0.01213</td></tr><tr><td>3-2-1-2-1-1</td><td>1.148</td><td>0.6285</td><td>0.7064</td></tr><tr><td>3-2-1-4-1-1</td><td>85.07</td><td>64.9</td><td>0.07011</td></tr><tr><td>3-2-1-4-1-2</td><td>1.305</td><td>0.2028</td><td>0.3483</td></tr><tr><td>3-2-1-4-3-1</td><td>3.732</td><td>0</td><td>0.3045</td></tr><tr><td>3-2-3-2-1-1</td><td>295.5</td><td>334.6</td><td>0.1975</td></tr><tr><td>3-2-3-2-1-2</td><td>7.775</td><td>4.195</td><td>0.2888</td></tr><tr><td>3-2-3-2-3-1</td><td>4.929</td><td>8.097</td><td>0.1492</td></tr><tr><td>3-2-3-4-1-1</td><td>5.902</td><td>0.8962</td><td>0.06286</td></tr><tr><td>3-2-3-4-1-2</td><td>48.69</td><td>19.48</td><td>0.0004034</td></tr><tr><td>3-2-3-4-3-1</td><td>1114</td><td>1153</td><td>0.3141</td></tr><tr><td>3-2-3-4-3-2</td><td>5.975</td><td>2.85</td><td>0.2993</td></tr><tr><td>3-4-1-4-1-1</td><td>1.055</td><td>4.961</td><td>0.1278</td></tr><tr><td>3-4-1-4-1-2</td><td>1.301</td><td>2.3</td><td>0.6549</td></tr><tr><td>3-4-1-4-3-1</td><td>1.013</td><td>0</td><td>0.3212</td></tr><tr><td>3-4-1-4-3-2</td><td>0</td><td>0.6906</td><td>0.09517</td></tr><tr><td>3-4-3-2-1-1</td><td>7.049</td><td>1.218</td><td>0.3176</td></tr><tr><td>3-4-3-2-1-2</td><td>12.86</td><td>31.44</td><td>0.008042</td></tr><tr><td>3-4-3-4-1-1</td><td>17.34</td><td>20.11</td><td>0.555</td></tr><tr><td>3-4-3-4-1-2</td><td>2422</td><td>2309</td><td>0.02225</td></tr><tr><td>3-4-3-4-3-1</td><td>0</td><td>12.7</td><td>0.004522</td></tr></table> |
90d7a0c213c7615915df19dcadb540d2efe614e2839a3f3b18464eaa833a1ed4.png | simple | <table><tr><td>Stage dose and route</td><td>Patients, <i>n </i>(active:placebo)</td></tr><tr><td>SAD stage dose, route (cohort)</td><td></td></tr><tr><td> 0.3 IV (A)</td><td>4:1</td></tr><tr><td> 1.0 IV (B)</td><td>4:1</td></tr><tr><td> 1.0 SC (C)</td><td>4:1</td></tr><tr><td> 3.0 IV (D)</td><td>4:1</td></tr><tr><td> 3.0 SC (E)</td><td>4:1</td></tr><tr><td> 5.0 IV (F)</td><td>4:1</td></tr><tr><td>MAD stage dose, route (cohort)</td><td></td></tr><tr><td> 1.0 SC (G)</td><td>8:2</td></tr><tr><td> 3.0 SC (H)</td><td>16:4</td></tr><tr><td> 5.0 IV (I)</td><td>4:1</td></tr></table> |
2c504635b0d03f80f03978ef339ea19b9fd5dde813d55b2540c78e9d3212ca61.png | simple | <table><tr><td>Adsorption Concentration (mol/L)</td><td>10<sup>−3</sup></td><td>10<sup>−2</sup></td><td>10<sup>−1</sup></td></tr><tr><td>Absorbance</td><td>1.004</td><td>0.860</td><td>0.377</td></tr><tr><td>Drug concentration</td><td>0.125 × 10<sup>−3</sup></td><td>0.106 × 10<sup>−2</sup></td><td>0.045 × 10<sup>−1</sup></td></tr><tr><td>The remaining amount of R6G in 20 mL solution (mg)</td><td>1.198</td><td>10.189</td><td>42.589</td></tr><tr><td>The amount of added magnetic particles (g)</td><td>0.001</td><td>0.01</td><td>0.1</td></tr><tr><td>The amount of the adsorbed drug (mg)</td><td>0.239</td><td>4.085</td><td>101.114</td></tr><tr><td>The amount of the adsorbed drug by 1.0 g particles (mg)</td><td>239.0</td><td>408.5</td><td>1011.1</td></tr></table> |
c47420b469d96f4b6692bef05015c80a2b0c67da845815054a7fccf1ebd04d2b.png | simple | <table><tr><td>DNA Binding Factor</td><td>No. of Bound Genes in the Genome</td><td>No. of Bound Genes in hESCs</td><td>No. of Bound POLR3G-Dependent Genes</td><td>Hypergeometric Test p Value</td><td>Adjusted p Value (Benjamini-Hochberg)</td></tr><tr><td>NANOG</td><td>25,071</td><td>1,668 (12.2%)</td><td>166 (16.3%)</td><td>3.64 × 10<sup>−5</sup></td><td>2.19 × 10<sup>−4</sup></td></tr><tr><td>KLF4</td><td>3,793</td><td>1,116 (8.2%)</td><td>105 (10.3%)</td><td>4.55 × 10<sup>−4</sup></td><td>1.36 × 10<sup>−3</sup></td></tr><tr><td>SOX2</td><td>5,682</td><td>467 (3.4%)</td><td>49 (4.8%)</td><td>6.57 × 10<sup>−3</sup></td><td>1.31 × 10<sup>−2</sup></td></tr><tr><td>EP300</td><td>3,093</td><td>280 (2.1%)</td><td>37 (3.6%)</td><td>9.08 × 10<sup>−3</sup></td><td>1.36 × 10<sup>−2</sup></td></tr><tr><td>POU5F1</td><td>3,889</td><td>1,524 (11.1%)</td><td>123 (12.1%)</td><td>1.74 × 10<sup>−1</sup></td><td>2.09 × 10<sup>−1</sup></td></tr><tr><td>POLR3A</td><td>389</td><td>40 (0.3%)</td><td>3 (0.3%)</td><td>5.81 × 10<sup>−1</sup></td><td>5.81 × 10<sup>−1</sup></td></tr></table> |
4c170e3fb69ef00628029e6ede5ae2147a26122d866ee0cadedefa4207a4bcf2.png | simple | <table><tr><td></td><td><i>M</i></td><td><i>SD</i></td><td>Range</td></tr><tr><td>Townsend disability score</td><td>2.4</td><td>1.38</td><td>0–4</td></tr><tr><td>Social resources (LSNS-6)</td><td>15.4</td><td>5.90</td><td>0–30</td></tr><tr><td>Cognitive impairment (MMSE)</td><td>26.9</td><td>3.02</td><td>8–30</td></tr><tr><td>Loneliness</td><td>1.0</td><td>1.18</td><td>0–6</td></tr></table> |
6a56624040a4f9654bd576a3e8cb8ac145ae4e6b130b44bbd99eb1d1c1f13254.png | simple | <table><tr><td></td><td></td><td>Livron 6 loci (without Pwalt_Te39)</td><td>Aouste 7 loci</td></tr><tr><td><i>N</i><sub>e</sub> - LDNe</td><td></td><td>892 (243 - Infinite)</td><td>-1470 (585 - Infinite)</td></tr><tr><td><i>N</i><sub>e</sub> - ONeSAMP</td><td>Run 1</td><td>186 (103-327)</td><td>533 (202-1995)</td></tr><tr><td></td><td>Run 2</td><td>182 (93-314)</td><td>1209 (434-5855)</td></tr><tr><td></td><td>Run 3</td><td>142 (83-260)</td><td>1844 (557-10265)</td></tr></table> |
51560cbcd0a7afefc39ce9838570c78c4044736c904873c089a391ccd04fe0e3.png | simple | <table><tr><td></td><td>Overall</td><td>Monotherapy</td><td>Part of double combination therapy</td><td>Part of triple combination therapy</td></tr><tr><td>Amikacin</td><td>17.3</td><td>15.7</td><td>19.4</td><td>9.5</td></tr><tr><td>Meropenem</td><td>11.8</td><td>7.2</td><td>10.8</td><td>26.2</td></tr><tr><td>Piperacillin-tazobactam</td><td>11.2</td><td>27.7</td><td>6.3</td><td>4.8</td></tr><tr><td>Ampicillin</td><td>10.1</td><td>1.2</td><td>14.0</td><td>7.1</td></tr><tr><td>Gentamicin</td><td>9.2</td><td>3.6</td><td>13.1</td><td>0</td></tr><tr><td>Cefotaxime</td><td>5.8</td><td>15.7</td><td>3.2</td><td>0</td></tr><tr><td>Fluconazole</td><td>4.9</td><td>2.4</td><td>4.1</td><td>14.3</td></tr><tr><td>Ciprofloxacin</td><td>3.8</td><td>4.8</td><td>4.1</td><td>0</td></tr><tr><td>Vancomycin</td><td>3.5</td><td>1.2</td><td>4.1</td><td>4.8</td></tr><tr><td>Ceftriaxone</td><td>2.6</td><td>4.8</td><td>2.3</td><td>0</td></tr><tr><td>Colistin</td><td>2.3</td><td>0</td><td>2.7</td><td>4.8</td></tr><tr><td>Levofloxacin</td><td>2.0</td><td>2.4</td><td>2.3</td><td>0</td></tr><tr><td>Cefoperazone Sulbactam</td><td>3.2</td><td>0</td><td>4.5</td><td>2.4</td></tr><tr><td>Amphotericin B/Amphotericin B liposomal</td><td>1.7</td><td>2.4</td><td>1.4</td><td>2.4</td></tr><tr><td>Cefoperazone</td><td>1.4</td><td>1.2</td><td>1.4</td><td>2.4</td></tr></table> |
25db41320027c4316da1c2865283f754594834ef505d9b73799c0c2ef5fecc46.png | simple | <table><tr><td>Section</td><td>Number of infants with indicators for OPD</td><td>Frequency distribution (%)</td></tr><tr><td>A. Functioning of physiological subsystems?</td><td>2</td><td>10</td></tr><tr><td>B. State of alertness during feeding†</td><td>-</td><td>-</td></tr><tr><td>C. Stress cues during feeding</td><td>15</td><td>75</td></tr><tr><td>D. Movement and muscle tone screening</td><td>4</td><td>20</td></tr><tr><td>E. Oral peripheral examination</td><td>8</td><td>40</td></tr><tr><td>F. Clinical feeding and swallowing evaluation</td><td>14</td><td>70</td></tr><tr><td>Diagnosis of OPD</td><td>9</td><td>45</td></tr></table> |
79abc9c8374bb04143b175c3e4b6f5e2217a8379a84ebbd4e5a093368521e739.png | complex | <table><tr><td rowspan="3">Day from onset of fever</td><td rowspan="3">Day of defervescence</td><td colspan="5">Total fluid intake in ml</td><td colspan="5">IV fluids in ml</td></tr><tr><td colspan="2">DHF group</td><td colspan="2">DF group</td><td rowspan="2">P value*</td><td colspan="2">DHF group</td><td colspan="2">DF group</td><td rowspan="2">P value*</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>D2</td><td>D-3</td><td>2123</td><td>492</td><td>2314</td><td>1449</td><td>0.706</td><td>1113</td><td>308</td><td>1053</td><td>678</td><td>0.810</td></tr><tr><td>D3</td><td>D-2</td><td>2733</td><td>1457</td><td>2158</td><td>833</td><td>0.135</td><td>1464</td><td>612</td><td>1245</td><td>476</td><td>0.198</td></tr><tr><td>D4</td><td>D-1</td><td>2846</td><td>1250</td><td>2798</td><td>1164</td><td>0.851</td><td>1648</td><td>523</td><td>1537</td><td>460</td><td>0.290</td></tr><tr><td>D5</td><td>D0</td><td>2981</td><td>1247</td><td>2754</td><td>1071</td><td>0.268</td><td>1857</td><td>609</td><td>1563</td><td>531</td><td>0.004</td></tr><tr><td>D6</td><td>D + 1</td><td>3139</td><td>880</td><td>2812</td><td>966</td><td>0.032</td><td>1889</td><td>541</td><td>1512</td><td>417</td><td><0.001</td></tr><tr><td>D7</td><td>D + 2</td><td>3154</td><td>913</td><td>2918</td><td>884</td><td>0.129</td><td>1870</td><td>555</td><td>1533</td><td>422</td><td><0.001</td></tr><tr><td>D8</td><td>D + 3</td><td>2791</td><td>690</td><td>2979</td><td>936</td><td>0.255</td><td>1589</td><td>487</td><td>1599</td><td>494</td><td>0.920</td></tr><tr><td>D9</td><td>D + 4</td><td>2762</td><td>598</td><td>2825</td><td>762</td><td>0.782</td><td>1449</td><td>543</td><td>1583</td><td>503</td><td>0.494</td></tr><tr><td>D10</td><td>D + 5</td><td>2281</td><td>639</td><td>2957</td><td>1163</td><td>0.152</td><td>1310</td><td>617</td><td>1583</td><td>514</td><td>0.377</td></tr></table> |
3a1221e95c03a4ff2131e1dc16cd0bf1c6b7e3fa2cbaa525f2ee1a77c73ff997.png | simple | <table><tr><td>Variables</td><td>Total n (%)</td><td>Boys n (%)</td><td>Girls n (%)</td></tr><tr><td>Alcohol use & bullying others</td><td>15 (2.2)</td><td>13 (4.0)</td><td>2 (0.6)</td></tr><tr><td>Alcohol use & sexual activity</td><td>12 (1.8)</td><td>11 (3.4)</td><td>1 (0.3)</td></tr><tr><td>Early sexual intercourse & sexual activity</td><td>10 (1.5)</td><td>6 (1.8)</td><td>4 (1.1)</td></tr><tr><td>Alcohol use & cigarette use</td><td>9 (1.3)</td><td>4 (1.2)</td><td>5 (1.4)</td></tr><tr><td>Sexual activity & bullying others</td><td>4 (0.6)</td><td>3 (0.9)</td><td>1 (0.3)</td></tr><tr><td>Tablets use & bullying others</td><td>3 (0.4)</td><td>3 (0.9)</td><td>0 (0.0)</td></tr><tr><td>Cigarette use & sexual activity</td><td>5 (0.7)</td><td>2 (0.6)</td><td>3 (0.8)</td></tr><tr><td>Cigarette use & bullying others</td><td>4 (0.6)</td><td>3 (0.9)</td><td>1 (0.3)</td></tr><tr><td>Alcohol use & tablets use</td><td>2 (0.3)</td><td>2 (0.6)</td><td>0 (0.0)</td></tr><tr><td>Alcohol use & cigarette use & sexual activity</td><td>12 (1.8)</td><td>5 (1.5)</td><td>7 (2.0)</td></tr><tr><td>Alcohol use & sexual activity & bullying others</td><td>10 (1.5)</td><td>8 (2.4)</td><td>2 (0.6)</td></tr><tr><td>Alcohol use & early sexual intercourse & sexual activity</td><td>9 (1.3)</td><td>6 (1.8)</td><td>3 (0.8)</td></tr><tr><td>Alcohol use & cigarette use & bullying others</td><td>6 (0.9)</td><td>4 (1.2)</td><td>2 (0.6)</td></tr><tr><td>Early sexual intercourse & sexual activity & bullying others</td><td>5 (0.7)</td><td>4 (1.2)</td><td>1 (0.3)</td></tr><tr><td>Alcohol use & tablets use & bullying others</td><td>2 (0.3)</td><td>0 (0.0)</td><td>2 (0.6)</td></tr><tr><td>Cigarette use & early sexual intercourse & sexual activity</td><td>3 (0.4)</td><td>1 (0.3)</td><td>2 (0.6)</td></tr><tr><td>Cigarette use & sexual activity & bullying others</td><td>1 (0.1)</td><td>1 (0.3)</td><td>0 (0.0)</td></tr><tr><td>Cigarette use & tablets use & bullying others</td><td>2 (0.3)</td><td>0 (0.0)</td><td>2 (0.6)</td></tr><tr><td>Cigarette & alcohol & early sexual intercourse & sexual activity</td><td>5 (0.7)</td><td>5 (1.5)</td><td>0 (0.0)</td></tr><tr><td>Cigarette & early sexual intercourse & sexual activity & bullying</td><td>2 (0.3)</td><td>2 (0.6)</td><td>0 (0.0)</td></tr><tr><td>Cigarette & Alcohol & early sexual intercourse & bullying others</td><td>1 (0.1)</td><td>1 (0.3)</td><td>0 (0.0)</td></tr><tr><td>Alcohol use & early sexual intercourse & sexual activity & bullying</td><td>1 (0.1)</td><td>1 (0.3)</td><td>0 (0.0)</td></tr><tr><td>Cigarette & alcohol & early sex & sexual activity & bullying others</td><td>5 (0.7)</td><td>4 (1.2)</td><td>1 (0.3)</td></tr><tr><td>Cigarette & alcohol & tablets & early sex & sexual activity</td><td>1 (0.1)</td><td>0 (0.0)</td><td>1 (0.3)</td></tr><tr><td>Cigarette & alcohol & tablets & early sex & sexual activity & bullying</td><td>0 (0.0)</td><td>0 (0.0)</td><td>0 (0.0)</td></tr></table> |
01cfbec5a210b0dd3f1f8d84467b8367421f2824f98fd323f9890ca7653d84c1.png | complex | <table><tr><td></td><td colspan="3">All</td><td colspan="4">Age 35-59 years</td><td colspan="5">Age 60-74 years</td></tr><tr><td></td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td></td><td colspan="3">eGFR (mL/min/1.73 m<sup>2</sup>) </td><td></td><td></td></tr><tr><td></td><td>Coeff.</td><td>HR at more adverse level*</td><td>p-value</td><td>Coeff.</td><td>HR at more adverse level*</td><td>p-value</td><td></td><td>Coeff.</td><td>HR at more adverse level*</td><td>p-value</td><td></td><td></td></tr><tr><td><i>All</i><i></i><i>cause</i><i></i><i>mortality</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Classical</i><i></i><i>risk</i><i></i><i>factors</i><i></i><i>adjusted</i></td><td>-0.0025</td><td>0.97</td><td>0.6829</td><td>0.0181</td><td>1.18</td><td>0.3290</td><td></td><td>-0.0178</td><td>0.81</td><td>0.0020</td><td></td><td></td></tr><tr><td><i>Incident cardiovascular disease</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Classical</i><i></i><i>risk</i><i></i><i>factors</i><i></i><i>adjusted</i></td><td>-0.0020</td><td>0.98</td><td>0.8030</td><td>0.0262</td><td>1.28</td><td>0.2063</td><td></td><td>-0.0162</td><td>0.83</td><td>0.0451</td><td></td><td></td></tr></table> |
6aa25d675073ecb78628041dcdde162e2c693c83791798fe9bfb59b856c37d97.png | simple | <table><tr><td>Gene symbol</td><td>Gene full name</td><td>Fold regulation</td><td>p-value</td></tr><tr><td>TLR2</td><td>Toll-like receptor 2</td><td>−30.20</td><td>0.02</td></tr><tr><td>IL1A</td><td>Interleukin 1, alpha</td><td>−7.85</td><td>0.01</td></tr><tr><td>LTB</td><td>Lymphotoxin beta (TNF superfamily, member 3)</td><td>−5.80</td><td>0.02</td></tr><tr><td>IL23A</td><td>Interleukin 23, alpha subunit p19</td><td>−5.67</td><td>0.01</td></tr><tr><td>TLR4</td><td>Toll-like receptor 4</td><td>−4.03</td><td>0.01</td></tr><tr><td>CCL7</td><td>Chemokine (C-C motif) ligand 7</td><td>−3.78</td><td>0.00</td></tr><tr><td>CXCL3</td><td>Chemokine (C-X-C motif) ligand 3</td><td>−3.66</td><td>0.02</td></tr><tr><td>CXCR2</td><td>Chemokine (C-X-C motif) receptor 2</td><td>−3.55</td><td>0.02</td></tr><tr><td>TLR1</td><td>Toll-like receptor 1</td><td>−3.31</td><td>0.01</td></tr><tr><td>IL15</td><td>Interleukin 15</td><td>−3.23</td><td>0.00</td></tr><tr><td>CCR1</td><td>Chemokine (C-C motif) receptor 1</td><td>−2.91</td><td>0.03</td></tr><tr><td>IL18</td><td>Interleukin 18</td><td>−2.49</td><td>0.00</td></tr><tr><td>IL10</td><td>Interleukin 10</td><td>−2.20</td><td>0.05</td></tr><tr><td>IL1R1</td><td>Interleukin 1 receptor, type I</td><td>−2.02</td><td>0.01</td></tr><tr><td>LY96*</td><td>Lymphocyte antigen 96 (MD-2)</td><td>2.49</td><td>0.01</td></tr></table> |
062762c1a8a4bb249b12824f0b7797de7ee77af37c6fb0767304bf202913e407.png | simple | <table><tr><td></td><td>Intervention N = 392</td><td>Comparison N = 394</td><td></td></tr><tr><td>Birth interval (months)</td><td></td><td></td><td></td></tr><tr><td>Mead (SD)</td><td>40.0 (30)</td><td>38.1 (26)</td><td>F 0.89, p 0.35; unequal variance in birth interval</td></tr><tr><td>Missing</td><td>(2)</td><td>(1)</td><td></td></tr><tr><td>Birth weight</td><td></td><td></td><td></td></tr><tr><td>Mean (SD)</td><td>3403 (509)</td><td>3500 (504)</td><td>Difference -97 g</td></tr><tr><td>Missing data</td><td>(3)</td><td>(2)</td><td></td></tr><tr><td>Low birth weight (<2500 g)</td><td>25/393</td><td>14/394</td><td>OR (exact) 1.85 [0.91, 3.91]</td></tr><tr><td>Birth weight <10<sup>th</sup>percentile*</td><td>40/378 (11%)</td><td>31/382(8%)</td><td>OR (exact) 1.14 [0.55, 2.38]</td></tr><tr><td>Low birth weight</td><td></td><td></td><td></td></tr><tr><td><1000 g</td><td>6</td><td>0</td><td></td></tr><tr><td>1000–1499</td><td>3</td><td>0</td><td></td></tr><tr><td>1500–1999</td><td>7</td><td>2</td><td></td></tr><tr><td>2000–2499</td><td>9</td><td>12</td><td></td></tr><tr><td>All with birth weight (≥ 2,500 g</td><td>367</td><td>380</td><td></td></tr><tr><td>Missing data</td><td>(3)</td><td>(2)</td><td></td></tr><tr><td>All births</td><td>395</td><td>396</td><td></td></tr><tr><td>Gestation</td><td></td><td></td><td></td></tr><tr><td>Mean (SD)</td><td>39.3 (2.2)</td><td>39.5 (1.5)</td><td></td></tr><tr><td>Preterm birth (<37 weeks)</td><td>24 (6%)</td><td>17 (4%)</td><td>OR (exact) 1.44 (0.73, 2.91)</td></tr><tr><td>Preterm birth</td><td></td><td></td><td></td></tr><tr><td>20–27 weeks</td><td>4</td><td>0</td><td></td></tr><tr><td>28–31 weeks</td><td>6</td><td>1</td><td></td></tr><tr><td>32–36 weeks</td><td>14</td><td>16</td><td></td></tr><tr><td>All with gestations ≥ 37 weeks</td><td>366</td><td>374</td><td></td></tr><tr><td>Missing data</td><td>(2)</td><td>(3)</td><td></td></tr><tr><td>All gestations</td><td>392</td><td>394</td><td></td></tr></table> |
b8e22c81c2f23c8ab1f4f534f288cfe626b3cea860c84aa1c119d845401435a7.png | simple | <table><tr><td>Plasmid</td><td>Description</td><td>Source</td></tr><tr><td>pRL446</td><td></td><td>Elhai and Wolk, 1988</td></tr><tr><td>pMD18T</td><td>TA cloning vector</td><td>TaKaRa clonetech</td></tr><tr><td>pMD18Tslr1670</td><td></td><td>This study</td></tr><tr><td>pMD18Tslr1670KmR</td><td>Construction Δ<i>slr1670</i></td><td>This study</td></tr><tr><td>pXT323</td><td>Construction Δ<i>glpK</i></td><td>This study</td></tr></table> |
c6400f4903d4b2f3240a01ff28567ab391744b70ad19a28ab93215dc5df5bda2.png | simple | <table><tr><td> </td><td>Number of patients (%)</td></tr><tr><td>Histology</td><td> </td></tr><tr><td>Non-small cell lung cancer</td><td>56 (88%)</td></tr><tr><td>Other</td><td>6 (9%)</td></tr><tr><td>No pathology</td><td>2 (3%)</td></tr><tr><td>Dose schedule</td><td> </td></tr><tr><td>6 Gy × 5 fractions</td><td>2 (3%)</td></tr><tr><td>8 Gy × 5 fractions</td><td>7 (11%)</td></tr><tr><td>9 Gy × 5 fractions</td><td>1 (1.5%)</td></tr><tr><td>10 Gy × 5 fractions</td><td>10 (16%)</td></tr><tr><td>10.5 Gy × 5 fractions</td><td>7 (11%)</td></tr><tr><td>12 Gy × 4 fractions</td><td>17 (27%)</td></tr><tr><td>18 Gy* × 3 fractions</td><td>19 (29%)</td></tr><tr><td>Other</td><td>1 (1.5%)</td></tr><tr><td>Tumor size</td><td> </td></tr><tr><td>≤ 3 cm</td><td>36 (56%)</td></tr><tr><td>>3 cm</td><td>28 (44%)</td></tr><tr><td>SBRT indication</td><td> </td></tr><tr><td>Refused surgery</td><td>7 (11%)</td></tr><tr><td>Medically inoperable</td><td>47 (73%)</td></tr><tr><td>Surgically incurable</td><td>10 (16%)</td></tr><tr><td>Location</td><td> </td></tr><tr><td>Central</td><td>23 (36%</td></tr><tr><td>Peripheral</td><td>41 (64%)</td></tr></table> |
c9aab763bca2a4ea931575e771d8be4b48bb1ba52d9ef60217591b63d48fcfe5.png | simple | <table><tr><td></td><td>n</td><td>TAC M (SE)</td><td>Activity counts/min M (SE)</td><td>MVPA percentage M (SE)</td><td>Lifestyle percentage M (SE)</td><td>Light percentage M (SE)</td><td>Sedentary percentage M (SE)</td><td>Wear time M (SE)</td></tr><tr><td>High OA men</td><td>252</td><td>410,694 (10,303)</td><td>465.6 (11.0)</td><td>5.1 (0.2)</td><td>15.6 (0.4)</td><td>32.6 (0.3)</td><td>46.7 (0.5)</td><td>891.5 (9.4)</td></tr><tr><td>High OA women</td><td>37</td><td>337,066 (32,206)</td><td>388.1 (39.2)</td><td>3.2 (0.7)</td><td>13.4 (1.6)</td><td>35.4 (1.8)</td><td>48.0 (2.8)</td><td>876.2 (16.0)</td></tr><tr><td><i>p</i>-value</td><td></td><td>0.004</td><td>0.005</td><td><0.001</td><td>0.033</td><td>0.118</td><td>0.371</td><td>0.75</td></tr><tr><td>Intermediate OA men</td><td>175</td><td>346,091 (8743)</td><td>390.6 (10.7)</td><td>3.7 (0.2)</td><td>13.3 (0.5)</td><td>31.1 (0.5)</td><td>51.9 (0.8)</td><td>897.5 (9.5)</td></tr><tr><td>Intermediate OA women</td><td>125</td><td>279,822 (10,002)</td><td>326.7 (11.1)</td><td>2.1 (0.2)</td><td>11.8 (0.5)</td><td>34.5 (0.8)</td><td>51.4 (1.2)</td><td>863.9 (7.6)</td></tr><tr><td><i>p</i>-value</td><td></td><td><0.001</td><td><0.001</td><td><0.001</td><td>0.092</td><td><0.001</td><td>0.554</td><td>0.018</td></tr><tr><td>Low OA men</td><td>207</td><td>317,172 (9801)</td><td>359.4 (9.3)</td><td>3.9 (0.2)</td><td>10.5 (0.5)</td><td>26.3 (0.8)</td><td>59.2 (1.1)</td><td>890.4 (8.0)</td></tr><tr><td>Low OA women</td><td>316</td><td>258,408 (4913)</td><td>295.8 (5.0)</td><td>2.3 (0.1)</td><td>9.1 (0.2)</td><td>30.6 (0.2)</td><td>57.9 (0.4)</td><td>880.4 (4.8)</td></tr><tr><td><i>p</i>-value</td><td></td><td><0.001</td><td><0.001</td><td><0.001</td><td><0.001</td><td><0.001</td><td>0.227</td><td>0.373</td></tr></table> |
5ac0004f9f01bdc70014600af5a19dde108e6da8f686e74c29434d1c9a2ae7ae.png | simple | <table><tr><td>Variable</td><td>ML score (95% CI)<sup>a</sup></td><td>MEWS (95% CI)<sup>b</sup></td><td>Difference (95% CI for difference)<sup>c</sup></td><td><i>P </i>value</td></tr><tr><td>Cardiac arrest within 72 hours after presentation</td><td></td><td></td><td></td><td></td></tr><tr><td> Area under ROC curve</td><td>0.781</td><td>0.680</td><td>0.101 (0.006 to 0.197)</td><td>0.037</td></tr><tr><td> Sensitivity</td><td>81.4</td><td>74.4</td><td>7.0 (-11.1 to 21.9)</td><td>0.581</td></tr><tr><td> Specificity</td><td>72.3</td><td>54.2</td><td>18.1 (14.3 to 22.0)</td><td>< 0.001</td></tr><tr><td> Positive predictive value</td><td>12.5 (9.0 to 17.1)</td><td>7.4 (5.3 to 10.3)</td><td></td><td>< 0.001</td></tr><tr><td> Negative predicting value</td><td>98.8 (97.5 to 99.4)</td><td>97.8 (95.9 to 98.8)</td><td></td><td>0.133</td></tr><tr><td> Likelihood ratio (+)<sup>d</sup></td><td>2.94 (2.46 to 3.52)</td><td>1.62 (1.34 to 1.96)</td><td></td><td></td></tr><tr><td>Death after admission<sup>e</sup></td><td></td><td></td><td></td><td></td></tr><tr><td> Area under ROC curve</td><td>0.741</td><td>0.693</td><td>0.048 (-0.023 to 0.119)</td><td>0.185</td></tr><tr><td> Sensitivity</td><td>69.8</td><td>74.4</td><td>-4.7 (-16.7 to 7.4)</td><td>0.572</td></tr><tr><td> Specificity</td><td>73.9</td><td>55.7</td><td>18.2 (14.3 to 22.2)</td><td>< 0.001</td></tr><tr><td> Positive predictive value</td><td>21.5 (16.9 to 26.9)</td><td>14.7 (11.5 to 18.4)</td><td></td><td>< 0.001</td></tr><tr><td> Negative predicting value</td><td>96.0 (94.1 to 97.3)</td><td>95.5 (93.2 to 97.1)</td><td></td><td>0.608</td></tr><tr><td> Likelihood ratio (+)<sup>d</sup></td><td>2.67 (2.23 to 3.20)</td><td>1.68 (1.45 to 1.94)</td><td></td><td></td></tr></table> |
75cd49f78e9f0d1eaffeefcb53de4c0feeb43fb641424020d3e785894c40e5e9.png | simple | <table><tr><td></td><td>Prospective cohort</td><td>Fixed effects (all)</td><td>Fixed effects (worked > 41 h)</td><td>Fixed effects (worked >48 h)</td></tr><tr><td>N</td><td>5910</td><td>18,221</td><td>5889</td><td>1631</td></tr><tr><td>Long working hours (>48 h)</td><td>1%</td><td>9%</td><td>28%</td><td>100%</td></tr><tr><td>Semi-long hours (41–48 h)</td><td>6%</td><td>31%</td><td>96%</td><td>86%</td></tr><tr><td>Short sickness absence</td><td>73%</td><td>64%</td><td>64%</td><td>52%</td></tr><tr><td>Long sickness absence</td><td>23%</td><td>14%</td><td>14%</td><td>13%</td></tr><tr><td>Extra-long sickness absence</td><td>12%</td><td>6%</td><td>6%</td><td>5%</td></tr><tr><td>Age</td><td>45 (SD 12)</td><td>42 (SD 12)</td><td>43 (SD 12)</td><td>44 (SD 11)</td></tr><tr><td>Salary</td><td>506,685 (SD 160094)</td><td>649,470 (SD 369401)</td><td>746,052 (SD 438982)</td><td>887,558 (SD 479854)</td></tr><tr><td>Female</td><td>67%</td><td>71%</td><td>58%</td><td>43%</td></tr><tr><td>Temporary contract</td><td>16%</td><td>32%</td><td>38%</td><td>45%</td></tr><tr><td>Multiple jobholders</td><td>3%</td><td>5%</td><td>5%</td><td>6%</td></tr><tr><td>Norwegian</td><td>92%</td><td>92%</td><td>92%</td><td>91%</td></tr><tr><td>Other Nordic</td><td>3%</td><td>4%</td><td>4%</td><td>4%</td></tr><tr><td>Other western</td><td>2%</td><td>2%</td><td>2%</td><td>3%</td></tr><tr><td>Non Western</td><td>2%</td><td>2%</td><td>2%</td><td>2%</td></tr><tr><td>Physician</td><td>11%</td><td>16%</td><td>37%</td><td>67%</td></tr><tr><td>Nurse</td><td>30%</td><td>32%</td><td>27%</td><td>12%</td></tr><tr><td>Other patient-related</td><td>20%</td><td>22%</td><td>14%</td><td>10%</td></tr><tr><td>Administration/management</td><td>23%</td><td>17%</td><td>10%</td><td>6%</td></tr><tr><td>Kitchen/cleaning/orderly</td><td>6%</td><td>4%</td><td>5%</td><td>0%</td></tr><tr><td>Other operations</td><td>6%</td><td>4%</td><td>4%</td><td>2%</td></tr><tr><td>Other</td><td>6%</td><td>5%</td><td>3%</td><td>2%</td></tr></table> |
0409cc40daa3004ab8fa857c746c84784a2488f9230fb9a1fb26b702ce9a209e.png | complex | <table><tr><td></td><td colspan="2">Dawn</td><td colspan="2">Michelle</td></tr><tr><td>State PCL-5 TRASC*</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td></tr><tr><td>#1: Flashbacks of traumatic events</td><td>3</td><td>3</td><td>0</td><td>2</td></tr><tr><td>#2: Altered sense of time</td><td>3</td><td>3</td><td>0</td><td>0</td></tr><tr><td>#3: Marked loss of emotional feeling</td><td>2</td><td>4</td><td>0</td><td>0</td></tr><tr><td>#4: Feeling what you are experiencing is not real</td><td>3</td><td>3</td><td>0</td><td>0</td></tr><tr><td>#5: Out of body experience</td><td>2</td><td>2</td><td>0</td><td>0</td></tr><tr><td>#6: Feeling like a part of your body is not your own</td><td>2</td><td>2</td><td>0</td><td>0</td></tr><tr><td>#7: Identity confusion</td><td>1</td><td>2</td><td>1</td><td>0</td></tr><tr><td>#8: Divided or multiple senses of self</td><td>3</td><td>2</td><td>3</td><td>1</td></tr><tr><td>#9: Loss of time</td><td>3</td><td>2</td><td>0</td><td>0</td></tr><tr><td>#10: Hearing voices</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></table> |
28fb4e913395efe92e366c432c3a236f20147e641f07fe399fe91ab4c094d3cb.png | simple | <table><tr><td>Antinuclear antibodies</td><td>P1</td><td>P2</td></tr><tr><td>Anti-nRNP/SM</td><td>3+, 2+, 2+</td><td>3+, 2+, 1+</td></tr><tr><td>Anti-SM</td><td>N, N, N</td><td>2+, 1+, N</td></tr><tr><td>Anti-SSA</td><td>3+, 3+, 3+</td><td>3+, 3+, 3+</td></tr><tr><td>Anti-RO-52</td><td>N, N, N</td><td>3+, 3+, 3+</td></tr><tr><td>Anti-SSB</td><td>N, N, N</td><td>1+, N, N</td></tr><tr><td>Anti-SCOL-70</td><td>N, N, N</td><td>N, N, N</td></tr><tr><td>Anti-JO-1</td><td>N, N, N</td><td>N, N, N</td></tr><tr><td>Anti-CENP B</td><td>N, N, N</td><td>N, N, N</td></tr><tr><td>Anti-dsDNA</td><td>3+, 2+, 2+</td><td>1+, N, N</td></tr><tr><td>Anti-nucleosome</td><td>3+, 3+, 3+</td><td>N, N, N</td></tr><tr><td>Anti-histone</td><td>3+, 1+, 1+</td><td>N, N, N</td></tr><tr><td>Anti-ribosomal P</td><td>N, N, N</td><td>3+, 3+, 2+</td></tr><tr><td>ACA</td><td>N, N, N</td><td>N, N, N</td></tr></table> |
038d34393a893bf2852abf72c2c7c713bfe9cb7e636e0943835ba6438bccbabe.png | complex | <table><tr><td><i>Question</i></td><td><i>Number</i></td><td><i>%</i></td></tr><tr><td colspan="3">Blood on your tooth brush during brushing may be a sign of:</td></tr><tr><td>1. Gum disease</td><td>57</td><td>95.0</td></tr><tr><td>2. Tooth decay</td><td>2</td><td>3.3</td></tr><tr><td>3. I don’t know</td><td>1</td><td>1.7</td></tr><tr><td colspan="3">What should you do when you see blood on your toothbrush?</td></tr><tr><td>1. Stop brushing</td><td>1</td><td>1.7</td></tr><tr><td>2. Stop brushing the area that is bleeding </td><td>4</td><td>6.7</td></tr><tr><td>3. Continue brushing</td><td>22</td><td>36.7</td></tr><tr><td>4. See a dentist </td><td>33</td><td>55.0</td></tr><tr><td>5. I don’t know what to do</td><td>0</td><td>0</td></tr></table> |
e2180c698c3f69d81c25a96c8353f8f5c300a5a5cf99be8e9d669c1fcd19a5e9.png | complex | <table><tr><td>Group</td><td>Biopsy</td><td colspan="2">Reaction</td><td></td><td></td></tr><tr><td></td><td></td><td>0</td><td>I</td><td>II</td><td>III</td></tr><tr><td>Dercum</td><td>Painful abdomen (n = 41)</td><td>11 (27)</td><td>14 (34)</td><td>16 (39)</td><td>-</td></tr><tr><td></td><td>Painful knee (n = 47)</td><td>11 (23)</td><td>21 (45)</td><td>14 (30)</td><td>1 (2)</td></tr><tr><td></td><td>Non-painful area (n = 28)</td><td>8 (29)</td><td>14 (50)</td><td>6 (21)</td><td>-</td></tr><tr><td>Obese controls</td><td>Abdomen (n = 41)</td><td>12 (29)</td><td>15 (37)</td><td>12 (29)</td><td>2 (5)</td></tr><tr><td></td><td>Knee (n = 41)</td><td>10 (24)</td><td>13 (32)</td><td>16 (39)</td><td>2 (5)</td></tr><tr><td>Normal weight controls</td><td>Knee (n = 11)</td><td>6 (55)</td><td>5 (45)</td><td>-</td><td>-</td></tr><tr><td>Differences between groups (p-value)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="3">Dercum vs. Obese controls - abdomen</td><td>0.022</td><td></td><td></td></tr><tr><td colspan="3">Dercum vs. Obese controls - knee</td><td>0.33</td><td></td><td></td></tr><tr><td colspan="3">Dercum vs. Normal weight controls - knee</td><td>0.81</td><td></td><td></td></tr><tr><td colspan="3">Obese vs. Normal weight controls - knee</td><td>< 0.001</td><td></td><td></td></tr><tr><td colspan="3">Dercum - painful abdomen vs. Dercum - non-painful abdomen<sup>1</sup></td><td>0.4</td><td></td><td></td></tr><tr><td colspan="3">Dercum - painful knee vs. Dercum - non-painful knee<sup>2</sup></td><td>0.5</td><td></td><td></td></tr></table> |
abd182839cef970ae013ee983a4b52e657acf0339e4caaaa741d1b8326ca3a7a.png | complex | <table><tr><td></td><td>Coiling [n (%)]</td><td>Clipping [n (%)]</td><td>P</td></tr><tr><td>Deteriorated</td><td>2 (10.5)</td><td>7 (38.9)</td><td rowspan="3">0.1900</td></tr><tr><td>Unchanged</td><td>4 (21.1)</td><td>2 (11.1)</td></tr><tr><td>Improved</td><td>13 (68.4)</td><td>9 (50.0)</td></tr></table> |
f087a4758953d46c070f6265c9264462ddc335d43dcfc9bd34673e9bc4da5306.png | complex | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>(<i>n</i> = 19)</td><td>(<i>n</i> = 7)</td></tr><tr><td>Age (years), mean ± SD</td><td>29.4 ± 10.8</td><td>26.6 ± 9.2</td><td>0.549<sup>a</sup></td></tr><tr><td>BMI (kg/m<sup>2</sup>), mean ± SD</td><td>20.5 ± 3.4</td><td>20.0 ± 2.1</td><td>0.693<sup>a</sup></td></tr><tr><td colspan="4">Side, n (%)</td></tr><tr><td> left</td><td>6 (31.6)</td><td>3 (42.9)</td><td>0.945<sup>b</sup></td></tr><tr><td> right</td><td>13 (68.4)</td><td>4 (57.1)</td><td></td></tr><tr><td colspan="4">Quadrant, n (%)</td></tr><tr><td> up-out</td><td>8 (42.1)</td><td>2 (28.6)</td><td>0.454<sup>b</sup></td></tr><tr><td> up-in</td><td>6 (31.6)</td><td>3 (42.9)</td><td></td></tr><tr><td> low-in</td><td>3 (15.8)</td><td>0 (0.0)</td><td></td></tr><tr><td> low-out</td><td>2 (10.5)</td><td>2 (28.6)</td><td></td></tr><tr><td>Depth (mm), mean ± SD</td><td>15.3 ± 3.9</td><td>15.9 ± 3.6</td><td>0.710<sup>a</sup></td></tr><tr><td>Basal volume (mL), median (range)</td><td>1.82 (0.35–5.95)</td><td>8.14 (1.53–10.39)</td><td>0.0140<sup>c</sup></td></tr><tr><td colspan="4">Color flow Doppler pattern (%)</td></tr><tr><td> 0</td><td>8 (42.1)</td><td>2 (28.5)</td><td>0.194<sup>b</sup></td></tr><tr><td> I</td><td>8 (42.1)</td><td>1 (14.3)</td><td></td></tr><tr><td> II</td><td>2 (10.5)</td><td>3 (42.9)</td><td></td></tr><tr><td> III</td><td>1 (5.3)</td><td>1(14.3)</td><td></td></tr></table> |
3a248e3a3f261d358cfe5fb0ce32593cfd4b4d516f2bf034a91208398b8a85b2.png | complex | <table><tr><td>Study</td><td>Intact +ve/−ve</td><td>Circumcised +ve/−ve</td><td>Odds ratio</td><td>95% confidence interval</td><td>Exact odds ratio</td><td>Exact 95% confidence interval</td></tr><tr><td>Agot </td><td>207/237</td><td>184/210</td><td>1.00</td><td>0.76–1.31</td><td>0.9968</td><td>0.7525–1.3206</td></tr><tr><td>Bailey </td><td>58/118</td><td>65/79</td><td>0.60</td><td>0.38–0.94</td><td>0.5984</td><td>0.3657–0.9654</td></tr><tr><td>Burundi</td><td>48/1612</td><td>22/864</td><td>1.17</td><td>0.70–1.95</td><td>1.1693</td><td>0.6870–2.0486</td></tr><tr><td>Bwayo </td><td>88/88</td><td>376/383</td><td>1.02</td><td>0.73–1.41</td><td>1.0186</td><td>0.7238–1.4336</td></tr><tr><td>Gray et al. [44]*</td><td>156/4443</td><td>33/875</td><td>0.92</td><td>0.64–1.36</td><td>0.9310</td><td>0.6312–1.4097</td></tr><tr><td>Gray et al. [163]*</td><td>503/3967</td><td>97/728</td><td>0.93</td><td>0.64–1.36</td><td>0.9516</td><td>0.7528–1.2123</td></tr><tr><td>Lavreys </td><td>47/48</td><td>297/354</td><td>1.17</td><td>0.76–1.80</td><td>1.1668</td><td>0.7404–1.8383</td></tr><tr><td>Newell </td><td>77/1279</td><td>58/588</td><td>0.61</td><td>0.43–0.87</td><td>0.6105</td><td>0.4222–0.8866</td></tr><tr><td>Seed </td><td>236/358</td><td>136/107</td><td>0.52</td><td>0.38–0.70</td><td>0.5159</td><td>0.3790–0.7095</td></tr><tr><td>Tyndall </td><td>86/92</td><td>311/321</td><td>0.96</td><td>0.69–1.35</td><td>0.9649</td><td>0.6818–1.3646</td></tr><tr><td>Warner</td><td>2316/2849</td><td>14352/21054</td><td>1.19</td><td>1.12–1.26</td><td>1.1925</td><td>1.1239–1.2653</td></tr><tr><td colspan="2">Random effects summary effect:</td><td> </td><td> </td><td> </td><td>0.8902</td><td>0.7277–1.0891</td></tr></table> |
9848f7f7316751ed566e44d69b84532a2ac6b89edcbd35dc7c57fead78b3f47e.png | simple | <table><tr><td>Patient</td><td>Tumor site</td><td>T stage</td><td>N stage</td><td>M stage</td></tr><tr><td><i>1</i></td><td><i>Oral cavity</i></td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>2</i></td><td><i>Oral cavity</i></td><td>4a</td><td>2b</td><td>0</td></tr><tr><td><i>3</i></td><td><i>Oral cavity</i></td><td>4a</td><td>2c</td><td>0</td></tr><tr><td><i>4</i></td><td><i>Oropharynx</i></td><td>2</td><td>0</td><td>0</td></tr><tr><td><i>5</i></td><td><i>Oropharynx</i></td><td>2</td><td>2b</td><td>0</td></tr><tr><td><i>6</i></td><td><i>Oropharynx</i></td><td>3</td><td>2b</td><td>0</td></tr><tr><td><i>7</i></td><td><i>Oropharynx</i></td><td>4a</td><td>0</td><td>0</td></tr><tr><td><i>8</i></td><td><i>Oropharynx</i></td><td>4a</td><td>2c</td><td>0</td></tr><tr><td><i>9</i></td><td><i>Oropharynx</i></td><td>4a</td><td>2c</td><td>1</td></tr><tr><td><i>10</i></td><td><i>Hypopharynx</i></td><td>3</td><td>2b</td><td>0</td></tr></table> |
975de7af531b3124069d7c83e664140461a94ea4f34d4d1f02b8525a20f5298f.png | complex | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="4">Idealistic Distortion</td><td rowspan="2">χ<sup>2</sup></td><td rowspan="2">p Value</td></tr><tr><td>Lown (%)</td><td>Averagen (%)</td><td>Highn (%)</td><td>Very Highn (%)</td></tr><tr><td rowspan="2">Place of Residence</td><td>Urban</td><td>3 (0.5)</td><td>189 (29.3)</td><td>318 (49.3)</td><td>135 (20.9)</td><td rowspan="2">5.314</td><td rowspan="2">0.105</td></tr><tr><td>Rural</td><td>13 (1.5)</td><td>243 (27.5)</td><td>420 (47.6)</td><td>207 (23.4)</td></tr><tr><td rowspan="2">Job</td><td>Employed</td><td>4 (1.8)</td><td>63 (27.9)</td><td>113 (50)</td><td>46 (20.4)</td><td rowspan="2">1.98</td><td rowspan="2">0.58</td></tr><tr><td>Housewife</td><td>12 (0.9)</td><td>369 (28.3)</td><td>625 (48)</td><td>296 (22.7)</td></tr><tr><td rowspan="4">Education</td><td>Illiterate</td><td>1 (2.6)</td><td>7 (18.4)</td><td>24 (63.2)</td><td>6 (15.8)</td><td rowspan="4">10.55</td><td rowspan="4">0.31</td></tr><tr><td>Below diploma</td><td>10 (1.4)</td><td>212 (29.7)</td><td>332 (46.6)</td><td>159 (22.3)</td></tr><tr><td>High school Diploma</td><td>2 (0.4)</td><td>141 (29.1)</td><td>232 (47.9)</td><td>109 (22.5)</td></tr><tr><td>Higher Education</td><td>3 (1)</td><td>72 (24.6)</td><td>150 (51.2)</td><td>68 (23.2)</td></tr><tr><td rowspan="4">Spouse’s Education</td><td>Illiterate</td><td>0 (0)</td><td>0 (0)</td><td>4 (80)</td><td>1 (20)</td><td rowspan="4">11.99</td><td rowspan="4">0.214</td></tr><tr><td>Below diploma</td><td>11 (1.5)</td><td>220 (29.7)</td><td>334 (45.1)</td><td>175 (23.6)</td></tr><tr><td>High school Diploma</td><td>1 (0.6)</td><td>54 (31)</td><td>87 (50)</td><td>32 (18.4)</td></tr><tr><td>Higher Education</td><td>4 (0.7)</td><td>158 (25.9)</td><td>313 (51.4)</td><td>134 (22)</td></tr><tr><td rowspan="2">Spouse’s Job</td><td>Unemployed</td><td>2 (4.8)</td><td>18 (42.9)</td><td>18 (42.9)</td><td>4 (9.5)</td><td rowspan="2">12.40</td><td rowspan="2">0.006</td></tr><tr><td>Employed</td><td>14 (0.9)</td><td>414 (27.9)</td><td>720 (48.5)</td><td>338 (27.7)</td></tr><tr><td rowspan="3">Income</td><td>Less than 100$</td><td>7 (1.7)</td><td>105 (25.4)</td><td>197 (47.6)</td><td>105 (25.4)</td><td rowspan="3">12.68</td><td rowspan="3">0.048</td></tr><tr><td>100-300$</td><td>7 (0.8)</td><td>237 (27.5)</td><td>431 (50.1)</td><td>186 (21.6)</td></tr><tr><td>More than 300$</td><td>2 (0.8)</td><td>90 (35.6)</td><td>110 (43.5)</td><td>51 (20.2)</td></tr><tr><td rowspan="2">Fertility Status</td><td>Fertile</td><td>10 (1)</td><td>288 (28.3)</td><td>503 (49.5)</td><td>216 (21.2)</td><td rowspan="2">2.75</td><td rowspan="2">0.433</td></tr><tr><td>Infertile</td><td>6 (1.2)</td><td>144 (28.2)</td><td>235 (46)</td><td>126 (24.7)</td></tr></table> |
3fd0d907104eeca6050be386436302f73c482b9a3070b634ac32a6a21c027428.png | complex | <table><tr><td> </td><td><i>BMI</i></td><td colspan="2"><i>Associated UK 1990 centile</i><sup><i><sup>2</sup></i></sup></td></tr><tr><td> </td><td> </td><td><i>Boys</i></td><td><i>Girls</i></td></tr><tr><td colspan="4"><i>(a) Classify their children as currently overweight</i></td></tr><tr><td> 7 yearsb</td><td>23.1</td><td>99</td><td>99</td></tr><tr><td> 12 years</td><td>24.4</td><td>99</td><td>97</td></tr><tr><td> 15 years</td><td>29.1</td><td>99</td><td>99</td></tr><tr><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4"><i>(b) Express concern that their children will become overweight in the future</i></td></tr><tr><td> 7 yearsb</td><td>17.1</td><td>81</td><td>75</td></tr><tr><td> 12 years</td><td>20.3</td><td>88</td><td>79</td></tr><tr><td> 15 years</td><td>24.1</td><td>94</td><td>91</td></tr></table> |
b22cca56dead2742fa3e03f37a611da298d7d6014a310f4fe448c8214753bedc.png | simple | <table><tr><td></td><td>All groups (average)</td><td>≥ 9 years (average)</td><td>< 9 years (average)</td><td><i>P</i> value (<i>t</i> test)</td></tr><tr><td>Resource consumption</td><td></td><td></td><td></td><td></td></tr><tr><td>Hospitalized</td><td>158 (12.4%)</td><td>96 (10.7%)</td><td>62 (16.4%)</td><td></td></tr><tr><td> Length of stay (hospitalization days)</td><td>4.1</td><td>4.0</td><td>4.3</td><td>0.003</td></tr><tr><td> Consultations (<i>N</i>)</td><td>3.2</td><td>3.0</td><td>3.5</td><td>0.0006</td></tr><tr><td> Workdays lost</td><td>2.1</td><td>2.2</td><td>1.9</td><td>0.0036</td></tr><tr><td> School days missed</td><td>4.9</td><td>4.9</td><td>4.9</td><td>0.078</td></tr><tr><td>Nonhospitalized</td><td>1,121 (87.6%)</td><td>805 (89.3%)</td><td>316 (83.6%)</td><td></td></tr><tr><td> Consultations (<i>N</i>)</td><td>2.4</td><td>2.4</td><td>2.4</td><td></td></tr><tr><td> Workdays lost</td><td>0.4</td><td>0.3</td><td>0.6</td><td></td></tr><tr><td> School days missed</td><td>1.7</td><td>1.7</td><td>1.7</td><td></td></tr><tr><td>All episodes*</td><td>1,279</td><td>901</td><td>378</td><td></td></tr><tr><td> Length of stay(hospitalization days)</td><td>0.5</td><td>0.4</td><td>0.7</td><td></td></tr><tr><td> Consultations (<i>N</i>)</td><td>2.5</td><td>2.5</td><td>2.6</td><td></td></tr><tr><td> Workdays lost</td><td>0.6</td><td>0.5</td><td>0.8</td><td></td></tr><tr><td> School days missed</td><td>2.1</td><td>2.0</td><td>2.3</td><td></td></tr></table> |
c3baf3893f653e331f1ad379b0f7e4a3fdf073986ca41ae8f0c06864ddee6820.png | simple | <table><tr><td>Plasma characteristics</td><td>β coefficient (S.E.)</td><td><i>P</i>value</td></tr><tr><td>Neurocognitive impairment</td><td>−0.03 (0.16)</td><td>0.859</td></tr><tr><td>Gender, male</td><td>−0.48 (0.23)</td><td>0.042</td></tr><tr><td>Current CD4+ count, per 50 copies</td><td>−0.04 (0.02)</td><td>0.021</td></tr><tr><td>Detectable HIV VL</td><td>0.37 (0.16)</td><td>0.021</td></tr><tr><td>IL-10, per 10 units</td><td>0.18 (0.10)</td><td>0.061</td></tr></table> |
285a209dcbe92d2e1085b2dce4ce0705d10837736d1be86222eb368d369c5c5a.png | simple | <table><tr><td>Characteristics</td><td>n (%)</td></tr><tr><td>Symptom occurrence (%)</td><td></td></tr><tr><td> Mean (range)</td><td>61 (21-100)</td></tr><tr><td>Incubation time (hr)</td><td></td></tr><tr><td> Mean (range)</td><td>2 (1-15)</td></tr><tr><td>Clinical symptoms<sup>2</sup></td><td></td></tr><tr><td> Diarrhea</td><td>78 (82.9)</td></tr><tr><td> Vomiting</td><td>78 (82.9)</td></tr><tr><td> Abdominal pain</td><td>60 (63.8)</td></tr><tr><td> Nausea</td><td>56 (59.5)</td></tr><tr><td> Chillness</td><td>55 (58.5)</td></tr><tr><td> Fever</td><td>35 (37.2)</td></tr><tr><td> Headache</td><td>6 (6.0)</td></tr></table> |
dfecf56606ec3096d12e47602c0b2a9396e01bc1558f8dbd89c652aab46c738f.png | complex | <table><tr><td>Final clinical outcome</td><td>Number (%) of patients</td></tr><tr><td colspan="2">Favorable (44 hips)</td></tr><tr><td>Excellent</td><td>19 (32.8)</td></tr><tr><td>Good</td><td>25 (43.1)</td></tr><tr><td colspan="2">Unfavorable (14 hips)</td></tr><tr><td>Fair</td><td>4 (6.9)</td></tr><tr><td>Poor</td><td>10 (17.2)</td></tr><tr><td>Total</td><td>58 (100)</td></tr></table> |
f46e84f97046f60b805fa2eb37280a5211c9c7165f12e3196099fbb09558f456.png | simple | <table><tr><td>Traits/gene transcripts</td><td><i>BTN1A1</i></td><td><i>SCD</i></td><td><i>LPL</i></td><td><i>GPAM</i></td><td><i>ACACA</i></td><td><i>LPIN</i></td></tr><tr><td>CMY60 (kg)</td><td>0.43</td><td>0.48</td><td>0.40</td><td>0.65*</td><td>0.22</td><td>0.19</td></tr><tr><td>TDMY (kg)</td><td>0.17</td><td>0.28</td><td>0.16</td><td>0.36</td><td>0.13</td><td>0.12</td></tr><tr><td>FPCTDMY (kg)</td><td>0.20</td><td>0.32</td><td>0.26</td><td>0.47</td><td>0.21</td><td>0.19</td></tr><tr><td>Fat percent</td><td>0.20</td><td>0.18</td><td>0.43</td><td>0.49</td><td>0.38</td><td>0.34</td></tr><tr><td>SNF percent</td><td>−0.30</td><td>−0.37</td><td>−0.41</td><td>0.00</td><td>−0.57</td><td>−0.56</td></tr><tr><td>Protein percent</td><td>−0.23</td><td>−0.54</td><td>−0.37</td><td>−0.03</td><td>−0.56</td><td>−0.54</td></tr><tr><td>Lactose percent</td><td>−0.36</td><td>−0.65*</td><td>−0.49</td><td>−0.19</td><td>−0.67*</td><td>−0.65*</td></tr></table> |
31b37e33fd67e2d7e5f0a9da4066599084ee6f55058b12d112804d6fe4565d16.png | complex | <table><tr><td>Cropping pattern</td><td colspan="4">SGS</td><td colspan="4">NGS</td></tr><tr><td></td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td><td>HF</td><td>MF</td><td>LF</td><td>Mean</td></tr><tr><td>MZ-CP within row</td><td>1.92</td><td>1.71</td><td>1.30</td><td>1.65</td><td>1.92</td><td>1.73</td><td>1.01</td><td>1.56</td></tr><tr><td>MZ-CP 1:1 rows</td><td>1.51</td><td>1.32</td><td>1.01</td><td>1.28</td><td>1.45</td><td>1.23</td><td>0.85</td><td>1.17</td></tr><tr><td>MZ-CP 2:2 rows</td><td>1.27</td><td>1.13</td><td>0.97</td><td>1.12</td><td>1.41</td><td>1.20</td><td>0.73</td><td>1.11</td></tr><tr><td>Sole cowpea</td><td>2.84</td><td>2.52</td><td>1.37</td><td>2.24</td><td>2.73</td><td>1.82</td><td>1.15</td><td>1.90</td></tr><tr><td>Mean</td><td>1.89</td><td>1.67</td><td>1.16</td><td>1.57</td><td>1.88</td><td>1.49</td><td>0.94</td><td>1.44</td></tr><tr><td>SED (arrangement)</td><td></td><td></td><td></td><td>0.09</td><td></td><td></td><td></td><td>0.09</td></tr><tr><td>SED (fertility)</td><td></td><td></td><td></td><td>0.07</td><td></td><td></td><td></td><td>0.11</td></tr><tr><td>SED (interaction)</td><td></td><td></td><td></td><td>0.15</td><td></td><td></td><td></td><td>0.17</td></tr><tr><td>MZ-SB within row</td><td>3.45</td><td>3.42</td><td>2.96</td><td>3.27</td><td>3.51</td><td>2.09</td><td>1.26</td><td>2.28</td></tr><tr><td>MZ-SB 1:1 rows</td><td>3.17</td><td>2.77</td><td>2.76</td><td>2.90</td><td>2.37</td><td>1.51</td><td>0.88</td><td>1.59</td></tr><tr><td>MZ-SB 2:2 rows</td><td>2.97</td><td>2.77</td><td>2.65</td><td>2.80</td><td>2.35</td><td>1.39</td><td>0.92</td><td>1.55</td></tr><tr><td>Sole soybean</td><td>5.84</td><td>6.10</td><td>5.60</td><td>5.85</td><td>4.90</td><td>2.67</td><td>1.69</td><td>3.09</td></tr><tr><td>Mean</td><td>3.86</td><td>3.76</td><td>3.49</td><td>3.70</td><td>3.28</td><td>1.92</td><td>1.19</td><td>2.13</td></tr><tr><td>SED (arrangement)</td><td></td><td></td><td></td><td>0.19</td><td></td><td></td><td></td><td>0.14</td></tr><tr><td>SED (fertility)</td><td></td><td></td><td></td><td>n.s.</td><td></td><td></td><td></td><td>0.21</td></tr><tr><td>SED (interaction)</td><td></td><td></td><td></td><td>n.s.</td><td></td><td></td><td></td><td>0.29</td></tr><tr><td>MZ-GN within row</td><td>1.17</td><td>0.86</td><td>0.89</td><td>0.97</td><td>0.87</td><td>0.81</td><td>0.66</td><td>0.78</td></tr><tr><td>MZ-GN 1:1 rows</td><td>0.86</td><td>0.88</td><td>0.79</td><td>0.84</td><td>0.76</td><td>0.68</td><td>0.56</td><td>0.66</td></tr><tr><td>MZ-GN 2:2 rows</td><td>0.94</td><td>0.87</td><td>0.87</td><td>0.90</td><td>0.76</td><td>0.69</td><td>0.60</td><td>0.69</td></tr><tr><td>Sole groundnut</td><td>1.79</td><td>1.74</td><td>1.52</td><td>1.68</td><td>1.40</td><td>1.17</td><td>0.87</td><td>1.14</td></tr><tr><td>Mean</td><td>1.19</td><td>1.09</td><td>1.02</td><td>1.10</td><td>0.94</td><td>0.84</td><td>0.67</td><td>0.82</td></tr><tr><td>SED (arrangement)</td><td></td><td></td><td></td><td>0.11</td><td></td><td></td><td></td><td>0.05</td></tr><tr><td>SED (fertility)</td><td></td><td></td><td></td><td>n.s</td><td></td><td></td><td></td><td>0.05</td></tr><tr><td>SED (interaction)</td><td></td><td></td><td></td><td>n.s.</td><td></td><td></td><td></td><td>0.08</td></tr></table> |
84e89f24a215fd06e144a44c62157f9bc9b969a4d89b6fad89b06816895bfa80.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2">Disease</td><td rowspan="2">EC<sub>50</sub> (95% CI) [pM]</td><td rowspan="2">Max. spec. lysis [%]</td><td colspan="2">Antigen Density [molecules/cell]</td></tr><tr><td>CD19</td><td>CD33</td></tr><tr><td>B cell lines</td><td>SEM</td><td><i>Pre-B ALL</i></td><td>12 (8 – 18)</td><td>58.7</td><td>50,000 ± 17,000</td><td>< 100</td></tr><tr><td></td><td>BV173</td><td><i>Pre-B ALL</i></td><td>3 (1 – 6)</td><td>61.0</td><td>60,000 ± 11,000</td><td>4,500 ± 800</td></tr><tr><td></td><td>Raji</td><td><i>Burkitt's lymphoma</i></td><td>42 (18 – 98)</td><td>60.8</td><td>31,000 ± 19,000</td><td>650 ± 100</td></tr><tr><td></td><td>ARH77</td><td><i>Plasma cell leukemia</i></td><td>460 (179 – 1,177)</td><td>39.4</td><td>3,000 ± 2,000</td><td>< 100</td></tr><tr><td>AML cell lines</td><td>MOLM-13</td><td><i>AML-M5a</i></td><td>100 (58 – 173)</td><td>42.3</td><td>0</td><td>32,000 ± 6,500</td></tr><tr><td></td><td>THP-1</td><td><i>AML-M5</i></td><td>2,442 (1,105 – 5,311)</td><td>14.6</td><td>0</td><td>17,000 ± 4,000</td></tr><tr><td>Patient samples</td><td></td><td><i>ALL</i></td><td>39 (9 – 165)</td><td>72.9</td><td>n.d</td><td>n.d.</td></tr><tr><td></td><td></td><td><i>MPAL(NOS)</i></td><td>72 (63 – 84)</td><td>46.6</td><td>8,500 ± 3,000</td><td>300</td></tr><tr><td></td><td></td><td><i>B-CLL</i></td><td>101 (1 – 44,550)</td><td>99.2</td><td>n.d.</td><td>n.d.</td></tr></table> |
9a71d7f9d05d3c682d7d5852d9ec5608018ff1607ab875d8f5e6b4c9e4040fe0.png | simple | <table><tr><td>Variable</td><td>Value</td><td>Effect</td><td>S.E.</td><td><i>CI</i></td><td><i>95%</i></td></tr><tr><td>Mother's BMI</td><td>4 points increment</td><td>0.85</td><td>0.12</td><td>0.62</td><td>1.08</td></tr><tr><td>Age (Mother)</td><td>5 years increment</td><td>0.73</td><td>0.17</td><td>0.41</td><td>1.06</td></tr><tr><td>Time studying per day (hours)</td><td>6 hrs increment</td><td>0.83</td><td>0.15</td><td>0.53</td><td>1.13</td></tr><tr><td>Time in sport activities per day (hours)</td><td>3 hrs increment</td><td>-0.43</td><td>0.18</td><td>-0.77</td><td>-0.08</td></tr><tr><td>Time in front of TV per day</td><td>≤ 1 h vs. 1-2 hrs</td><td>-2.09</td><td>0.36</td><td>-2.8</td><td>-1.38</td></tr><tr><td></td><td>>2 hrs vs. 1-2 hrs</td><td>-0.26</td><td>0.29</td><td>-0.83</td><td>0.3</td></tr><tr><td>Municipality income (low vs. high)</td><td></td><td>1.82</td><td>0.28</td><td>1.26</td><td>2.37</td></tr></table> |
67c42a463ea471947a4b65649c39d44c41d9210e63827c882004d9a99cad3770.png | simple | <table><tr><td>Items</td><td>n (%)</td><td>Male (n = 32)</td><td>Female (n = 35)</td></tr><tr><td>Knowledge about worm infection:</td><td> </td><td> </td><td> </td></tr><tr><td>Heard about liver fluke <i>“san tap</i>” or “<i>pha yat bai mai nai tap</i>”</td><td>34 (50.7)</td><td>34.4</td><td>65.7</td></tr><tr><td>How to get infection with <i>O. viverrini</i>:</td><td> </td><td> </td><td> </td></tr><tr><td>Eating raw vegetables</td><td>3 (4.5)</td><td>3.1</td><td>5.7</td></tr><tr><td>Not maintaining good personal hygiene: hand washing, nail clipping, unclean environment</td><td>8 (11.9)</td><td>15.6</td><td>11.4</td></tr><tr><td>Eating any raw food: meat, snail, shrimp</td><td>29 (43.3)</td><td>34.4</td><td>51.4</td></tr><tr><td>Eating raw fish dishes <i>(Koi Pa, Lap Pa Nuew)</i></td><td>8 (11.9)</td><td>12.5</td><td>11.4</td></tr><tr><td>Heard about roundworm</td><td>52 (77.6)</td><td>84.4</td><td>71.4</td></tr><tr><td>How to get infection with roundworm:</td><td> </td><td> </td><td> </td></tr><tr><td>It just occurs in our body</td><td>2 (2.9)</td><td>0</td><td>5.7</td></tr><tr><td>Eat any raw: meat, fish, shrimp, vegetables</td><td>7 (10.4)</td><td>15.6</td><td>5.7</td></tr><tr><td>Not maintaining good personal hygiene: not hand washing before eating, not clipping nails, flies touching our food, drinking dirty water</td><td>16 (23.9)</td><td>18.7</td><td>28.6</td></tr><tr><td>Heard about hookworm</td><td>3 (4.5)</td><td>6.2</td><td>2.8</td></tr><tr><td>Do not know</td><td>3 (4.5)</td><td>6.2</td><td>2.8</td></tr><tr><td>Heard about whipworm</td><td>2 (2.9)</td><td>6.2</td><td>0</td></tr><tr><td>Do not know</td><td>2 (2.9)</td><td>6.2</td><td>0</td></tr><tr><td>Heard about tapeworm</td><td>33 (49.3)</td><td>46.9</td><td>51.4</td></tr><tr><td>Eating raw food</td><td>8 (11.9)</td><td>21.9</td><td>2.8</td></tr><tr><td>Eating raw fish dishes</td><td>33 (49.3)</td><td>53.1</td><td>45.7</td></tr><tr><td>Perceptions of latrine use:</td><td> </td><td> </td><td> </td></tr><tr><td>Village will not be dirty</td><td>15 (22.4)</td><td>34.4</td><td>11.4</td></tr><tr><td>Flies do not touch our food anymore</td><td>4 (5.9)</td><td>12.5</td><td>0</td></tr><tr><td>Prevention of diseases/no transmission of diseases</td><td>10 (14.9)</td><td>18.8</td><td>11.4</td></tr><tr><td>Animals will not eat human faeces</td><td>6 (8.9)</td><td>0</td><td>17.1</td></tr><tr><td>Convenience (not getting wet from rain, convenience during the night and when sick)</td><td>13 (19.4)</td><td>6.2</td><td>31.4</td></tr><tr><td>Perceived liver fluke as health problem in community</td><td>6 (8.9)</td><td>12.5</td><td>5.7</td></tr><tr><td>Practices personal hygiene:</td><td> </td><td> </td><td> </td></tr><tr><td>Hand washing before eating</td><td>31 (46.3)</td><td>31.2</td><td>60.0</td></tr><tr><td>Saying that most of people in village do not wash hands with soap</td><td>10 (14.9)</td><td>0</td><td>28.6</td></tr><tr><td>Perceptions of personal hygiene:</td><td> </td><td> </td><td> </td></tr><tr><td>Hands will be clean if we wash hands before eating</td><td>10 (14.9)</td><td>0</td><td>28.6</td></tr><tr><td>We will be healthy if we wash hands before eating</td><td>3 (4.5)</td><td>9.4</td><td>0</td></tr><tr><td>We can not get any worm infections or diseases if we wash our hands before eating</td><td>20 (29.9)</td><td>28.1</td><td>31.4</td></tr><tr><td>Deworming in community:</td><td> </td><td> </td><td> </td></tr><tr><td>Getting dewormed</td><td>37 (55.2)</td><td>75.0</td><td>37.1</td></tr><tr><td>Treatment of tapeworm with traditional medicine</td><td>19 (28.3)</td><td>43.7</td><td>14.3</td></tr><tr><td>Treatment with modern medicine</td><td>18 (26.9)</td><td>31.2</td><td>22.8</td></tr><tr><td>Treatment of roundworm using modern medicine</td><td>2 (2.9)</td><td>2.9</td><td>0</td></tr></table> |
3700f744568a3c5d3ba55ab1326d76b5a545db4072f4a38fd0e06f9cbc15d3d7.png | simple | <table><tr><td></td><td>Intervention Mean(SE)</td><td>Control Mean(SE)</td><td>Estimated Intervention Effect Mean (95%CI)</td><td>p-value from GEE model</td></tr><tr><td>Pre-intervention mean score</td><td>7.71 (0.11)</td><td>7.48 (0.09)</td><td></td><td></td></tr><tr><td>Post-intervention mean score</td><td>3.63 (0.26)</td><td>4.24 (0.27)</td><td></td><td></td></tr><tr><td>Pre-post difference</td><td>4.08 (0.23)</td><td>3.24 (0.30)</td><td>0.84 (0.10; 1.58)</td><td>0.03</td></tr><tr><td>Pre-post difference adjusted for number of physician visits</td><td>4.10 (0.18)</td><td>3.25(0.27)</td><td>0.85 (0.21 ;1.48)</td><td>0.01</td></tr></table> |
d6032dd12109d0140ced072b2b704223cd381f04129c65ee96e612045758976c.png | complex | <table><tr><td rowspan="2">Predictors</td><td rowspan="2">OR</td><td rowspan="2"><i>P</i> value</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Right side operation</td><td>2.37</td><td><0.001</td><td>1.52</td><td>3.70</td></tr><tr><td>Male</td><td>2.66</td><td><0.001</td><td>1.65</td><td>4.28</td></tr><tr><td>Pleural adhesion</td><td>1.76</td><td>0.005</td><td>1.18</td><td>2.62</td></tr><tr><td>BMI < 25.5 kg/m<sup>2</sup></td><td>1.72</td><td>0.02</td><td>1.08</td><td>2.75</td></tr></table> |
df7d8f22377d6cfb2a8c0e7b7dfe21d290ebbf06089458a4b9e4aefcb397e31b.png | simple | <table><tr><td>Reference</td><td>Author</td><td>Article </td><td>Published in journal</td><td>Year published</td><td><i>n</i>subjects</td><td><i>n</i>teeth</td><td>Study design</td></tr><tr><td>[6]</td><td>Pogrel et al.</td><td>“Coronectomy: a technique to protect the inferior alveolar nerve” </td><td>J Oral Maxillofac Surg </td><td>2004</td><td>41</td><td>50</td><td>Prospective cohort </td></tr><tr><td>[7]</td><td>Renton et al. </td><td>“A randomised controlled clinical trial to compare the incidence of injury to the inferior alveolar nerve as a result of coronectomy and removal of mandibular third molars” </td><td>Br J Oral Maxillofac Surg</td><td>2005</td><td>128</td><td>94</td><td>Randomized controlled trial</td></tr><tr><td>[8]</td><td>Pogrel </td><td>“An update on coronectomy” </td><td>J Oral Maxillofac Surg </td><td>2009</td><td>Not available</td><td>450</td><td>Prospective cohort </td></tr><tr><td>[9]</td><td>Leung and Cheung</td><td>“Safety of coronectomy versus excision of wisdom teeth: a randomized controlled trial” </td><td>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</td><td>2009</td><td>231</td><td>171</td><td>Randomized controlled trial</td></tr><tr><td>[10]</td><td>Hatano et al.</td><td>“Clinical evaluations of coronectomy (intentional partial odontectomy) for mandibular third molars using dental computed tomography: a case-control study” </td><td>J Oral Maxillofac Surg </td><td>2009</td><td>220</td><td>102</td><td>Case control study</td></tr><tr><td>[11]</td><td>Dolanmaz et al.</td><td>“A preferable technique for protecting the inferior alveolar nerve: coronectomy” </td><td>J Oral Maxillofac Surg </td><td>2009</td><td>43</td><td>47</td><td>Prospective cohort </td></tr><tr><td>[12]</td><td>Cilasun et al. </td><td>“Coronectomy in patients with high risk of inferior alveolar nerve injury diagnosed by computed tomography” </td><td>J Oral Maxillofac Surg </td><td>2011</td><td>120</td><td>175</td><td>Prospective cohort </td></tr><tr><td>[13]</td><td>Leung and Cheung </td><td>“Coronectomy of the lower third molar is safe within the first 3 years”</td><td>J Oral Maxillofac Surg </td><td>2012</td><td>98</td><td>135</td><td>Prospective cohort </td></tr></table> |
c2621825237b012019ff91ba94b4beaddc1003d046fe956e4676a9f0c63be991.png | simple | <table><tr><td>Astaxanthin Content mg/g</td><td>C <sup>2</sup></td><td>G <sup>3</sup></td><td>F <sup>4</sup></td><td>E <sup>5</sup></td><td>U <sup>6</sup></td><td>R <sup>7</sup></td></tr><tr><td>0</td><td>4304.24 ± 177.48 <sup>a</sup></td><td>612.47 ± 95.0 <sup>a</sup></td><td>1027.15 ± 105.80 <sup>a</sup></td><td>120.56 ± 14.02 <sup>a</sup></td><td>182.17 ± 14.02 <sup>a</sup></td><td>2361.89 ± 146.96 <sup>b</sup></td></tr><tr><td>3</td><td>4413.37 ± 151.21 <sup>a</sup></td><td>678.24 ± 107.11 <sup>a</sup></td><td>1079.89 ± 77.55 <sup>a</sup></td><td>141.24 ± 23.59 <sup>a</sup></td><td>186.47 ± 13.59 <sup>a</sup></td><td>2327.53 ± 139.19 <sup>b</sup></td></tr><tr><td>6</td><td>4315.56 ± 147.14 <sup>a</sup></td><td>845.24 ± 125.24 <sup>a,b</sup></td><td>1024.54 ± 86.78 <sup>a</sup></td><td>155.73 ± 16.10 <sup>a</sup></td><td>196.59 ± 16.10 <sup>a</sup></td><td>2093.46 ± 170.37 <sup>a,b</sup></td></tr><tr><td>9</td><td>4532.36 ± 284.82 <sup>a</sup></td><td>1048.12 ± 76.37 <sup>b</sup></td><td>1263.78 ± 97.73 <sup>a</sup></td><td>221.47 ± 31.68 <sup>b</sup></td><td>201.21 ± 21.68 <sup>a</sup></td><td>1797.78 ± 114.54 <sup>a</sup></td></tr><tr><td>12</td><td>4557.24 ± 147.97 <sup>a</sup></td><td>1175.11 ± 92.45 <sup>b</sup></td><td>1243.45 ± 107.73 <sup>a</sup></td><td>233.45 ± 21.68 <sup>b</sup></td><td>214.53 ± 21.68 <sup>a</sup></td><td>1690.70 ± 114.54 <sup>a</sup></td></tr></table> |
ad15b8b2cdccc9d1edb9cbf629785aa864bfd0da248623cc8490edba41704766.png | simple | <table><tr><td>DEG_Set</td><td>Annotated</td><td>COG</td><td>GO</td><td>KEGG</td><td>KOG</td><td>Pfam</td><td>Swiss-Prot</td><td>eggNOG</td><td>Nr</td></tr><tr><td>FD1/FD2</td><td>1825</td><td>573</td><td>981</td><td>603</td><td>959</td><td>1355</td><td>1230</td><td>1676</td><td>1795</td></tr><tr><td>FD2/FD3</td><td>1753</td><td>607</td><td>995</td><td>587</td><td>928</td><td>1369</td><td>1255</td><td>1638</td><td>1731</td></tr><tr><td>FD1/FD3</td><td>2658</td><td>741</td><td>1455</td><td>835</td><td>1306</td><td>1993</td><td>1858</td><td>2463</td><td>2615</td></tr><tr><td>MD1/MD2</td><td>2038</td><td>667</td><td>1094</td><td>716</td><td>1068</td><td>1505</td><td>1317</td><td>1881</td><td>1957</td></tr><tr><td>MD2/MD3</td><td>518</td><td>158</td><td>323</td><td>189</td><td>231</td><td>422</td><td>398</td><td>485</td><td>510</td></tr><tr><td>MD1/MD3</td><td>3002</td><td>926</td><td>1696</td><td>1049</td><td>1556</td><td>2231</td><td>2055</td><td>2801</td><td>2916</td></tr></table> |
a4caccb0d2aacff4a9b9f073360df1a21ccd863e1eef5deef36f9d7ce5d4583b.png | simple | <table><tr><td>Tear location</td><td>Autograft</td><td>Allograft</td></tr><tr><td>Near femoral attachment</td><td>14</td><td>2</td></tr><tr><td>Near tibial attachment</td><td>1</td><td>2</td></tr><tr><td>Mid-substance</td><td>1</td><td>4</td></tr><tr><td>Stretched</td><td>2</td><td>2</td></tr><tr><td>No graft seen</td><td>1</td><td>1</td></tr></table> |
4038fbeb2302a8f34a1f2cf33044656f80191ede880a947f60c7f59cc48894dc.png | simple | <table><tr><td></td><td>Possible answers</td></tr><tr><td>How often do you use wikipedia as an information source in general?</td><td></td></tr><tr><td></td><td>Never</td></tr><tr><td></td><td>1-5x/week</td></tr><tr><td></td><td>Daily</td></tr><tr><td></td><td>1-5x/month</td></tr><tr><td>How often do you use Wikipedia as an information source in your medical studies?</td><td></td></tr><tr><td></td><td>Never</td></tr><tr><td></td><td>1-5x/week</td></tr><tr><td></td><td>Daily</td></tr><tr><td></td><td>1-5x/month</td></tr><tr><td>Given that you read a medical article on Wikipedia, do you draw any criteria to evaluate its quality? (Multiple answer possible)</td><td></td></tr><tr><td></td><td>I compare it to my knowledge</td></tr><tr><td></td><td>Number of references</td></tr><tr><td></td><td>Authors are well-known</td></tr><tr><td></td><td>High number of revisions</td></tr><tr><td></td><td>Date of latest revision</td></tr><tr><td></td><td>I compare it to specific literature</td></tr><tr><td></td><td>I discuss the content with my colleagues/teachers</td></tr><tr><td></td><td>I do not draw any criteria</td></tr><tr><td></td><td>I trust my gut feeling</td></tr><tr><td>Given that you find incorrect information, what do you do?</td><td></td></tr><tr><td></td><td>I correct the error</td></tr><tr><td></td><td>I am not familiar how to correct articles</td></tr><tr><td></td><td>I know how to correct articles but leave the entry unaltered</td></tr><tr><td></td><td>I draw attention to the false information in any other way</td></tr></table> |
241ffc94e90c41606faa5054580a910ed1db05483d4e93ae336dbbaee31e0587.png | simple | <table><tr><td>ODI item</td><td>No sick-leave for PGP</td><td>Sick-leave for PGP</td><td>E.S.</td><td><i>p</i></td></tr><tr><td>Pain intensity</td><td>2.30 (0.84)</td><td>2.33 (0.88)</td><td>0.039</td><td>=.954</td></tr><tr><td>Personal care</td><td>0.90 (1.11)</td><td>0.94 (1.14)</td><td>0.033</td><td>=.889</td></tr><tr><td>Lifting</td><td>1.40 (1.21)</td><td>1.90 (1.29)</td><td>0.395</td><td>=.044</td></tr><tr><td>Walking</td><td>0.96 (1.01)</td><td>1.44 (0.97)</td><td>0.483</td><td>=.011</td></tr><tr><td>Sitting</td><td>0.96 (1.00)</td><td>1.46 (0.87)</td><td>0.528</td><td>=.003</td></tr><tr><td>Standing</td><td>1.50 (1.33)</td><td>2.00 (1.22)</td><td>0.392</td><td>=.031</td></tr><tr><td>Sleeping</td><td>1.12 (0.85)</td><td>1.48 (1.03)</td><td>0.379</td><td>=.113</td></tr><tr><td>Sex</td><td>1.18 (1.41)</td><td>1.23 (1.49)</td><td>0.037</td><td>=.969</td></tr><tr><td>Social function</td><td>1.26 (1.27)</td><td>1.33 (1.31)</td><td>0.056</td><td>=.677</td></tr><tr><td>Travelling</td><td>0.92 (1.12)</td><td>1.25 (1.23)</td><td>0.280</td><td>=.180</td></tr></table> |
9627ddceef97c345f127a7d327699294d55c939ddfb741105a8c71638b1aa37a.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Anda</td><td colspan="2">Sør‐Gjæslingan</td></tr><tr><td>Oceanic</td><td>Coastal</td><td>Oceanic</td><td>Coastal</td></tr><tr><td colspan="5">Habitat</td></tr><tr><td>Intrinsic</td><td>0.000</td><td colspan="2">0.929</td><td></td></tr><tr><td>Weather</td><td>1.000</td><td colspan="2">0.153</td><td></td></tr><tr><td>Time</td><td>1.000</td><td colspan="2">0.030</td><td></td></tr><tr><td colspan="5">Commuting</td></tr><tr><td>Intrinsic</td><td>0.998</td><td>0.669</td><td>0.834</td><td>0.010</td></tr><tr><td>Weather</td><td>0.002</td><td>0.323</td><td>0.991</td><td>0.999</td></tr><tr><td>Time</td><td>1.000</td><td>0.700</td><td>0.010</td><td>0.000</td></tr><tr><td colspan="5">Foraging</td></tr><tr><td>Intrinsic</td><td>0.300</td><td>0.950</td><td>0.237</td><td>1.000</td></tr><tr><td>Weather</td><td>0.697</td><td>0.999</td><td>0.421</td><td>0.000</td></tr><tr><td>Time</td><td>0.916</td><td>0.008</td><td>0.151</td><td>1.000</td></tr><tr><td colspan="5">Resting</td></tr><tr><td>Intrinsic</td><td>1.000</td><td>1.000</td><td>0.933</td><td>0.171</td></tr><tr><td>Weather</td><td>0.000</td><td>0.000</td><td>0.995</td><td>0.613</td></tr><tr><td>Time</td><td>1.000</td><td>1.000</td><td>0.003</td><td>0.894</td></tr><tr><td colspan="5">Behavior</td></tr><tr><td>Intrinsic</td><td>0.766</td><td>0.873</td><td>0.668</td><td>0.394</td></tr><tr><td>Weather</td><td>0.233</td><td>0.441</td><td>0.802</td><td>0.537</td></tr><tr><td>Time</td><td>0.972</td><td>0.569</td><td>0.055</td><td>0.631</td></tr></table> |
797fbecc5171f71d662ae7d5c112ea54258c5e84b15852c35db66fb92b9dce7d.png | simple | <table><tr><td>Variable</td><td>Odds ratio</td><td>95%confidence interval</td></tr><tr><td>Guideline-recommended vancomycin dosing</td><td>0.91</td><td>0.53-1.56</td></tr><tr><td>Vancomycin duration > 15 days</td><td>3.65</td><td>2.16-6.17</td></tr><tr><td>Weight greater than 100 kilograms</td><td>2.08</td><td>1.18-3.67</td></tr><tr><td>Pitt Bacteremia Score of four or greater</td><td>3.80</td><td>2.17-6.63</td></tr><tr><td>Vancomycin trough greater than 20 mcg/ml</td><td>2.51</td><td>1.28-4.92</td></tr><tr><td>Age greater than 52 years</td><td>2.40</td><td>1.38-4.15</td></tr><tr><td>Intensive care unit resident</td><td>3.64</td><td>2.15-6.18</td></tr><tr><td>Concomitant nephrotoxin</td><td>2.08</td><td>1.24-3.49</td></tr><tr><td>Male gender</td><td>1.04</td><td>0.56-1.57</td></tr><tr><td>Charlson comorbidity index 5 or greater</td><td>1.14</td><td>0.57-2.27</td></tr><tr><td>Baseline serum creatinine greater than 1.0 mg/dL</td><td>0.94</td><td>0.56-1.57</td></tr></table> |
fe1238296b0ad3b9740cca22d6ad04dcbbc3d1901802aee9711dd8861c4a88ff.png | simple | <table><tr><td>GEO ID</td><td>Sample count (case:control)</td><td>Platform</td><td>Sample source</td><td>Tissue</td></tr><tr><td>GSE14359</td><td>18: 2</td><td>GPL96 [HG-U133A] Affymetrix Human Genome U133A Array</td><td>in vivo</td><td>Bone, lung</td></tr><tr><td>GSE16102</td><td>48: 6</td><td>GPL96 [HG-U133A] Affymetrix Human Genome U133A Array</td><td>in vivo</td><td>Bone</td></tr><tr><td>GSE12865</td><td>12: 2</td><td>GPL6244 [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array</td><td>in vivo</td><td>Bone</td></tr><tr><td>GSE11414</td><td>4: 2</td><td>GPL6244 [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array</td><td>in vitro</td><td>Bone</td></tr><tr><td>GSE42352</td><td>103:15</td><td>GPL10295 Illumina human-6 v2.0 expression beadchip (using nuIDs as identifier)</td><td>in vivo/in vitro</td><td>Bone</td></tr><tr><td>GSE36001</td><td>19: 6</td><td>GPL6102 Illumina human-6 v2.0 expression beadchip</td><td>in vitro</td><td>Bone</td></tr><tr><td>GSE32964</td><td>35: 1</td><td>GPL6947 Illumina HumanHT-12 V3.0 expression beadchip</td><td>in vivo</td><td>Bone</td></tr><tr><td>GSE30807</td><td>1: 1</td><td>GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td>in vitro</td><td>Bone</td></tr></table> |
bba88094d3a094e87525892799993c5fca80332a9db1d5696a14ea5f9de84518.png | simple | <table><tr><td>Gene</td><td>Primer sequences</td><td>Amplicon length</td><td>Annealing temperature</td></tr><tr><td>MBD-1</td><td>5' TCTGGTTGCCAAGGTCCAAA 3'5' ACATCCATCTTCCCTTCCCGA 3'</td><td>122bp</td><td>61°C</td></tr><tr><td>vimentin</td><td>5' TGGAAGAGAACTTTGCCGTTG 3'5' AAGGTGACGAGCCATTTCCTC 3'</td><td>101bp</td><td>60°C</td></tr><tr><td>GRP78</td><td>5' CACCAATGACCAGAATCGCCT 3'5' CAATGCGCTCCTTGAGCTTT 3'</td><td>101bp</td><td>60°C</td></tr></table> |
0611e08ff517dbced53634f61934c5cf4b72a3e5ffb084ceafc485f9358ff470.png | simple | <table><tr><td>Conjugate</td><td><i>N</i></td><td>F<sub>0</sub>, RFU</td><td>F<sub>enz</sub>, RFU</td><td>F<sub>max</sub></td></tr><tr><td>BSA-FITC<sub>(Voss et al.)</sub></td><td>25</td><td>-</td><td>-</td><td>3450</td></tr><tr><td>KLH-sCy5</td><td>380-750</td><td>6.25</td><td>1140</td><td>18100</td></tr><tr><td>BSA-sCy5</td><td>6.7</td><td>2.37</td><td>1680</td><td>70800</td></tr><tr><td>rhBChE-sCy5</td><td>30</td><td>6.17</td><td>1750</td><td>28300</td></tr><tr><td>BSA-sCy7</td><td>6.5</td><td>1.8</td><td>660</td><td>36500</td></tr><tr><td>rhBChE-sCy7 OFF</td><td>32</td><td>2.71</td><td>597</td><td>21900</td></tr><tr><td>rhBChE-sCy7 ON</td><td>1</td><td>50</td><td>50.05</td><td>0.1</td></tr></table> |
f6d5a7dcad5fc4461c08ed4038362c87304bce0bbc5fbd6a099ff6d66d15c992.png | complex | <table><tr><td rowspan="2">AE or laboratory abnormality</td><td colspan="4">n (%)</td></tr><tr><td>Grade 1/2</td><td>Grade 3</td><td>Grade 4</td><td>Any grade</td></tr><tr><td colspan="5">Non-hematologic AEs of any cause occurring in ≥ 15% of patients</td></tr><tr><td> Fatigue/asthenia</td><td>33 (55)</td><td>12 (20)</td><td>0</td><td>45 (75)</td></tr><tr><td> Diarrhea</td><td>33 (55)</td><td>3 (5)</td><td>0</td><td>36 (60)</td></tr><tr><td> Stomatitis, oral discomfort, and related oral syndromes</td><td>29 (48)</td><td>3 (5)</td><td>0</td><td>32 (53)</td></tr><tr><td> Dysgeusia</td><td>27 (45)</td><td>0</td><td>0</td><td>27 (45)</td></tr><tr><td> Hypertension</td><td>18 (30)</td><td>8 (13)</td><td>0</td><td>26 (43)</td></tr><tr><td> Skin and subcutaneous tissue disorders</td><td>25 (42)</td><td>0</td><td>0</td><td>25 (42)</td></tr><tr><td> Vomiting</td><td>19 (32)</td><td>2 (3)</td><td>0</td><td>21 (35)</td></tr><tr><td> Dyspepsia</td><td>20 (33)</td><td>0</td><td>0</td><td>20 (33)</td></tr><tr><td> Epistaxis</td><td>18 (30)</td><td>2 (3)</td><td>0</td><td>20 (33)</td></tr><tr><td> Nausea</td><td>20 (33)</td><td>0</td><td>0</td><td>20 (33)</td></tr><tr><td> Headache</td><td>17 (28)</td><td>2 (3)</td><td>0</td><td>19 (32)</td></tr><tr><td> Decreased appetite</td><td>14 (23)</td><td>4 (7)</td><td>0</td><td>18 (30)</td></tr><tr><td> Dry skin</td><td>14 (23)</td><td>1 (2)</td><td>0</td><td>15 (25)</td></tr><tr><td> Ejection fraction decreased</td><td>10 (17)</td><td>3 (5)</td><td>1 (2)</td><td>14 (23)</td></tr><tr><td> Abdominal pain</td><td>11 (18)</td><td>0</td><td>0</td><td>11 (18)</td></tr><tr><td> Hand–foot syndrome and related disorders</td><td>8 (13)</td><td>3 (5)</td><td>0</td><td>11 (18)</td></tr><tr><td> Pyrexia</td><td>11 (18)</td><td>0</td><td>0</td><td>11 (18)</td></tr><tr><td> Weight decreased</td><td>11 (18)</td><td>0</td><td>0</td><td>11 (18)</td></tr><tr><td> Constipation</td><td>10 (17)</td><td>0</td><td>0</td><td>10 (17)</td></tr><tr><td> Left ventricular dysfunction</td><td>8 (13)</td><td>2 (3)</td><td>0</td><td>10 (17)</td></tr><tr><td> Insomnia</td><td>8 (13)</td><td>1 (2)</td><td>0</td><td>9 (15)</td></tr><tr><td> Dyspnea</td><td>8 (13)</td><td>1 (2)</td><td>0</td><td>9 (15)</td></tr><tr><td colspan="5">Hematologic laboratory abnormalities</td></tr><tr><td> Leukopenia</td><td>46 (77)</td><td>4 (7)</td><td>1 (2)</td><td>51 (85)</td></tr><tr><td> Anemia</td><td>46 (77)</td><td>2 (3)</td><td>0</td><td>48 (80)</td></tr><tr><td> Neutropenia</td><td>36 (60)</td><td>9 (15)</td><td>1 (2)</td><td>46 (77)</td></tr><tr><td> Lymphopenia</td><td>36 (60)</td><td>6 (10)</td><td>1 (2)</td><td>43 (72)</td></tr><tr><td> Thrombocytopenia</td><td>34 (57)</td><td>6 (10)</td><td>3 (5)</td><td>43 (72)</td></tr></table> |
318bec218aa81a3c5de1ead3e7e08b934351f889a53926e3179656cdb6189581.png | complex | <table><tr><td>Topic</td><td>Sub-Topic</td><td>Positive Feedback</td></tr><tr><td rowspan="3">Usability </td><td>Utilization</td><td>“Both the motor and cognitive tasks were easy.”</td></tr><tr><td>Learning</td><td>“There was no problem in learning the use of the system.”</td></tr><tr><td>Pleasantness</td><td>“The 3D glass was not uncomfortable.”“The environment was beautiful.”“The cycle-ergometer was manageable.”</td></tr><tr><td rowspan="3">Sense of Presence</td><td>Spatial Presence</td><td>“The feeling was to be in the real park.”“I had the feeling of being suspended.” “The environment was relaxing.”</td></tr><tr><td>Engagement</td><td>“I was focused on the task.”“I think I’ve been pedaling for 5 min.”“I forget you (the examiners) were here too.”</td></tr><tr><td>Realism</td><td>“The environment was realistic.”</td></tr><tr><td>Cyber Sickness</td><td>Physical side-effects</td><td>None present side effect like cyber-sickness or nausea</td></tr><tr><td>Expectations</td><td></td><td>“This system could be useful for several types of patients.”“I think it’s easier to train with this tool.”</td></tr></table> |
eea0a6a4010d559c5608f9786768c2f9502c010b4fe65189b83ab5001b85c322.png | complex | <table><tr><td></td><td colspan="6">Outdoor exposure from 10 am-4 pm corrected for protective factors (years; fifths)</td></tr><tr><td></td><td>< 0.073*</td><td>0.073 – 0.190</td><td>0.191 – 0.428</td><td>0.429 – 0.800</td><td>> 0.800</td><td><i>Trend test (p-value)</i><sup>‡</sup></td></tr><tr><td colspan="2">Pure nuclear (No. of cases = 100)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>2.37</td><td>3.36</td><td>2.02</td><td>3.19</td><td><i>0.05</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.88, 6.38)</td><td>(1.32, 8.54)</td><td>(0.75, 5.44)</td><td>(1.24, 8.21)</td><td></td></tr><tr><td colspan="2">Pure cortical (No. of cases = 40)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>0.55</td><td>0.58</td><td>0.51</td><td>0.29</td><td><i>0.09</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.18, 1.71)</td><td>(0.20, 1.72)</td><td>(0.16, 1.67)</td><td>(0.78, 1.09)</td><td></td></tr><tr><td colspan="2">Pure posterior (No. of cases = 62)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>0.76</td><td>1.01</td><td>0.58</td><td>0.57</td><td><i>0.23</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.27, 2.12)</td><td>(0.40, 2.56)</td><td>(0.21, 1.62)</td><td>(0.20, 1.60)</td><td></td></tr><tr><td></td><td colspan="6">Outdoor exposure from 10 am-4 pm (years; fifths)</td></tr><tr><td></td><td>< 0.312*</td><td>0.312 – 0.612</td><td>0.613 – 0.968</td><td>0.969 – 1.428</td><td>> 1.428</td><td><i>Trend test (p-value)</i></td></tr><tr><td colspan="2">Pure nuclear (No. of cases = 100)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>2.22</td><td>1.28</td><td>1.86</td><td>3.68</td><td><i>0.01</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.88, 5.61)</td><td>(0.47, 3.52)</td><td>(0.70, 4.91)</td><td>(1.50, 9.01)</td><td></td></tr><tr><td colspan="2">Pure cortical (No. of cases = 40)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>0.50</td><td>0.47</td><td>0.12</td><td>0.67</td><td><i>0.28</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.17, 1.44)</td><td>(0.16, 1.42)</td><td>(0.03, 0.55)</td><td>(0.22, 2.00)</td><td></td></tr><tr><td colspan="2">Pure posterior (No. of cases = 62)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR§</td><td>1</td><td>0.42</td><td>0.62</td><td>0.42</td><td>0.57</td><td><i>0.09</i></td></tr><tr><td>(95% CI)</td><td></td><td>(0.15, 1.16)</td><td>(0.24, 1.60)</td><td>(0.15, 1.14)</td><td>(0.22, 1.45)</td><td></td></tr></table> |
cb4e8996aadad123b3b7f07239f68c582dae775a7f0b364186672b1e66ed468d.png | complex | <table><tr><td></td><td colspan="2">Boys (N = 3,256)</td><td colspan="2">Girls (N = 3,158)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td> 9</td><td>476</td><td>14.6</td><td>482</td><td>15.3</td></tr><tr><td> 10</td><td>479</td><td>14.7</td><td>489</td><td>15.5</td></tr><tr><td> 11</td><td>473</td><td>14.5</td><td>475</td><td>15.0</td></tr><tr><td> 12</td><td>473</td><td>14.5</td><td>479</td><td>15.2</td></tr><tr><td> 13</td><td>454</td><td>13.9</td><td>426</td><td>13.5</td></tr><tr><td> 14</td><td>453</td><td>13.9</td><td>400</td><td>12.7</td></tr><tr><td> 15</td><td>448</td><td>13.8</td><td>407</td><td>12.9</td></tr><tr><td>School Type</td><td></td><td></td><td></td><td></td></tr><tr><td> Government</td><td>2,403</td><td>73.8</td><td>2,335</td><td>73.9</td></tr><tr><td> Catholic</td><td>655</td><td>20.1</td><td>677</td><td>21.4</td></tr><tr><td> Independent</td><td>198</td><td>6.1</td><td>146</td><td>4.6</td></tr><tr><td>SES</td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>310</td><td>9.7</td><td>272</td><td>8.8</td></tr><tr><td> Medium-low</td><td>1,230</td><td>38.5</td><td>1,197</td><td>38.6</td></tr><tr><td> Medium-high</td><td>914</td><td>28.6</td><td>886</td><td>28.6</td></tr><tr><td> High</td><td>742</td><td>23.2</td><td>748</td><td>24.1</td></tr><tr><td>Weight status*</td><td></td><td></td><td></td><td></td></tr><tr><td> Under/acceptable weight</td><td>2,899</td><td>89.0</td><td>2,778</td><td>88.0</td></tr><tr><td> Overweight</td><td>301</td><td>9.2</td><td>335</td><td>10.6</td></tr><tr><td> Obese</td><td>56</td><td>1.7</td><td>45</td><td>1.4</td></tr><tr><td>Parental Exercise</td><td></td><td></td><td></td><td></td></tr><tr><td> Both parents active</td><td>553</td><td>18.4</td><td>630</td><td>21.5</td></tr><tr><td> Mother active only</td><td>518</td><td>17.3</td><td>537</td><td>18.3</td></tr><tr><td> Father active only</td><td>627</td><td>20.9</td><td>565</td><td>19.3</td></tr><tr><td> Both parents inactive</td><td>1,303</td><td>43.4</td><td>1,196</td><td>40.9</td></tr><tr><td> Incomplete data</td><td>255</td><td>7.8</td><td>230</td><td>7.3</td></tr><tr><td>Number of sports</td><td></td><td></td><td></td><td></td></tr><tr><td> 0 sport</td><td>184</td><td>5.7</td><td>230</td><td>7.3</td></tr><tr><td> 1 sport</td><td>586</td><td>18.0</td><td>691</td><td>21.9</td></tr><tr><td> 2 sports</td><td>881</td><td>27.1</td><td>857</td><td>27.1</td></tr><tr><td> 3 sports</td><td>740</td><td>22.7</td><td>658</td><td>20.8</td></tr><tr><td> 4 sports</td><td>484</td><td>14.9</td><td>404</td><td>12.8</td></tr><tr><td> 5 sports</td><td>235</td><td>7.2</td><td>187</td><td>5.9</td></tr><tr><td> 6 sports</td><td>146</td><td>4.5</td><td>131</td><td>4.2</td></tr></table> |
ad5643c0542aff4cf52200574b8246b6b20c7f147a4911f8029b4706c762aead.png | complex | <table><tr><td>Synthesis feature</td><td>Traditional systematic review</td><td>Critical interpretive synthesis</td></tr><tr><td>Research question</td><td>• A research question is developed a priori and is not changed during the course of the research study.</td><td>• A compass question is developed, which can evolve over the course of the research study, in a transparent manner.</td></tr><tr><td>Literature search</td><td>• Exhaustive literature search</td><td>• Exhaustive literature search but can purposively sample literature outside of original search parameters</td></tr><tr><td rowspan="3">Article selection</td><td>• Static inclusion and exclusion criteria are applied to search results;</td><td>• Inclusion and exclusion criteria are iteratively refined to reflect the evolving compass questions (often through successive pilot testing of the criteria using small batches of references with the final criteria applied to all search results);</td></tr><tr><td>• Included articles are empirical studies and often consist only of a small number of specific methodological designs (e.g., RCT, CCT, observational studies); and</td><td>• Included articles can consist of both empirical and non-empirical (e.g., editorials, essays) analyses that offer insight into the topic under investigation (i.e., articles are not limited to those that meet certain design or quality criteria); and</td></tr><tr><td>• All relevant articles meeting inclusion criteria and minimum quality standard are included in the analysis.</td><td>• A purposive sample of eligible articles is typically selected based on the unique insights they can provide to the topic under investigation.</td></tr><tr><td>Quality rating of articles</td><td>• Quality ratings are usually applied to all articles included in a systematic review and used to help interpret the findings.</td><td>• Relevance ratings are applied to articles, not quality ratings (i.e., articles are rated on their ability to answer the compass question).</td></tr><tr><td rowspan="2">Synthesis</td><td>• Data is extracted from all studies meeting the inclusion criteria using an a priori approach; and</td><td>• Data is extracted from a purposive sample of studies using an analytic framework where the constructs are iteratively revised and reapplied to the included papers to ensure the constructs are grounded in the data; and</td></tr><tr><td>• Findings are synthesized either quantitatively (i.e., in a meta-analysis) or qualitatively, which typically involves reporting findings from studies according to the pre-defined outcomes of interest.</td><td>• The analytical constructs that emerged from the iterative analysis are used to derive an explanatory framework.</td></tr></table> |
eceb22f5f731eac85b63313fe0c59afbf31f1d2e5a9674865bec6f982af39ff1.png | simple | <table><tr><td>Model for total tibial cartilage volume</td><td>r<sup>2</sup></td><td>p Value for Δ r<sup>2 </sup>compared with the specified model</td><td>ΔF with addition to the model (p value for ΔF is the same as for Δr<sup>2</sup>)</td></tr><tr><td>Bone area only (+)</td><td>0.14</td><td>< 0.001</td><td>N/A</td></tr><tr><td>Bone area (+) age (-)</td><td>0.21</td><td>< 0.001 compared with bone area only</td><td>14.84</td></tr><tr><td>Bone area (+) age (-) smoking, alcohol</td><td>0.22</td><td>0.43 compared with bone area and age</td><td>0.86</td></tr><tr><td>Bone area (+) age (-) smoking, alcohol, BMI</td><td>0.22</td><td>0.53 compared with bone area, age, smoking and alcohol</td><td>0.39</td></tr><tr><td>Bone area (+) age (-) smoking, alcohol, ln hsCRP (-)</td><td>0.28</td><td>< 0.001 compared with bone area, age, smoking, alcohol</td><td>13.15</td></tr><tr><td>Bone area (+) age (-) smoking, alcohol, BMI ln hsCRP(-)</td><td>0.28</td><td>< 0.001 compared with bone area age smoking alcohol</td><td>7.23 (both variables added together); if BMI added first, ΔF = 0.43 (p for ΔF = 0.51) followed by lnCRP ΔF = 13.99, (p for ΔF < 0.001); if ln CRP added first, ΔF = 13.15, (p for ΔF < 0.001) followed by BMI ΔF = 1.28, (p for ΔF = 0.26)</td></tr></table> |
52721d02e4796cc1d74bc6ad8897f3ac3dad3b21f5c16fcc1afcabaf6c82f8a1.png | simple | <table><tr><td></td><td>No COPD</td><td></td><td>COPD</td><td></td><td>COPD/CHF</td></tr><tr><td>Number of beneficiaries</td><td>1,319,680</td><td></td><td>245,958</td><td></td><td>118,617</td></tr><tr><td> As % of all beneficiaries</td><td>84.30%</td><td></td><td>15.70%</td><td></td><td>7.60%</td></tr><tr><td>Personal Characteristics</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Females, %</td><td>59.70%</td><td></td><td>54.50%</td><td></td><td>55.10%</td></tr><tr><td>Age (yrs), mean (sd)</td><td>75.8 (7.3)</td><td></td><td>77.4 (7.2)</td><td></td><td>78.9 (7.4)</td></tr><tr><td>Medicare-Disabled/ESRD, %</td><td>7%</td><td></td><td>14%</td><td></td><td>16%</td></tr><tr><td>Bottom quartile household income,%</td><td>24%</td><td></td><td>30%</td><td></td><td>31%</td></tr><tr><td>Comorbidities</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Diabetes</td><td>21.00%</td><td></td><td>33.60%</td><td></td><td>44.70%</td></tr><tr><td>CHF</td><td>17.80%</td><td></td><td>48.20%</td><td></td><td>100.00%</td></tr><tr><td>Ischemic heart disease</td><td>35.50%</td><td></td><td>65.40%</td><td></td><td>84.60%</td></tr><tr><td> Atrial fibrillation</td><td>9.60%</td><td></td><td>20.60%</td><td></td><td>36.00%</td></tr></table> |
bdd19a33958b0f90da56868206791ba7afbe58f5f8700992f4015b74ceb44972.png | simple | <table><tr><td>Author</td><td>Cell line name</td><td>Species</td><td>Location</td></tr><tr><td>Hishikawa et al. [61]</td><td>SP cells</td><td>Mouse</td><td>Renal interstitial space</td></tr><tr><td>Challen et al. [62]</td><td>SP cells</td><td>Mouse</td><td>Proximal tubules</td></tr><tr><td>Inowa et al. [30]</td><td>SP cells</td><td>Human</td><td>Not identified</td></tr><tr><td>Dekel et al. [33]</td><td>Sca1<sup>+</sup> cells</td><td>Mouse</td><td>Nontubular</td></tr><tr><td>Gupta et al. [34]</td><td>MRPCs</td><td>Rat</td><td>Renal tubules</td></tr><tr><td>Maeshima et al. [4, 35]</td><td>LRC cells</td><td>Rat</td><td>Renal tubular cells</td></tr><tr><td>Oliver et al. [63]</td><td>Slow-cycling cells</td><td>Mouse, rat</td><td>Renal papilla</td></tr><tr><td>Bussolati et al. [36, 39]</td><td>CD133<sup>+</sup> CD24<sup>+</sup> cells</td><td>Human</td><td>Bowman's capsule, inner medullary papilla, S3 segment of proximal tubules, interstitium</td></tr><tr><td>Sallustio et al. [37, 38]</td><td>CD133<sup>+</sup> CD24<sup>+</sup> cells</td><td>Human</td><td>Tubules, glomerulus</td></tr><tr><td>Sagrinati et al. [64]</td><td>CD133<sup>+</sup> CD24<sup>+</sup> cells</td><td>Human</td><td>Bowman's capsule</td></tr><tr><td>Lindgren et al. [65]</td><td>CD133<sup>+</sup> CD24<sup>+</sup> cells</td><td>Human</td><td>Renal proximal tubules</td></tr><tr><td>Kitamura et al. [41]</td><td>KS cells</td><td>Rat</td><td>S3 segment of proximal tubules</td></tr></table> |
c224ebef39a383279ee96911d72304a7854e51813d6d07e235af3c1dcd8fa05a.png | simple | <table><tr><td>Classification</td><td>Co-biased as <i>At</i></td><td>Biased as <i>At </i>and <i>Aa</i></td><td>Co-biased as <i>Aa</i></td></tr><tr><td>Occurrence</td><td>219</td><td>302</td><td>325</td></tr><tr><td>Expected</td><td>173.1</td><td>419.2</td><td>253.7</td></tr></table> |
f7bea5f1ef69f59698d51e4e5dcd2445b2e9258005e35056cea966092e3be322.png | complex | <table><tr><td colspan="2">P300</td><td colspan="2">N400 & N100</td></tr><tr><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td><td>Amplitude (X)/Latency (L)</td><td>BVS Score</td></tr><tr><td>X > μ −σ</td><td>5</td><td>X < μ + σ</td><td>5</td></tr><tr><td>L < μ + σ</td><td></td><td>L < μ + σ</td><td></td></tr><tr><td>μ − 1.5σ < X < μ −σ</td><td>4</td><td>μ + 1.5σ > X > μ + σ</td><td>4</td></tr><tr><td>μ + 1.5σ > L > μ + σ</td><td></td><td>μ + 1.5σ > L > μ + σ</td><td></td></tr><tr><td>μ − 2σ < X < μ − 1.5σ</td><td>3</td><td>μ + 2σ > X > μ + 1.5σ</td><td>3</td></tr><tr><td>μ + 2σ > L > μ + 1.5σ</td><td></td><td>μ + 2σ > L > μ + 1.5σ</td><td></td></tr><tr><td>μ − 2.5σ < X < μ − 2σ</td><td>2</td><td>μ + 2.5σ > X > μ + 2σ</td><td>2</td></tr><tr><td>μ + 2.5σ > L > μ + 2σ</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>μ + 2.5σ > L > μ + 2σ</td><td></td></tr><tr><td>X < μ − 2.5σ</td><td>1</td><td>X > μ + 2.5σ</td><td>1</td></tr><tr><td>L > μ + 2.5σ</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>L > μ + 2.5σ</td><td></td></tr></table> |
ceb46f8ae4ac3888a3a491f1051b7118d5714d32ef831c45fc513b9274819df1.png | simple | <table><tr><td>Formulation</td><td><i>n</i></td></tr><tr><td>Drug type</td><td></td></tr><tr><td> Caffeine</td><td>0.60</td></tr><tr><td> Acetaminophen</td><td>0.66</td></tr><tr><td> Theophylline</td><td>0.71</td></tr><tr><td> Salicylic acid</td><td>0.73</td></tr><tr><td> Indomethacin</td><td>0.98</td></tr><tr><td>Cross-linker</td><td></td></tr><tr><td> 1:2</td><td>1.24</td></tr><tr><td> 1:4</td><td>1.25</td></tr></table> |
3c97df5cf0531551c9647b18bf52c26342efed6a6f3947a9832d987a3fee6656.png | complex | <table><tr><td></td><td colspan="2"></td><td colspan="2"></td><td colspan="8">Genotype calling</td></tr><tr><td>Read</td><td colspan="2">Read mapping</td><td colspan="2">Reference TR mapping</td><td colspan="2">Unmodified TR</td><td colspan="3">Homozygous VNTR</td><td colspan="3">Heterozygous VNTR†</td></tr><tr><td>Set</td><td>Sen</td><td>Spec</td><td>Sen</td><td>Spec</td><td>Sen</td><td>Spec</td><td>Sens</td><td>Spec</td><td>PPV</td><td>Sens</td><td>Spec</td><td>PPV</td></tr><tr><td>454 Exact (avg. 261 nt)</td><td>97.5%</td><td>99.6%</td><td>96.9%</td><td>99.2%</td><td>97.7%</td><td>100%*</td><td>95.8%</td><td>100%*</td><td>96.3%</td><td>84.2%</td><td>100%*</td><td>91.6%</td></tr><tr><td>454 Errors (avg. 261 nt)</td><td>90.1%</td><td>99.5%</td><td>94.7%</td><td>99%</td><td>93.7%</td><td>99.9%</td><td>91.9%</td><td>100%*</td><td>91.8%</td><td>76.6%</td><td>100%*</td><td>85.8%</td></tr><tr><td>Illumina Exact (100 nt)</td><td>94.5%</td><td>99.5%</td><td>96.8%</td><td>99.6%</td><td>95.0%</td><td>100%*</td><td>93.6%</td><td>100%*</td><td>98.1%</td><td>83.1%</td><td>100%*</td><td>86.5%</td></tr><tr><td>Illumina Errors (100 nt)</td><td>70.4%</td><td>97.7%</td><td>78.1%</td><td>97.4%</td><td>67.6%</td><td>100%*</td><td>64.8%</td><td>100%*</td><td>94.2%</td><td>47.3%</td><td>100%*</td><td>74.5%</td></tr></table> |
730837b3c7eab7f604bc8457c5bb3908f04510b6ce59d624f1d18513c9af7978.png | complex | <table><tr><td></td><td colspan="5">Time point</td></tr><tr><td>Parameter (unit)</td><td>Baseline</td><td>BL 10 ml∙kg<sup>− 1</sup></td><td>BL 20 ml∙kg<sup>− 1</sup></td><td>BL 30 ml∙kg<sup>− 1</sup> (haemorrhagic shock)</td><td>Resuscitation</td></tr><tr><td>MAP (mmHg)</td><td>117 (108; 122)</td><td>80 (74; 98)</td><td>44 (37; 72)</td><td>33 (30; 38)*</td><td>93 (76; 100)</td></tr><tr><td>HR (1∙min<sup>−1</sup>)</td><td>86 (85; 94)</td><td>98 (84; 108)</td><td>107 (77; 118)</td><td>107 (92; 131)</td><td>128 (112; 139)*</td></tr><tr><td>CI (L∙min<sup>−1</sup>∙m<sup>− 2</sup>)</td><td>2.5 (2.2; 2.7)</td><td>1.5 (1.4; 1.6)</td><td>1.2 (1.0; 1.9)</td><td>1.1 (0.8; 1.2)</td><td>3.0 (2.7; 3.8)<sup>#</sup></td></tr><tr><td>CVP (mmHg)</td><td>3 (1; 10)</td><td>6 (3; 9)</td><td>2 (0; 11)</td><td>0 (0; 6)</td><td>5 (1; 9)</td></tr><tr><td>SVI (ml∙m<sup>−2</sup>)</td><td>20 (22; 41)</td><td>17 (15; 23)</td><td>13 (9; 18)</td><td>11 (6; 21)</td><td>24 (22; 24)</td></tr><tr><td colspan="6">Retinal microcirculation (OCT-A)</td></tr><tr><td> Flow density<sub>WF</sub> (%)</td><td>44.7 (40.3; 50.5)</td><td>44.1 (36.5; 49.7)</td><td>38.7 (22.2; 44.1)</td><td>34.5 (32.8; 40.4)*</td><td>46.9 (41.7; 50.7)<sup>#</sup></td></tr><tr><td> Flow density<sub>Central</sub> (%)</td><td>45.2 (36.7; 48.6)</td><td>43.4 (34.3; 46.4)</td><td>39.2 (21.3; 42.2)<sup>§</sup></td><td>32.5 (32.2; 40.0)<sup>§</sup></td><td>48.6 (38.4; 50.3)</td></tr></table> |
80382facaa9a60f92de1046b4a8ee97a2956d0b75c4f84835036aebf782c1532.png | complex | <table><tr><td colspan="5">Electrochemical Aptasensors Applied for Food Safeguard</td></tr><tr><td>Analyte</td><td>Matrix</td><td>Method details</td><td>Linear range and LOD</td><td>Reference</td></tr><tr><td><i>Salmonella Typhimurium</i></td><td>Pork</td><td>EIS based on AuNPs and GO</td><td>2.4–2.4 × 10<sup>3</sup> CFU/mL, 3 CFU/mL</td><td>[17]</td></tr><tr><td><i>Staphylococcus aureus</i></td><td>Pig Skin</td><td>Potentiometry using SWCNT</td><td>800 CFU/mL</td><td>[18]</td></tr><tr><td>Lysozyme</td><td>wine</td><td>Aptamer–antibody diazonium coupling, DPV</td><td>5 fM–5 nM, 4.3 fM</td><td>[21]</td></tr><tr><td>Ochratoxin A</td><td>cocoa beans</td><td>Anti-OTA-aptamer on SPCE, EIS</td><td>0.15–2.5 ng/mL, 0.15 ng/mL</td><td>[22]</td></tr><tr><td>Aflatoxin M1</td><td>Milk</td><td>Hexaethyleneglycol modified aptamers on SPE, EIS</td><td>2–150 ng/L, 1.15 ng/mL</td><td>[23]</td></tr><tr><td>Aflatoxin B1</td><td>Alcoholic beverage</td><td>MB-tagged aptamer on SPCE, hexamethylenediamine and carbodiimide, DPV</td><td>0.05–6.0 ng/mL, 0.05 ng/mL</td><td>[6]</td></tr><tr><td>Kanamycin</td><td>Milk</td><td>Aptamer on SPCE, EIS</td><td>1.2–75 ng/mL, 0.11 ng/mL</td><td>[25]</td></tr></table> |
683cea178fd03d1db416d9b3a863283f00c489c495f52f9558d2ac64e8bf2db6.png | complex | <table><tr><td>Item</td><td>Budget share</td><td>Expenditure</td><td colspan="3">Prices</td></tr><tr><td></td><td></td><td></td><td>Cigarettes</td><td>Alcohol</td><td>Betel nuts</td></tr><tr><td></td><td></td><td>1.0062</td><td>-0.6517</td><td><i>-0.2503</i></td><td><i>-0.1041</i></td></tr><tr><td>Cigarettes</td><td>0.439</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>(4.708)**</td><td>(-6475)**</td><td>(-2.842)**</td><td>(-2.526)**</td></tr><tr><td></td><td></td><td>0.8104</td><td><i>-0.1881</i></td><td>-0.5871</td><td><i>-0.0351</i></td></tr><tr><td>Alcohol</td><td>0.401</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>(2.433)**</td><td>(-1.247)</td><td>(-4.407)**</td><td>(-0.546)</td></tr><tr><td></td><td></td><td>1.4578</td><td><i>-0.4840</i></td><td><i>-0.3476</i></td><td>-0.6261</td></tr><tr><td>Betel nuts</td><td>0.160</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td>(1.116)</td><td>(-0.857)</td><td>(-0.857)</td><td>(-2.481)**</td></tr></table> |
2c7791ff4aabc1b107e3704d0d29a3b6ffbdfd2e696f26d599a8c939770885ec.png | complex | <table><tr><td colspan="2">Demographic variables</td><td>N*</td><td>%</td><td colspan="2">Demographic variables</td><td>N*</td><td>%</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>110</td><td>24.6</td><td rowspan="4">Age in years</td><td>21-30</td><td>92</td><td>20.6</td></tr><tr><td>Female</td><td>338</td><td>75.4</td><td>31-40</td><td>152</td><td>33.9</td></tr><tr><td rowspan="2">Marital status</td><td>Married</td><td>386</td><td>86.2</td><td>41-50</td><td>161</td><td>35.9</td></tr><tr><td>Others</td><td>62</td><td>13.8</td><td>>50</td><td>43</td><td>9.6</td></tr><tr><td rowspan="5">Occupation</td><td>Administrative staff</td><td>43</td><td>9.6</td><td rowspan="5">Years worked</td><td>≤5</td><td>84</td><td>18.8</td></tr><tr><td>General practitioner</td><td>138</td><td>30.9</td><td>6-10</td><td>55</td><td>12.3</td></tr><tr><td>Public health physician</td><td>105</td><td>23.4</td><td>11-15</td><td>57</td><td>12.7</td></tr><tr><td>Nurse</td><td>122</td><td>27.2</td><td>16-20</td><td>66</td><td>14.7</td></tr><tr><td>Other</td><td>40</td><td>8.9</td><td>≥21</td><td>186</td><td>41.5</td></tr><tr><td rowspan="4">Working hours (per week)</td><td>≤40</td><td>212</td><td>47.3</td><td rowspan="4">Monthly income (RMB)</td><td><2000</td><td>186</td><td>41.5</td></tr><tr><td>41-48</td><td>140</td><td>31.3</td><td>2000-2999</td><td>194</td><td>43.3</td></tr><tr><td>49-56</td><td>62</td><td>13.8</td><td>3000- 3999</td><td>58</td><td>12.9</td></tr><tr><td>>56</td><td>34</td><td>7.6</td><td>≥4000</td><td>10</td><td>2.3</td></tr><tr><td rowspan="4">Title</td><td>Senior</td><td>88</td><td>19.6</td><td rowspan="4">Educational background</td><td>High school or below</td><td>92</td><td>20.5</td></tr><tr><td>Middle</td><td>190</td><td>42.4</td><td>Junior college</td><td>185</td><td>41.3</td></tr><tr><td>Junior</td><td>144</td><td>32.1</td><td>College and above</td><td>171</td><td>38.2</td></tr><tr><td>No title</td><td>26</td><td>5.9</td><td></td><td></td><td></td></tr></table> |
beca684708eb080eee0b29656ef4a3092865bbeca3085a1d5d795a6583af70a2.png | simple | <table><tr><td></td><td>Open abdominal wall hernia repair</td><td>Laparoscopic abdominal wall hernia repair</td></tr><tr><td>Hematoma</td><td>6 %</td><td>1 %</td></tr><tr><td>Seroma</td><td>4 %</td><td>3 %</td></tr><tr><td>Visceral lesions</td><td>0</td><td>0</td></tr><tr><td>Sub-occlusion</td><td>0</td><td>0</td></tr><tr><td>Respiratory infections</td><td>1 %</td><td>0</td></tr><tr><td>Infections of prosthesis</td><td>0</td><td>0</td></tr><tr><td>Fascial necrosis</td><td>0</td><td>0</td></tr><tr><td>Postop. Pain (6 mesi)</td><td>3 %</td><td>1 %</td></tr><tr><td>Recurrence</td><td>7 %</td><td>4 %</td></tr><tr><td>Mortality</td><td>0</td><td>0</td></tr></table> |
aca29999ed6637e5174654fb88981743e82d17502048b06f9f6d6e946f3f397b.png | complex | <table><tr><td></td><td colspan="4">Pearson Correlation (r) with Sleep Quality Scale (-)</td></tr><tr><td></td><td colspan="2">Study 1056</td><td colspan="2">Study 1077</td></tr><tr><td></td><td>r</td><td>p-value</td><td>r</td><td>p-value</td></tr><tr><td>Average Daily Diary Pain Numeric Rating Scale (-)</td><td>0.64</td><td><0.001</td><td>0.58</td><td><0.001</td></tr><tr><td>MOS Sleep Scales</td><td></td><td></td><td></td><td></td></tr><tr><td> Sleep Disturbance (-)</td><td>0.45</td><td><0.001</td><td>0.42</td><td><0.001</td></tr><tr><td> Snoring (-)</td><td>0.01</td><td>0.884</td><td>0.00</td><td>0.993</td></tr><tr><td> Awaken Short of Breath or with Headache (-)</td><td>0.21</td><td><0.001</td><td>0.14</td><td><0.001</td></tr><tr><td> Quantity of Sleep (+)</td><td>-0.31</td><td><0.001</td><td>-0.34</td><td><0.001</td></tr><tr><td> Sleep Adequacy (+)</td><td>-0.21</td><td><0.001</td><td>-0.32</td><td><0.001</td></tr><tr><td> Somnolence (-)</td><td>0.11</td><td>0.004</td><td>0.15</td><td><0.001</td></tr></table> |
cdaef0d21c253142cdcaf8ac612fed4104682cf1fef783337f9cf40a52f3785b.png | simple | <table><tr><td>Isolate ID</td><td>Laccase (4<sup>th</sup>day)</td><td>Lipase (3<sup>rd</sup>day)</td><td>Cellulase (3<sup>rd</sup>day)</td><td>Source of isolation</td><td>Depth (m)</td></tr><tr><td>PKU F1</td><td>-</td><td>+</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F2</td><td>+</td><td>-</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F3</td><td>+</td><td>++</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F4</td><td>++</td><td>+</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F5</td><td>-</td><td>++</td><td>-</td><td>Sediment</td><td>0</td></tr><tr><td>PKU F6</td><td>-</td><td>-</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F7</td><td>++</td><td>+</td><td>++</td><td>Sediment</td><td>0</td></tr><tr><td>PKU F8</td><td>-</td><td>+</td><td>++</td><td>Sediment</td><td>0</td></tr><tr><td>PKU F9</td><td>-</td><td>++</td><td>++</td><td>Sediment</td><td>0</td></tr><tr><td>PKU F10</td><td>+</td><td>-</td><td>-</td><td>Sediment</td><td>0</td></tr><tr><td>PKU F11</td><td>+</td><td>++</td><td>+++</td><td>Seawater</td><td>10</td></tr><tr><td>PKU F12</td><td>-</td><td>++</td><td>++</td><td>Seawater</td><td>10</td></tr><tr><td>PKU F13</td><td>-</td><td>++</td><td>+++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F14</td><td>++</td><td>+++</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F15</td><td>+</td><td>-</td><td>-</td><td>Seawater</td><td>10</td></tr><tr><td>PKU F16</td><td>+++</td><td>+++</td><td>++</td><td>Seawater</td><td>5</td></tr><tr><td>PKU F17</td><td>-</td><td>++</td><td>+</td><td>Seawater</td><td>10</td></tr><tr><td>PKU F18</td><td>+++</td><td>+</td><td>+++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F19</td><td>-</td><td>+</td><td>-</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F20</td><td>++</td><td>++</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F21</td><td>+</td><td>++</td><td>-</td><td>Seawater</td><td>0</td></tr><tr><td>PKU F22</td><td>-</td><td>+++</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y1</td><td>-</td><td>++</td><td>+</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y2</td><td>-</td><td>+</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y3</td><td>-</td><td>++</td><td>+</td><td>Seawater</td><td>10</td></tr><tr><td>PKU Y4</td><td>-</td><td>+</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y5</td><td>-</td><td>++</td><td>++</td><td>Seawater</td><td>10</td></tr><tr><td>PKU Y6</td><td>-</td><td>++</td><td>++</td><td>Seawater</td><td>5</td></tr><tr><td>PKU Y7</td><td>-</td><td>-</td><td>++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y8</td><td>-</td><td>+++</td><td>+++</td><td>Seawater</td><td>0</td></tr><tr><td>PKU Y9</td><td>-</td><td>++</td><td>++</td><td>Seawater</td><td>10</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.